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Abstract 
 
In recent years, considerable attention has been given to chitosan (CS)-based 
biomaterials and their applications in the field of soft tissue engineering (TE). CS is a 
glycosaminoglycan derived from chitin, the primary structural polymer in crustacean 
exoskeletons. CS is biocompatible, biodegradable, easily formed into various structures 
(i.e. sponges, nanofibers and films) under mild processing conditions and can be 
chemically modified through graft copolymerization and crosslinking. However, the rapid 
degradation of CS and its low mechanical strength are concerns that may limit its use in 
clinical applications. 
In the first part of the thesis, different non cytotoxic crosslinkers were used aiming at 
improving the structural properties of CS. Genipin (GP), γ-
glycidoxypropyltrimethoxysilane (GPTMS), dibasic sodium phosphate (DSP) were selected 
as biocompatible CS crosslinkers as reported in literature. After a preliminary physico-
chemical and mechanical characterization, the proper crosslinking compounds were 
selected for the development of different typologies of CS scaffolds for both human and 
veterinary applications. 
CS- based scaffolds were developed as nerve guidance channels (NGCs)  and internal 
fillers fabrication to promote peripheral nerve regeneration in humans. Two CS based 
hollow NGCs were prepared and tested in vitro and in vivo (coded as CS flat membrane 
and bi-layer CS membrane) and a CS based nanostructured internal filler was optimized 
and characterized in vitro. 
i. CS flat membranes were prepared by solvent casting. According to the results 
obtained in the first part of the thesis, DSP alone (CS/DSP) or in association with the 
GPTMS (CS/GPTMS_DSP) were used as crosslinkers. CS crosslinked membranes 
showed permeation to nutrients and did not exert any cytotoxic effect on RT4-D6P2T. 
The higher mechanical stability of CS/GPTMS_DSP under wet state allowed to confirm 
the RT4-D6P2T attachment and proliferation as well as the neurite outgrowth of dorsal 
root ganglia (DRG) on CS substrates. Before in vivo implantation in rats, 
CS/GPTMS_DSP and CS/DSP membranes were easily rolled up to form a NGC. Then, 
membranes were used to bridge median nerve defects in rats. After 12 week post-
operative CS/GPTMS_DSP tubes were found to be detached from the distal suturing 
site and functional recovery did not occurred. On the other hand, crushed nerve 
encircled with CS/DSP membranes, allowed nerve fibre regeneration and functional 
recovery, showing similar results to autografts. 
ii. Bi-layer CS membranes were developed using a two-step coating technique. CS/DSP 
and CS/GPTMS_DSP flat membranes were combined to produce scaffold structures 
with good biocompatibility in the inner layer (CS/DSP) and with the desired mechanical 
strength imparted by the outer (CS/GPTMS_DSP, GPTMS 25% wt./wt.). Gradual water 
xvii 
 
uptake and permeation to small molecules was observed compared to single layers. 
From in vivo tests, median nerves treated with bi-layer tubes displayed regenerated 
and aligned fibres at the injury site. 
iii. CS crosslinked electrospun nanofibres were fabricated by electrospinning solutions 
containing CS, polyethylene oxide (PEO), and dimethylsulphoxide (DMSO). PEO and 
DMSO were introduced to allow the spinnability of CS solutions at high polymer 
concentration with controllable fiber size and increase fiber yields by relaxing CS chain 
entanglement. Optimization of the process and solution parameters allowed to obtain 
CS nanofibres with size of 128±17 nm. To increase CS stability in aqueous media, DSP 
was used as crosslinker After DSP crosslinking fibre size decreased to 109±17 nm while 
an increase in the mechanical strength (E, from 63±10 MPa to 113±8 MPa) was 
observed compared to uncrosslinked nanofibrous matrices. 
In the third part of the thesis, CS porous membranes with improved antimicrobial 
properties were prepared for veterinary application. The developed scaffolds were 
fabricated by freeze-drying to promote the wound healing process and to reduce the 
bacterial proliferation in chelonian shell injury site. Different ratios of silver nanoparticles 
(AgNPs, 5%, 10% and 15% wt. /wt.) and gentamicin sulphate (GS, 3.5 mg/ml) were loaded 
into the CS/GPTMS_DSP membranes to impart the proper antibacterial properties and to 
favor drug release avoiding the risk of systemic toxicity. After a preliminary in vitro 
characterization, CS/GPTMS_DSP loaded with AgNPs at a concentration of 10% wt./wt 
(CS/GPTMS_DSP_AgNP10) was selected as ideal candidate for this application field. GS 
release profile from CS/GPTMS_DSP_GS evidenced high burst release of the antibiotics in 
the first day (about 70%). Finally, GS and AgNPs (10 % wt./wt.) effect on bacterial 
inhibition was evaluated and confirmed against Gram+ and Gram-. 
The results reported in this thesis work demonstrate that CS is a promising candidate for 
applications in human and veterinary soft TE. Mechanical and physico-chemical 
properties of CS scaffolds can be tuned by using different crosslinking methods. By the in 
vitro characterization, GPTMS and DSP were selected as ideal compounds to the 
development of scaffolds for peripheral nerve regeneration (in human) and wound 
healing (in animals). Four different morphologies (3 for peripheral nerve regeneration and 
1 for wound healing application) were obtained by varying the fabrication methods and 
the final composition. All membranes were found to satisfy the requirements for the 
application of interest. CS based membranes developed for peripheral nerve regeneration 
were found to be biocompatible, and successful functional recovery was observed in case 
of CS/DSP and bi-layer membranes. Porous membranes with improved antimicrobial 
properties were prepared to enhance wound healing in chelonians and were found to be 
effective against a broad spectrum of bacteria following the release of two different 
investigated antimicrobial agents (AgNPs and GS). 
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Executive Summary 
 
Repair and regeneration of tissues and organs using biomaterials, cells and/or growth 
factors is the ultimate goal of tissue engineers. One of the main challenges in tissue 
regeneration is to closely mimic the structures and properties of native tissues. In this 
context, in recent years, considerable attention has been given to chitosan based 
materials and their applications in the field of soft tissue engineering. Chitosan (CS) is a 
natural polymer from renewable resources, obtained from shell of shellfish that exhibits 
outstanding properties such as a marked biocompatibility, biodegradability and 
antibacterial activity. Due to these promising biological features and its easy chemical 
modification and processability into 2D and 3D scaffolds (i.e. gel, films, nanofibers, 
sponges, nanoparticles), CS has been investigated for wound dressing, drug delivery 
system and soft tissue engineering among which cartilage, liver, peripheral nerve and 
vascular field applications [1]. CS matrices present few drawbacks that limit their use in 
clinical applications such as low mechanical strength and low structural integrity under 
physiological condition. The improvement of CS properties can be achieved by modifying 
CS with different crosslinking agents (i.e. glutaraldehyde, γ-
glycidoxypropyltrimethoxysilane, tripolyphosphate, genipin) [2-5] or by combining the 
natural polymer to synthetic ones (i.e. poly(ε-capolactone), poly(vinyl alcohol), 
polyethylenoxide) [6, 7]. Blending with synthetic polymers can introduce a residue of 
solvents and other compounds/impurities that can damage the natural polymers and 
consequently affect cell growth and proliferation. For this reason, in the first part of the 
thesis, CS was crosslinked using different ionic and covalent compounds with the aim to 
provide the basis for the selection of a crosslinking strategy able to impart the required 
properties to CS membranes in the design of a biomaterial. CS crosslinked flat 
membranes were prepared via solvent casting following the addition of different 
crosslinking agents: genipin (GP), γ-glycidoxypropyltrimethoxysilane (GPTMS), dibasic 
sodium phosphate (DSP) and a combination of GPTMS and DSP (GPTMS_DSP). The three 
crosslinkers were selected since literature data reported interesting biological properties 
using these agents compared to others (epoxy compounds, aldehydes and 
carbodiimides). Although many works reported the use of crosslinked CS membranes, a 
complete characterization and comparison of CS membranes crosslinked with different 
biocompatible agents is still lacking. 
A chemico-physical and mechanical characterization of CS crosslinked samples (CS/GP, 
CS/GPTMS, CS/DSP and CS/GPTMS_DSP) was performed. CS membranes showed that the 
presence of GP or GPTMS did not affect the surface wettability but improved the 
mechanical resistance and the stability of CS samples in aqueous environment. On the 
contrary, DSP addition contributed to increase the hydrophilicity, the water uptake and 
the flexibility of CS. The simultaneous use of GPTMS and DSP allowed to combine the 
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features obtained both from GPTMS and DSP crosslinkers. From the obtained results, the 
proper crosslinking agents were selected for the development of different typologies of 
CS scaffolds for both human and veterinary applications in soft tissue engineering (Fig. 1). 
In the second part of the thesis, biocompatible and biodegradable innovative devices 
based on CS were developed to promote peripheral nerve regeneration in humans. 
Peripheral nerve regeneration is a challenging scientific field with relevant clinical and 
socioeconomic implications, since nerve injuries may lead to a lifelong function 
impairment and pain that may seriously compromise the quality of life. Transected 
peripheral nerve fibres are able to regenerate reaching functional recovery when an 
appropriate microenvironment is provided. Unfortunately, severe trauma often cause 
abundant substance loss and inherent regeneration is not possible; therefore, alternative 
surgical techniques should be used to bridge the proximal and distal stumps. Modern 
bioengineering and TE approaches are currently focused on the development of devices 
that provide an appropriate microenvironment to support and enhance the regeneration 
process [8]. Nerve guidance channels (NGCs) are a promising growth permissive substrate 
having nanostructured topography, haptotactic cues (ECM proteins), chemotactic cues 
(neurotrophic factors) that support Schwann cells or stem cells. Advances in engineered 
NGCs are directed to mimic the properties of natural tissues using multifunctional 
materials and/or conduits that can solve the limitations associated with traditional 
surgical approaches (short gap length, lay regeneration time, possible neuroma 
formation). Among the various biomaterials investigated, CS seems to be an ideal 
candidate for nerve regeneration due to its similarity in the molecular structure to GAGs 
and its neuroprotective properties. 
For this purpose, three different CS crosslinked membranes were developed to favor 
Schwann cells adhesion and proliferation as well as nerve functional recovery. Different 
morphologies were obtained by varying the fabrication methods and the final 
composition. Two alternative for CS based hollow nerve guide channels were developed 
and tested in vitro and in vivo (coded as CS flat membrane and bi-layer CS membrane) 
while a CS based nanostructured internal filler was optimized and characterized in vitro. 
CS flat membranes were prepared using DSP alone (CS/DSP) or in association with the 
GPTMS (CS/GPTMS_DSP) as crosslinkers. The constituent ratio of crosslinking agents and 
CS was selected in the first part of the thesis to obtain a composite material having both 
proper mechanical properties and good biocompatibility. CS/DSP and CS/GPTMS_DSP flat 
membranes were produced by solvent casting and they could be easily enwrapped to 
form a NGC in wet state (Fig. 1A). The developed membranes allowed nutrient 
permeation and were found not to exert any cytotoxic effect on RT4-D6P2T. The higher 
mechanical stability of CS/GPTMS_DSP under physiological condition allowed to evaluate 
and confirmed the RT4-D6P2T adhesion, proliferation and function on the biomaterial. 
Moreover, CS/GPTMS_DSP showed to direct RT4-D6P2T attachment resulting in 
characteristic cell morphology typical of SCs, and to support the neurite outgrowth of 
dorsal root ganglia (DRG) cultured on this substrate. The easily manipulation and 
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suturability of both the developed conduits allowed to perform in vivo tests. Membranes 
were used for bridge implantation across 10-mm long median nerve defects in rats, and 
the outcome of peripheral nerve repair at 12 weeks post-implantation was evaluated by a 
combination of electrophysiological assessment, immunohistochemical and histological 
investigation. During in vivo tests CS/GPTMS_DSP tubes were detached from the distal 
suturing site and functional recovery did not occurred as confirmed by confocal laser 
microscopy which displayed poor axonal regeneration and irregular orientation. On the 
other hand, crushed nerve encircled with CS/DSP membranes, allowed nerve fibre 
regeneration and functional recovery, with effects approaching those elicited by nerve 
autografts, which are generally considered as the gold standard for treating large 
peripheral nerve defects.  
Bi-layer CS membranes were developed by combining two kinds of CS flat 
membranes. They were crosslinked with different agents to produce scaffold structures 
with good biocompatibility in the inner layer and with the desired mechanical strength 
(following the addition of GPTMS) imparted by the outer one. In detail, CS/DSP and 
CS/GPTMS_DSP were selected for the realization of the internal and external layer, 
respectively. The amount of GPTMS was lowered from 50 wt.% to 25wt.% to allow the 
rolling up, suturability of bi-layer membranes and to reduce the risk of distal detachment 
(Fig. 1B). The developed membranes were prepared by a two-step coating technique 
method, which allowed to control the wall thickness and to achieve a tight connection 
between the two distinct layers. The single layers interacted during the double layer 
fabrication process as confirmed physico-chemical analysis. The preliminary 
characterization of the developed membranes showed an increase in the surface 
wettability of the inner layer (41°±9°) and improved mechanical properties compared to 
CS/DSP, associated to the presence of GPTMS in the external layer. Bi-layer samples also 
exhibited slower swelling rate and permeation to model molecules (Stokes radius around 
14 Å) compared to single layer inferring that the developed scaffold may be suitable for 
slow release of GFs and drug delivery application. Finally, preliminary in vivo tests were 
carried out on the bi-layer fat membranes for bridge implantation across 10-mm long 
median nerve defects in rats. After 12 weeks post-operative, nerves treated with bi-layer 
tubes displayed regenerated and aligned fibers at the injury site through light and 
transmission electron microscopy and observation as well as immunohistochemistry 
analysis (Fig. 2). 
CS crosslinked electrospun nanofibres mimicking the complex biological structures of 
the natural extracellular matrix (ECM) were prepared from acetic acid solutions. CS 
nanofibres were fabricated by electrospinning solutions containing CS, polyethylene oxide 
(PEO), and dimethylsulphoxide (DMSO). PEO is a biocompatible synthetic polymer and 
was used to allow the spinnability of CS solutions at high polymer concentration with 
controllable fiber size; DMSO was introduced into the CS/PEO solution as a co-solvent to 
improve processing conditions and increase fiber yields by relaxing CS chain 
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entanglement. Optimization of the process and solution parameters allowed to obtain CS 
nanofibres with size around 130 nm. To increase CS stability in aqueous media, DSP was 
used as crosslinker (Fig. 1C). DSP crosslinking did not modify the nanofibre matrix 
morphology but decreased fibre size from 128±17 nm to and 109±17 nm, respectively. 
The presence of DSP increased the mechanical strength (E, from 63±10 MPa to 113±8 
MPa) and the structural integrity of CS crosslinked nanofibres compared to uncrosslinked 
nanofibrous matrices. 
In the third part of the thesis, the possibility to apply CS as biomaterial for antibacterial 
membranes for veterinary application was investigated. CS membranes were fabricated 
with the aim to promote wound healing in chelonians by reducing the bacterial 
proliferation at the wound site.  
Skin TE is an emerging field in veterinary application: the development of biodegradable 
membranes apart from their fundamental protective functions could be conductive in 
wound regeneration, and would be able to shorten the healing process of the epidermis 
and skin of animals. Moreover, application of dressing materials based on natural 
products with improved antimicrobial properties could stimulate the healing processes. 
Consequently the damaged skin will be regenerated, limiting the systemic use of 
antibiotics. Antibiotic side-effects often result in wrong action or even damage to the 
patient’s kidney and liver, and decrease of the bacterial proliferation at the wound site. In 
this thesis work, CS porous membranes with improved antimicrobial properties were 
fabricated by freeze-drying to promote the wound healing process and reduce the 
bacterial proliferation in injured chelonian shells. To increase CS mechanical properties 
and biocompatibility, GPTMS and DSP crosslinkers were added to the CS solution 
(CS/GPTMS_DSP). The constituent ratio of crosslinking agents and CS was selected 
according to the results of the first part of the thesis. Different ratios of silver 
nanoparticles (AgNPs, 5%, 10% and 15% wt./wt. respect to the total amount of CS) and 
gentamicin sulphate (GS, 3.5 mg/ml dosage selected according to the conventional 
veterinary treatment for chelonian carapace healing) were incorporated into the CS 
matrices to impart the proper antibacterial properties and guarantee drug controlled 
release in time and in space avoiding the risk of systemic toxicity. Mechanical 
characterization performed on samples showed that the incorporation of AgNPs or GS 
enhanced the stiffness of CS/GPTMS_DSP samples. Moreover, a strict correlation was 
observed between the Young modulus and the amount of AgNPs incorporated into the 
membranes: E increased as the AgNPs concentration shifted from 5% wt. to 15 wt.%. The 
high swelling degree was observed for all samples loaded with the antimicrobial agent 
reaching final values of about 1200-1300 % and 950% for AgNPs and GS loaded 
membranes, after 24 hours of incubation in physiological solution, respectively. The 
incorporation of the antimicrobial agents into CS/GPTMS_DSP affected the surface 
morphologies of porous membranes: pore occlusion on the surface of CS based 
membranes containing AgNPs was detected, by increasing the amount of AgNPs. For this 
reason, CS/GPTMS_DSP loaded with AgNPs at a concentration of 10% wt./wt 
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(CS/GPTMS_DSP_AgNP10) was selected as the ideal candidate for this application. GS 
release profile from CS/GPTMS_DSP loaded with the antibiotics evidenced a high burst 
release of the antibiotics in the first 24 hours (about 70% with respect to the GS loaded 
into the membranes), followed by a gradual release at a decreasing rate over time. 
Finally, the effect of GS and AgNPs (10 % wt./wt., optimized concentration) on bacterial 
inhibition was evaluated. The presence of either AgNPs or GS improved the antimicrobial 
activity of CS based porous membranes. GS loaded samples were highly efficient against 
E. coli, S. aureus and E. fecalis strains while CS/GPTMS_DSP_AgNP10 increased the 
inhibitory effect against P. aeruginosa and P. mirabilis bacteria compared to control and 
GS loaded samples (Fig. 3). 
 
Fig. 1 Different morphologies of CS based scaffolds for peripheral nerve regeneration (A, B, C) and 
wound healing (D). Image of CS/DSP (A) and bi-layer membranes (B) before in vivo implantation; 
B) SEM image of CS crosslinked nanofibres; D) SEM image of the fracture section of 
CS/GPTMS_DSP porous membranes loaded with GS. 
 
Fig. 2.Peripheral nerve regeneration using bi-layer membranes after 12 weeks post-operative. A) 
Bi-layer membrane after implantation. B) Electron microscope images of regenerated nerves and 
C) neurofilament staining on longitudinal sections confirmed peripheral nerve regeneration by the 
formation of aligned and oriented fibres form the proximal to the distal stump. 
 
Fig. 3. Kinetics of growth inhibition of S. Aureus, E. Coli, E. Fecalis, P. aeruginosa and P. mirabilis in 
presence CS/GPTMS_DSP, CS/GPTMS_DSP_GS and CS/GPTMS_DSP_AgNP10. AgNPs or GS loaded 
into CS porous membranes increased the antibacterial activity against five different bacteria 
strains. 
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Introduction to the Thesis Format 
 
This thesis is divided into V sections, containing globally 9 chapters (5 of them describing 
the experimental work performed): the content of each section is summarized below. 
Section I (Chapter 1) gives an overview of the current state of the art of chitosan-based 
materials focusing on their application in soft tissue engineering, wound dressing and 
drug delivery. The section finishes with the definition of thesis goals. 
Section II (Chapter 2) describes the preparation and characterization of chitosan flat 
membranes using different crosslinking agents that are applied to improve chitosan 
mechanical strength and stability under physiological conditions. Chitosan films are 
obtained by solvent casting of the polymer solution crosslinked using genipin, γ-
glycidoxypropyltrimethoxysilane, dibasic sodium phosphate and a combination of γ-
glycidoxypropyltrimethoxysilane and dibasic sodium phosphate. The possibility to tailor 
the final properties of CS scaffolds through crosslinking is a key strategy to apply CS in 
different biomedical and tissue engineering applications optimizing the materials features 
to the biological and surgical requirements. 
Section III presents an overview of the current state of the art on peripheral nerve tissue 
engineering, focusing on all the scientific and technological aspects, which have been 
demonstrated to be crucial for a successful approach within this field, as well as some 
brief insights on future trends (Chapter 3). Section III is also focused on the preparation 
and characterization of flat membranes (Chapter 4), bi-layer membranes (Chapter 5) and 
nanofibrous structures (Chapter 6) that can be applied as artificial conduits or internal 
fillers for peripheral nerve repair after injuries. In Chapter 4, chitosan flat membranes are 
prepared by solvent casting of a chitosan solution crosslinked with dibasic sodium 
phosphate and a combination of γ-glycidoxypropyltrimethoxysilane and dibasic sodium 
phosphate. The flat membranes show permeability to nutrients and suitable biological 
properties, both in vitro and in vivo, for their use in clinical application. Chapter 5 
describes the fabrication of bi-layer membranes by solvent casting with the aim to 
produce scaffold structures with good biocompatibility in the inner layer and with the 
desired mechanical strength protruded by the outer. The multi-component membranes 
show a tight connection between the two layers, permeability to nutrients and promote 
peripheral nerve regeneration. In Chapter 6 crosslinked chitosan nanofibres are prepared 
by electrospinning to be used as internal filler to favor Schwann cells adhesion and 
proliferation. 
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Section IV describes the current state of the art on wound healing and skin tissue 
engineering, focusing the attention on advanced wound management dressings, their key 
advantages and shortcomings, which have been demonstrated to be crucial for a 
successful approach within this field (Chapter 7). Within this section, the preparation and 
characterization of chitosan porous membranes with improved antimicrobial properties 
for the treatment of chelonian shell injuries is described (Chapter 8). Porous membranes 
loaded with silver nanoparticles and gentamicin sulphate are prepared via freeze-drying 
technique with the aim to promote wound healing and to reduce the bacterial 
proliferation in chelonians after carapace lesions. The membranes loaded with 
gentamicin or silver nanoparticles show good bactericidal activity against both of Gram+ 
and Gram- bacteria. Preliminary in vivo tests are carried out on Testudo Hermanni for 
both the two typologies of membranes. 
Finally, Section V (Chapter 9) presents the main achievements of the work against the 
scope of the present thesis drawing general conclusions and indications for future work.  
 
 
 
 
 
Section I 
 
Chitosan as a biomaterial 
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Chapter 1 
Chitosan based biomaterials: state of the 
art and future perspective in soft tissue 
engineering regeneration and repair 
 
1.1 Introduction 
Tissue engineering (TE) is a multidisciplinary field that combines fundamental principles 
from materials engineering and molecular biology in efforts to solve critical medical 
problems, as tissue loss and organ failure. It involves the fundamental understanding of 
structure–function relationships in normal and pathological tissues and the development 
of biological substitutes that promote tissue repair and/or functional restoration. 
In this regenerative approach, the biomaterial scaffolds provide not only temporary three 
dimensional frameworks to form the designed tissues, but essentially acts as an artificial 
extracellular matrix to support cell growth and proliferation. In this regard, considerable 
attention has been given to chitosan (CS), because of its unique biological properties 
including biocompatibility, biodegradability to harmless products, nontoxicity, 
physiological antibacterial, haemostatic, antitumoral and anticholesteremic properties [1-
6]. Furthermore, due to the cationic nature of CS molecules and the abundant functional 
amine and hydroxyl groups on the molecular chain, CS has been selected as a promising 
biomaterial for carrying proteins and other active molecules through physical or chemical 
means [7]. These properties, find several biomedical applications in soft tissue 
engineering [8-10], wound healing [11-13] and as excipients for drug delivery [14-18]. 
CS can be easily processed into gels [15, 19, 20], membranes [21, 22] , nanofibers [16, 23-
27], nanoparticles [7, 17, 28-30], scaffolds [11, 31-33] and sponges [18, 34-36]. 
The first part of chapter 1 discusses the chemical and physical properties of CS, including 
the structure and extraction method, and structure-property relationship. Then, a second 
part of chapter 1 reviews the biological properties of CS that are fundamental properties 
for the applicability of CS as potential biomaterial for fabrication of biomedical devices. In 
the last part, the attention is focused on the use of CS based biomaterials and system for 
soft tissue engineering, wound dressing and drug delivery applications. 
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1.2 Chitosan: structure 
CS derives from chitin that is the second most abundant natural biopolymer commonly 
found in shells of marine crustaceans and cell walls of fungi. CS is a linear, semi-crystalline 
polysaccharide composed of (1→4)-2-acetamido-2-deoxy-b-D-glucan (N-acetyl D-
glucosamine) and (1→4)-2-amino-2-deoxyb- D-glucan (D-glucosamine) units [37]. It is 
obtained by partial deacetylation of chitin in the solid state under alkaline conditions 
(concentrated NaOH) or by enzymatic hydrolysis in the presence of particular enzymes, 
among of chitin deacetylase [38]. Because of the semicrystalline morphology of chitin, CS 
occurs as a copolymer of N-acetylglucosamine and N-glucosamine structural units 
randomly or block distributed throughout the biopolymer chain. Generally, CS has three 
types of reactive functional groups, an amino group (C2 position) as well as both primary 
and secondary hydroxyl groups (C3 and C6 positions) which allow CS modification such as 
graft copolymerization for the production of scaffolds for different TE applications. The 
structure of chitin and CS are showed in Fig. 1.1. The two most important structural 
parameters that affect the properties of CS are the deacetylation degree (DD) and 
molecular weight (Mw). The Mw of CS is dependent on the initial source material (shrimp, 
crab, fungi, etc.) and can decrease during deacetylation processes [39, 40]. The DD of CS 
is calculated as the ratio of D-glucosamine to the sum of D-glucosamine and N-acetyl D-
glucosamine and gives indication of the number of amino groups along the chains. To be 
named ‘‘chitosan’’, the deacetylated chitin should contain at least 60% of D-glucosamine 
residues [41] (which corresponds to a DD of 60). The deacetylation process of CS is based 
on processing of the native polymer with alkali: increasing time and temperature the 
highest DD (>90%) materials can be obtained [40, 42]. CS Mw can range from 300 to over 
1000 kDa with a DD from 30% to 95%. However, commercially available CS has an average 
Mw ranging from 3.8 to 20 kDa and a DD from 66 to 95%. CS is semi-crystalline and the 
degree of crystallinity is a function of the DD. Crystallinity is maximal for both chitin (i.e. 
0% deacetylated) and fully deacetylated (i.e. 100%) CS. The DD governs important 
physical-chemical properties of the CS polymer such as solubility and conformation, being 
critical for the effectiveness of various technological applications. The CS solubilization 
occurs in diluted acidic aqueous solutions (pH <6) by protonation of the –NH2 function on 
the C2 position of the D -glucosamine repeat unit, leading to the repulsion between 
positively charged macromolecular chains, allowing water molecules to diffuse into the 
macromolecular chains and conferring the cationic nature to the polymer [43]. Organic 
acids such as acetic, lactic, and formic acid and inorganic acid such as hydrochloric acid 
are generally used to dissolve CS. Due to its polycationic nature, CS possesses the ability 
to process scaffolds into various forms, such as gels [9, 15, 19], films [44-46] and fibers 
[23, 25, 26] and can form ionic complexes with a wide variety of natural or synthetic 
anionic species, such as metal ions [47-49], proteins [50, 51], DNA [52, 53] and some 
negatively charged synthetic polymers as poly(acrylic acid) [54, 55]. 
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Fig. 1.1. Chemical structure of chitin and CS. 
1.3 Structure-property relationship 
The physical and biological properties of CS are largely dependent on two main structural 
parameters: Mw and DD, among a few others. As discussed in paragraph 1.2, cristallinity 
depends on the DD and a maximum value of cristallinity is obtained for fully deacetylated 
CS (i.e., 100% deacetylated) because of higher chemical regularity and more flexible 
polymer chains. Cristallinity, DD and Mw affect CS solubility. Crystallinity and DD are 
responsible for the hydration of the polymer, which determines the accessibility with 
respect to internal sites of the polymer and is directly related to the kinetics of hydration 
and adsorption behavior. In addition, the solubility of CS in acidic solution (pH below 6) 
increases with the decrease of the Mw [56]. 
DD and Mw control CS degradability and affected the mechanical properties. The in vitro 
degradation rate has been shown to decrease with an increasing DD (if DD is greater than 
50%, i.e., in the “chitosan” range) while an opposite trend has been observed for CS with 
DDs lower than 50% [57] (“chitin” range). CSs of higher Mw have been shown to degrade 
more slowly than those having lower Mws [58]. Ratajska et al. have investigated the 
biodegradation process of three CS samples characterized by similar values of DD (DD = 
82-87%) but strongly differentiated Mw values (ranging from 97 to 473 kD) in an aqueous 
medium. The results obtained indicate that the shortest time of biodegradation was 
observed in the CS sample with the lowest Mw [59]. CS with higher Mw and higher DD 
possessed a lower affinity for the enzyme and a slower degradation rate. 
As regard the mechanical properties, several studies investigated the relationship 
between the mechanical properties of CS films and CS Mw and DD. In general, higher Mw, 
and as a consequence higher cristallinity, improves the mechanical properties as 
evidenced by the enhanced tensile strength [60-62]. During the film formation, CS forms 
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hydrogen bonds between hydroxyl groups and amino groups in CS film which increase 
with the increasing amount of amino and hydroxyl groups, due to the increase in 
concentration of CS [63]. Increase in DD also has a positive effect on the tensile strength 
of CS films [40], because of higher DD in the CS range (when DD > 50%) resulted in higher 
crystallinity. 
Viscosity and swelling degree are also associated to Mw, DD and cristallinity. The viscosity 
of CS increases with an increase in Mw, DD and cristallinity and decreases when 
temperature increased. Viscosity also influences the enzymatic degradation: low DD and 
viscosity tend to degrade CS more rapidly [64]. 
CS with a lower Mw has been found to have a low crystallinity and higher swelling index 
and permeability [62, 65, 66]. Moreover, by lowering the charge density CS’s binding 
capacity for anionic compounds decreases [62]. 
Due to the fact that the physicochemical properties are greatly influenced by CS structural 
parameters, controlling Mw and DD could be a useful tool to design finely tuned CS-based 
devices for biomedical applications. 
1.4 Biological properties of chitosan 
CS offers unique opportunities to the development of many different applications 
because of its remarkable biological properties: biocompatibility, low toxicity, 
biodegradability to harmless products, antibacterial activity, mucoadhesive and its affinity 
to anionic components. In this regard, CS have been used in food [67], pharmaceutical 
[68], textile [69, 70], water treatment [71, 72] and biomedical industries. The biological 
properties make also CS a promising candidate for the purpose of drug delivery for a host 
of drug moieties (antiinflammatories, peptides etc.) [2, 28]. 
The elucidation of the biological properties will lead to a better understanding of CS 
medical and pharmaceutical interest. 
1. Biocompatibility and toxicity depend on the preparation method and on the DD 
(biocompatibility increases with DD increase). Several studies have been performed in 
vitro to evaluate the biocompatibility of CS using a variety of cell types such as 
fibroblasts [73-75], osteoblasts [74, 76], chondrocytes [76], keratinocytes [73-75, 77], 
neural cells [74, 78, 79], and hepatocytes [6, 80, 81]. Results have shown that CS is 
nontoxic and can support these types of cells to adhere and proliferate, which suggests 
that CS is compatible with these cell types. 
2. Biodegradability: CS has been shown to be degraded in vivo by enzymes such as 
lysozymes [82] and chitinases [83], to N-glucosamine oligosaccharide, which is 
endogenous to human body. This oligosaccharide can be incorporated in metabolic 
pathways or be further excreted [84]. As the Mw decreases, the absorption of CS by 
intestine increases [85]. The degradation rate is also inversely related to the degree of 
crystallinity which is controlled mainly by the DD [86]. Structural parameters (Mw, DD 
and crystallinity) could be used to finely tune the degradation rate for biomedical 
applications. 
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3. Antimicrobial activity: numerous studies have demonstrated broad-spectrum 
antimicrobial activities of CS against Gram+ (i.e. Staphylococcus aureus) and Gram- (i.e. 
Escherichia coli) bacteria [87, 88]. This biological property of CS relied on numerous 
intrinsic and extrinsic factors, such as pH, microorganism species, presence or absence 
of metal cations and Mw. The exact mechanisms of the antimicrobial activities of CS are 
not clear; however, two modes have been proposed as an explanation to this property. 
The first one is attributable to the polycationic nature of CS: the amino groups present 
in the polymeric chain of CS interact with the negative charges from the residues of 
macromolecules (lipopolysaccharides and proteins) in the membranes of bacterial cells 
leading to altered membrane permeability which interfere with the nutrient exchange 
between the exterior and interior of the cell [89]. In this model the NH3+ groups can 
also compete with Ca2+ for the electronegative sites on the surface, compromising its 
integrity and causing cellular death. The second mechanism proposes that CS acts as a 
chelating agent that selectively binds trace metals and thus inhibits the production of 
toxins and microbial growth [90]. Finally, CS of low Mw has been shown to be capable 
of entering the cell's nucleus itself, interacting with the DNA and affecting the 
synthesis of proteins and inhibiting the action of various enzymes [91]. 
4. Mucoadhesion: CS can be explained by the presence of negatively charged residues 
(sialic acid) in the mucin – the glycoprotein that composes the mucus. In acidic 
medium, CS amino groups are positively charged and can thus interact with the mucin. 
This mucoadhesion is directly related to the DD of CS: actually, if CS DD increases, the 
number of positive charges also increases, which leads to improved mucoadhesive 
properties [92]. 
5. Affinity to biological anionic components: CS can be complexed with negatively 
charged because of the cationic primary amino groups of CS. This property makes CS a 
good candidate in the field of gene [93, 94] and drug [17, 28, 29, 44] delivery systems. 
Also, the mucoadhesive property of CS potentially permits a sustained interaction 
between the macromolecule being “delivered” and the membrane epithelia, 
promoting more efficient uptake [44, 95] and the ability to open intercellular tight 
junctions, facilitating its transport into the cells [96]. 
CS also exerts a haemostatic [97, 98], hipocholesterolemic [99, 100] and hipolipidemic 
activity [101] and immunity-enhancing [102] and antitumor effects [103] which may be 
attributed to its cationic nature. 
1.5 Application of CS based biomaterials 
1.5.1 Soft Tissue engineering 
TE is a multidisciplinary field based on the application of biological, chemical, and 
engineering principles to the repair, restoration, or regeneration of living tissues by using 
biomaterials, cells, and factors alone or in combination [104]. Scaffold-based TE is one of 
the most well studied approaches to regenerate different types of tissues, which involves 
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seeding cells together with signaling molecules on a biodegradable matrix, culturing them 
in vitro and implanting them into in vivo defects. In this context, biomaterials, usually in 
the form of porous scaffolds, play multiple significant roles to provide structural 
maintenance of the defect shape, act as a delivery vehicle for bioactive molecules and 
cells and serve as temporary ECM for cell adhesion, proliferation, differentiation, and 
maturation. The bioinspired cell–scaffold interface must necessarily meet a variety of 
demanding and coupled requirements, such as biocompatibility and biodegradability of 
the materials, physico-chemical and mechanical properties and morphological 
characteristics, all at different length scales. 
After some advances and relatively successful clinical applications for hard tissues over 
the past decade [105], much of the effort is now being directed at soft tissue 
reconstruction. Engineering two-dimensional (2D) soft tissues (i.e. cornea [106] and skin 
[5]), and complex three-dimensional (3D) tissues (i.e. cardiac, muscular and neural) is a 
far more challenging task.  
Among different biomaterials, CS is an ideal candidate in soft TE applications since its 
combined promising biological features (controllable biodegradability, biocompatibility 
and antimicrobial activity) with easy processability into 2D or 3D scaffolds. CS has been 
widely applied as bulk materials for TE scaffold fabrication showing good biocompatibility 
with a variety of cell types such as osteoblasts [74, 76], chondrocytes [76], fibroblasts [73-
75], neural [74, 78, 79], and endothelial cells [73-75, 77] and has the potential to be 
applied in cartilage, liver, nerve, skin and blood vessels applications. 
1.5.1.1 Chitosan in cartilage tissue engineering 
Articular cartilage damage is among the most encountered musculoskeletal diseases, 
eventually leading to total joint replacement if not treated properly. The articular 
cartilage consisting of hyaline cartilage tissue has very little capacity for spontaneous 
healing because of the avascular nature of the tissue. 
Due to the limited potential for self-repair of the articular cartilage, surgical operations 
have been used by orthopedics including allograft osteochondral transplantation [107], 
autologous chondrocyte transplantation [108], allogeneic juvenile cartilage 
transplantation (DeNovo NT®) [109], mosaicplasty [110], and microfracture technique 
[111]. However, no current procedures for cartilage repair have successfully regenerated 
long-lasting hyaline cartilage tissue to replace a cartilaginous lesion. To solve this 
limitation, TE provides a new method for cartilage repair by culturing isolated 
chondrocytes on a variety of scaffolds. To structurally mimic the environments of the 
cartilage tissue, the fundamental structure of a scaffold should be a 3D system with 
adequate mechanical strength considering the articular cartilage mobility. Both synthetic 
[112] and natural [113-115] scaffolding materials have been used for cell delivery in 
cartilage regeneration. Synthetic polymers present many drawbacks: i) the creation and 
accumulation of acidic by-products; ii) low biocompatibility; and iii) a possible in vivo 
inflammatory foreign body reactions [78]. In contrast, natural materials often have high 
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levels of biocompatibility and biofunctional motives. Such biomaterials including collagen 
[116], cellulose [117], CS [76, 118], fibrin [119] and silk [120] maintain a differentiated cell 
phenotype and allow rapid cell expansion. However, they are not mechanically stable 
enough and the rate of their biodegradation is practically high [121]. To enhance 
mechanical stability specific components including natural or synthetic materials are 
generally used to fabricate composite structures which can offer biological cues to 
promote tissue-specific interactions, while providing desired mechanical properties. 
Among the natural polymers, CS can be easely molded in various forms (i.e. bulk porous 
scaffolds, films, hydrogels and beads) and it has a superior biocompatibility because of its 
structural similarity with glycosaminoglycans (GAGs), naturally present in the extracellular 
matrix of cartilage [122, 123]. Lahiji et al., have demonstrated that chondrocytes grown 
on CS film exhibit a spherical morphology and express type II collagen and aggrecan [76, 
118]. Zhang et al. performed a series of studies using adipose-derived stem cells loaded 
on a polyelectrolyte complex scaffold based on poly(l-glutamic acid) and CS to repair full 
thickness articular cartilage defects. Poly(l-glutamic acid) was conjugated with CS through 
electrostatic interaction to develop a porous scaffold by a phase separation method. The 
scaffolds with a pore size of 150–200 μm and a porosity of about 93% provided a 
favorable environment for the maintenance of adipose-derived stem cells proliferation, 
migration and chondrogenic differentiation achieving a successful hyaline cartilage 
regeneration over a period of 12 weeks [124]. 
CS hydrogels holds great potential as an artificial ECM to regenerate hyaline cartilage 
since they can be delivered to the defect site in a minimally invasive manner and have 
shown to be able to maintain the round phenotype of chondrocytes. Remya et al. 
developed a hydrogel based on CS and hyaluronic acid derivative and cultured 
chondrocytes encapsulated into the gel over a period of one month. CS hyaluronic acid 
hydrogel were found to mimic the GAG-rich ECM and to preserve the typical round 
morphology of chondrocytes throughout the course of the investigation period. 
Moreover, the developed hydrogels were found to allow the retention of anionic GAGs, 
proteoglycans and other negatively charged species secreted by the active chondrocytes 
that further increases the ECM concentration around the cells [125]. The formation of 
ionic complexes of CS with the negatively charged GAGs has regarded further important 
property in cartilage TE. This ion complexing mechanism can be used to immobilize 
chondroitin sulfates with hydrogel materials which mimic the GAG-rich ECM of their 
articulation because CS has a protective effect against GAGs hydrolysis by their specific 
enzymes [126]. 
In addition to the CS properties mentioned above, signaling molecules such as GFs and 
small peptide sequences and plasmid DNA encoding specific GFs can be incorporated into 
CS scaffolds for cartilage TE. DNA complexation with CS has been shown to protect 
plasmids from degradation by nucleases and also facilitates cellular transfection by poorly 
understood interactions with cell membranes [127]. The release of specific GFs in a 
controlled fashion has been shown to promote the ingrowth and biosynthetic ability of 
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chondrocytes. Lee et al. developed a three-dimensional 
collagen/chitosan/glycosaminoglycan (GAG) scaffold in combination with transforming 
growth factor-beta1 (TGF-β1)-loaded CS microspheres. TGF-β1 was loaded into CS 
microspheres using an emulsion-crosslinking method. Then chondrocytes were seeded in 
the scaffold and incubated in vitro for 3 weeks This scaffold exhibited controlled release 
of TGF-β1 and promoted cartilage regeneration [128]. 
Recently, the treatment of cartilage defects by combining CS based scaffold and 
autologous whole blood have been shown to promote hyaline repair cartilage because of 
CS thrombogenic activity could improve the stabilization of the clot formed in the lesion 
[129, 130]. 
TE approach with more expanded understanding of articular cartilage and associated 
pathologies may provide the chitosan-based material that supports chondrogenesis, 
which can improve the quality of neocartilage produced and the integration with the host 
tissue as well as the long-termoutcomes of cartilage repair in clinical settings. 
1.5.1.2 Chitosan in liver tissue engineering 
It is widely accepted that of the currently available therapeutic options, orthotopic liver 
transplantation (OLT) seems to be the best solution for patients suffering from severe 
liver dysfunction or terminal liver failure. However, the insufficient donor organs for OLT 
worldwide, the high cost and the requirement for life-long immunosuppressive drugs 
have urgently increased the requirement for new therapies for acute and chronic liver 
disease [131]. Various non biological approaches, such as hemodialysis, hemoperfusion, 
and plasmapheresis, have limited success because of insufficient replacement of the 
synthetic and metabolic functions of the liver in these systems [132, 133]. On the other 
hand, extracorporeal biological treatment, including whole-liver perfusion, liver-slice 
perfusion, and cross-hemodialysis, have shown some beneficial results, but they are 
difficult to implement in a clinical setting [134]. For these reasons, many researchers have 
developed various extracorporeal biohybrid artificial liver (BAL) systems which consist of 
functional liver cells supported by an artificial cell culture material. In particular, it 
incorporates hepatocytes into a bioreactor in which the cells are immobilized, cultured, 
and induced to perform the hepatic functions by processing the blood or plasma of liver-
failure patients. The BAL devices for liver TE require a suitable ECM for hepatocyte culture 
because hepatocytes are anchorage-dependent cells and are highly sensitive to the ECM 
milieu for the maintenance of their viability and differentiated functions [135]. 
Hepatocytes in vivo survive in a three-dimensional system that is formed by various kinds 
of ECM components of human liver such as collagen and GAG, which provide mechanical 
integrity to the liver tissues and harbor several bioactive signals and molecules for cells 
[136]. Porous scaffolds with large surface-to-volume ratio are relevant to hepatocytes 
attachment. 
Among the natural polymer, CS is a promising biomaterial in liver TE due to the similarity 
of its structure to GAGs which are component of the liver ECM. CS membranes would 
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allow the organization of hepatocytes into a three-dimensional architecture, providing 
mechanical integrity and a space for the diffusion of nutrients and metabolites to and 
from the cells [137]. Verma et al. showed that unmodified CS can be used as a synthetic 
matrix to induce the aggregation of human hepatocyte cell line, HepG2, into three 
dimensional spheroids with appropriate liver tissue-specific functions like albumin 
secretion and urea synthesis [138]. Moreover, the presence of both the reactive amino 
and hydroxyl groups in CS allow to chemically modify and physically manipulate the 
scaffolds into different pore structures [41]. Li et al. showed that the micro-structure of 
porous scaffolds provided large surface area for cells to adhere and facilitate nutrient and 
oxygen transportation [139, 140]. Another strategy in liver TE concerned with developing 
CS based scaffolds modified with galactose moieties as a specific adhesive ligand to the 
asialoglycoprotein receptor (ASGPR) expressed on the surface of hepatocytes [141, 142]. 
Park et al. demonstrated galactosylated CS as a new synthetic ECM for hepatocyte 
attachment through the speciﬁc interaction between ASGPR on hepatocytes and 
galactose ligands of galactosylated CS [142]. Seo et al. developed a highly porous sponge 
composed of alginate and galactosylated CS as a synthetic ECM for hepatocytes. The 
presence of galactose ligands facilitated hepatocyte aggregation in the developed scaffold 
resulting in the maintenance of high cell activity by the intercellular adhesion molecules 
in the 3D culture system [143]. Furthermore, Fan et al. suggested a potential ability to 
improve primary hepatocytes bioactivity and liver specific functions on galactosylated 
CS/hyaluronic acid (HA) sponges by co-culturing both primary hepatocytes and 
endothelial cells on the hybrid scaffold - thus closely mimicking the dominant cell 
populations in the intact liver. The binding of the galactose ligand to ASGPR induced liver-
targeted transfer of glycoproteins while HA provided anchorage sites for endothelial cells 
through the cell surface receptor, CD44. As a result, the contact of hepatocytes with 
endothelial cells appeared to stimulate higher hepatic-speciﬁc gene expression and urea 
production as compared to that achieved in the monoculture system of hepatocytes 
[144]. The nanotopography of the galactosylated CS based scaffold has also been shown 
to influence liver specific functions. Feng et al. developed a nanofibrous scaffold based on 
galactosylated CS and found that the nanofibrous matrix enhanced the maintainance of 
the albumin secretion and urea synthesis of hepatocytes but did not show much effect on 
cell attachment. Moreover, the balancing action between galactose ligands and 
nanotopography induced the formation of ﬂat hepatocyte aggregates which were 
mechanically stable than spheroidal aggragates on GC films [145]. 
Although matrices composed of CS can provide an appropriate environment for the 
regeneration of liver cells, the low mechanical strength and the poor blood 
biocompatibility of the natural polymer have limited their use in liver TE. Considering that 
liver is a highly vascular inter-organ that must provide hepatocytes with sufﬁcient oxygen 
and nutrients, thrombus formation can lead to occlusion and decreased membrane 
efﬁciency. Therefore, technologists have proposed a new method to fabricate a BAL with 
new composition in order to prevent the thrombus formation. Wang et al., developed an 
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ammonia-treated collagen–CS–heparin matrix for an implantable BAL and found that the 
presence of heparin into the ammonia- treated collagen–CS matrices could improve the 
blood biocompatibility respect collagene/CS based scaffolds and did not affect the 
porosity, the mechanical strength and the stability in an enzyme solution [146]. 
1.5.1.3 Chitosan in nerve tissue engineering 
The regeneration of traumatized peripheral nerve has been attempted in many different 
ways, which have in common the goal of directing the regenerating nerve fibres into the 
proper endoneurial tubes. To repair peripheral nerve injuries with neural gaps (more than 
20 mm), the current standard treatment uses conventional autologous nerve graft to 
bridge the neural gap and facilitate nerve regeneration and reconnection. However, due 
to the intrinsic limitations of autografts, recent advancements in nerve regeneration have 
involved the application of TE principles based on the regulation of cell behavior and 
tissue progression through the development of an engineered nerve grafts that mimics 
the natural ECM and can support three-dimensional cell cultures. Successful nerve 
regeneration requires TE scaffolds not only for mechanical support of growing neuritis 
and impediment of ingrowths of fibrous scar tissues, but also to send biological signals to 
guide the axonal growth cone to the distal stump. Among the various biomaterials that 
have been investigated, scaffolds made of CS based materials have drawn much attention 
[147]. CS has been studied as a candidate material for nerve regeneration due to its 
neuroprotective properties [148] in addition to the already mentionated properties of, 
biodegradability, biocompatibility and antibacterial activity. Recent in vitro studies 
revealed the suitability of CS membranes as substrate for survival and orientation of 
Schwann cell (SC) [78] as well as survival and differentiation of neuronal cells [57]. In 
addition, CS tubes alone or in combination with other biomaterials such as polyglycolic 
acid (PGA), collagen, alginate can efficiently bridge peripheral nerve defects [149-152]. 
Chew et al. showed that CS aligned nanofibrous tubes supported the adhesion, migration 
and proliferation of SCs, providing a similar guide for regenerating axons to Büngner 
bands in the nervous system [153]. However, CS matrices have been shown to have low 
mechanical strength under physiological conditions and to be unable to maintain a 
predefined shape for transplantation, which has limited their use as nerve guidance 
conduits in clinical applications. The improvement of their mechanical properties can be 
achieved by modifying CS with different crosslinking agents (i.e. glutaraldehyde, γ-
glycidoxypropyltrimethoxysilane, tripolyphosphate, genipin) [33, 154, 155] or by 
combining CS to synthetic ones [23, 156]. Furthermore, to enhance functional outcomes 
of peripheral nerve regeneration yielded by nerve conduits alone, biochemical cues, such 
as support cells, GFs and peptides, are usually incorporated into CS based nerve conduit. 
Recently, CS based, nerve growth factor (NGF)-loaded nerve conduits have been prepared 
with the aim of CS nerve cell affinity. 8 mg of NGF were first immobilized onto CS in 
solution (20 ml) by means of genipin, a crosslinking agent of natural origin, followed by 
fabrication of nerve conduits through a technique of injection molding (Fig. 1.2A and B). 
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Genipin was selected to exert both to crosslink CS for polymer modification and 
concurrently to immobilize NGF onto modified CS. The NGF loaded CS conduits were non-
cytotoxic to primary cultured SCs and showed in vitro neuro-affinity to PC12 cells in terms 
of keeping the activity of NGF within nerve conduits, i.e., the ability to stimulate neuronal 
differentiation of PC12 cells. More intriguingly, the continuous release profile of NGF 
from NGF loaded CS crosslinked nerve conduits, within a 60-days, consisted of an initial 
burst that was controlled by concentration gradient-driven diffusion, followed by a zero-
order release due to the degradation of CS (Fig. 1.2C) [155]. 
Few studies reported the blending of CS with a peptide to enhance nerve cell attachment. 
Mingyu et al. showed an improved attachment, differentiation and growth on the 
CS/poly(L-lysine) composite materials when compared to cells cultured on CS 
membranes. The improved nerve cell affinity on the CS/poly(L-lysine) composite materials 
had been attributed to the increased hydrophilicity by the abundant hydroxyl group and 
the positive surface charge of CS [157]. Hsu et al., fabricated a laminin (LN)-modified CS 
multi-walled nerve conduit combined with bone marrow stem cell (BMSC) to enhance 
axonal regeneration. The in vitro and in vivo approaches were used to analyze the 
complex interactions between CS scaffold, cells and cell regulatory molecules and to 
evaluate long-term biosafety and efficiency for clinical application. LN-CS multi-walled 
conduit embedded with stem cells supported the regeneration of functional connections 
between two ends of a severed sciatic nerve. This study also demonstrates the capacity of 
stem cell therapy to prevent the inflammatory responses caused by CS, resulting in long-
term maintenance of the regenerative capacity and to enhance the long-term restoration 
of motor functions [158]. CS support nerve cell adhesion and neurite outgrowth, making 
this material potential candidates for scaffolds in neural TE. 
 
Fig. 1.2. SEM images of CS nerve conduits [155]. Side view of the conduit (A), cross-section view of 
conduit (B), (C) Daily in vitro release of NGF from the CS based nerve conduit to PBS (pH 7.4) at 
37°C. Copyright © 2007 Elsevier, © 2005 & 2008 Wiley. 
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1.5.1.4 Chitosan in vascular tissue engineering 
Nowadays, vascular diseases are the largest causes of mortality in the industrialized 
society. Despite progresses in prevention and treatment, an increasing aging population, 
the global spread of smoking, and the growing epidemics of obesity and diabetes ensure a 
rising the incidence of cardiovascular diseases in the next decades. Reconstructive surgery 
using autologous vessel grafts, particularly small diameter vein or artery (<4 mm), is the 
conventional therapeutic approach for substitution of diseased vessels or for generation 
of bypass to improve blood supply downstream of stenosed vessels. Conversely, its 
disadvantages including the secondary site injure and the potential coexistent diseases of 
autologous vessel limited its use and, in some circumstances, the application of artificial 
grafts is necessary. Although some artificial vascular grafts have achieved success in 
clinical application, products with small diameters (<4 mm) are rarely commercialized, 
owing to their high failure rate. The transplantation of small-diameter artificial vascular 
grafts is often ascribed to the poor blood compatibility of artificial vascular grafts, which 
leads to the adhesion of platelets and plasma protein, and subsequent aggregation and 
thrombus formation [159, 160]. In this context, TE at the vascular level aims to generate 
biological substitutes of arterial and vein conduits with functional characteristics of native 
vessels, combining cellular components with biodegradable scaffolds. The scaffolds made 
of different materials, such as synthetic polymers, natural materials, and decellularized 
xenogenous tissues, have been utilized in blood vessel TE. CS has been widely 
investigated in this field due to its structure similar to GAGs, which are the components of 
the ECM. However, one disadvantage of CS is its poor hemocompatibility, because the 
cationic profile causes the unnecessary adhesion of negatively charged platelets, which 
limits its application in vascular TE. However, the cationic nature of CS can be exploited 
for pH-dependent electrostatic interactions with anionic GAGs distributed widely 
throughout the body and other negatively charged species. GAG-based materials hold 
promise because of their growth inhibitory effects on vascular smooth muscle cells and 
their anticoagulant activity. For example, CS has been complexed with heparin in order to 
control heparin release, thereby enhancing the anti-thrombogenic property and 
attracting an protecting many heparin binding GFs, such as bFGF [161], VEGF [162], and 
PDGF [163]. Chupa et al. incorporated GAG into porous CS scaffolds with the aim to 
overcome both incomplete endothelialization and smooth muscle cell hyperplasia, which 
are two main problems contributing to the failure of existing small-diameter vascular 
grafts [164]. Madihally et al. fabricated a family of CS scaffolds, including heparin 
modified porous tubes, which had the potential for application in blood vessel TE [41]. 
More recently, a hybrid small-diameter vascular graft was developed from synthetic 
polymer poly(ε-caprolactone) (PCL) and natural polymer CS by the co-electrospinning 
technique (Fig. 1.3A, B). Heparin was immobilized on the grafts through ionic bonding 
between heparin and CS fibers. Heparin functionalization was found to improve the 
hemocompatibility of the PCL/CS vascular grafts, by the reduction of platelet adhesion 
(Fig 1.3C, D), and moderately to inhibit the proliferation of vascular smooth muscle cells, 
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a main factor for neointimal hyperplasia [165]. In an another study, nanocoatings of CS 
and HA were deposited onto arteries through a layer-by-layer technique coating 
significantly reduced the adhesion of blood platelets, thus demonstrating a restored 
patency of the denuded arteries [166]. The complex of CS and anionic GAG is supposed to 
be a promising approach for the development of artificial vascular graft due to the 
anticoagulant activity and the inhibitory effects on vascular smooth muscle cells. 
 
Fig. 1.3: SEM images of CS nerve conduits of electrospun PCL/CS hybrid mats [165]. (A), PCL/CS 
fiber hybrid mats (B) cross section of tri-layered PCL/CS hybrid tubular grafts (insert shows the 
enlargement), platelets adhering on the surface of PCL/CS hybrid mats (C) before and (D) after 
heparin functionalization. Copyright © 2007 Elsevier, © 2005 & 2008 Wiley. 
1.5.2 Wound dressing 
Wound healing can be problematic in several clinical settings because of massive tissue 
injury (burns), wound healing deficiencies (chronic wounds), or congenital conditions and 
diseases. The healing of a skin wound is complicated courses, including a wide range of 
cellular, molecular, physiological, and biological processes. The skin plays an important 
role in homeostasis and the prevention of invasion by microorganisms. Immediate 
coverage with a wound dressing is generally necessary after the skin is damaged with the 
attempt to rapidly produce a construct that offers the complete regeneration of 
functional skin by fulfilling its many normal functions: barrier formation; pigmentory 
defence against UV irradiation; thermoregulation; and mechanical and aesthetic functions 
[167]. In past decades, many biological skin substitutes such as xenograft, allografts, and 
autografts have been employed for wound healing. However, due to the antigenicity or 
the limitation of donor sites, the skin substitutes cannot accomplish the purpose of the 
skin recovery. In this context, engineered skin substitutes have been developed to 
address the medical need for wound coverage and tissue repair. An ideal engineered 
wound dressing should be elastic and biocompatible and it should protect the wound 
from bacterial infection. Moreover, current strategies are focused on the acceleration of 
the wound repair at molecular and systemic levels. Efforts have been focused on the use 
of biologically derived materials such as, chitins and its derivatives, which are capable of 
accelerating the healing process. CS has been found to promote tissue granulation and 
accelerate wound healing through the recruitment of inflammatory cells such as 
polymorphonuclear leukocytes (PMN) and macrophages to the wound site [168]. 
Moreover, CS has many others useful and advantageous biological properties in the 
application as a wound dressing, such as biocompatibility, biodegradability, hemostatic 
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activity and anti-infectional activity [169-171]. CS and its derivative have been found to 
evoke a minimal foreign body reaction, with little or no fibrous encapsulation. It observed 
the typical course of healing with formation of normal granulation tissue, often with 
accelerated angiogenesis. Okamoto et al. reported that CS influenced all stages of wound 
repair in experimental animal models [172]. In the inflammatory phase, CS has unique 
hemostatic properties that are independent of the normal clotting cascades. In vivo this 
polymer can also stimulate the proliferation of fibroblasts and modulate the migration 
behavior of neutrophils and macrophages modifying subsequent repair processes such as 
fibroplasias and reepithelialization. Due to the ease of processability of this natural 
polymer, CS based skin substitutes can be fabricated in the form of non-wovens, 
nanofibrils, composites, films, scaffolds and sponges to mimic the stratified 
microstructure of skin tissue and to provide a temporary ECM for cell infilitration and 
vascularization. Various forms of wound dressing based on CS and its derivatives are 
actually commercially available (Table 1.1). 
Freeze-drying CS solutions has been frequently used to fabricate CS-based scaffolds for 
skin regeneration, which typically exhibit pore sizes of 100-200 µm and pore volume of 
more than 90% [173]. Asymmetric CS based scaffolds have also been prepared by a 
controlled freezing-lyophilization process or by applying an additional dense layer of 
biomaterials on top of the CS substitutes, producing a bilayer structure to mimic the 
native skin structure [174]. For example, Mi et al. prepared asymmetric CS membrane 
with skin surface layer supported on a macroporous sponge-like sublayer through 
immerse-precipitation phase-inversion method [175]. Ma et al. fabricated CS bilayer 
scaffold via the formation of a dense film by the casting method and a porous sponger 
layer lyophilized with porogens at −28°C [176]. Recently, the use of polymeric nanofibres 
has attracted considerable interest due to high surface area to volume ratio, high 
porosity, pore size distribution and morphology. Chen et al. reported that electrospun 
CS/collagen/polyethylene oxide nanofibrous membrane crosslinked by glutaraldehyde 
vapor is beneficial in wound healing application. They indicated non-cytotoxicity for these 
nanofibres regarding 3T3 fibroblast growth and in vitro biocompatibility [177]. Naseri et 
al., developed electrospun CS/polyethylene oxide-based randomly oriented fiber mats 
reinforced with 50 wt% of chitin nanocrystals and crosslinked using genipin. The 
crosslinked nanocomposite fiber mats enriched with chitin nanocrystals improved the 
moisture stability of the electrospun mats and facilitated water-mediated crosslinking 
processes. Moreover, the addition of chitin nanocrystals had a positive impact on the 
mechanical properties of the fibrous mats showing a tensile strength of 64.9 MPa and 
modulus of 10.2 GPa and allowing the membranes to maintain their flexibility. Developed 
mats were also compatible toward adipose derived stem cells after 7 days and can be 
considered as a potential candidate for wound dressing application [178]. CS based skin 
substitutes, having hydrogel-forming properties have been also considered to be 
advantageous in their application as a wound dressing material because of their high 
water content and biocompatibility. A hydrogel sheet composed of a blended powder of 
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alginate, chitin/CS and fuciodan (ACF-HS) has been developed as a functional skin 
scaffolds with the aim to create in vivo a moist environment with exudates environment 
for rapid wound healing [179]. Full thickness skin defects were made on the backs of rats. 
After a pretreatment of mitomycin solution, ACF-HS was applied to the healing-impaired 
wounds. Histological examination demonstrated significanty advanced granulation tissue 
and capillary formation in the skin damage treated with ACF-HS on day 7, as compared to 
those left untreated. Furthermore, antibiotic-loaded CS-based scaffolds have been used 
to treat severe skin injuries. For example, artificial skin substitutes made of CS membrane 
or porous scaffolds could be used to release antibacterial agents such as nanotitanium 
dioxide [180] or silver (Ag), in the form of metallic nanoparticles [181] or sulfadiazine 
cream [13], and exhibit good antimicrobial properties. Lee et al. designed a novel wound 
dressing by obtaining electrospun CS nanofibres containing various ratios of silver 
nanoparticles (AgNPs) (AgNPs contents=0, 4, 2, 1.3, and 0.7 wt. %) with the aim to 
investigate its antibacterial efficacy in a zone of inhibition antibacterial test system. 
AgNPs were synthesized directly by chemical reduction within the CS solution. In 
antibacterial testing, the pure CS nanofibres were observed to not substantially inhibit 
bacterial growth. But CS/AgNPs nanofibers displayed a high degree of effectiveness 
against Gram- Pseudomonas aeruginosa and Gram+ Methicillin-resistant Staphylococcus 
aureus. Additionally, the quantity of AgNPs was increased in the fibres and consequently 
antibacterial properties were enhanced against both microorganisms [182]. In addition, 
CS-based scaffold can be fuctionalized to carry GFs able to accelerate skin wound healing. 
For example, Mizuno et al. reported that CS was a good wound healing material and 
incorporation of that to basic fibroblast growth factor (BFGF) accelerated the rate of 
healing. 
Table 1.1 Commercialy available CS and its derivatives based wound dressing materials 
Material Trade name Manufacturer 
 Tegasorb® 3M 
 Tegaderm® 3M 
Chitosan and its derivatives HemCon Bandage TM HemCon 
 Chitodine® IMS 
 Trauma DEX® Medafor 
 
1.5.3 Drug delivery 
Apart from applications soft TE and wound dressing, CS has been applied for drug delivery 
system fabrication. Thanks to its unique feature of being positively charged in 
physiological condition, CS is especially advantageous in forming stable complex with 
negative compounds, which makes CS a good candidate for drug encapsulation and 
controlled release [183]. CS has also showed the ability to adhere to the mucosal surface 
and it is capable of penetrating the tight junctions between epithelial cells [96]. In 
addition, CS and its derivatives can be processed under mild conditions, avoiding GFs and 
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drug inactivation due to otherwise harsh processing conditions, and it can be fabricated 
into different forms and shapes to incorporate bioactive molecules for various in vivo 
applications. To date CS and its derivatives have been applied as carriers for drugs [184, 
185], peptides [186] or genes [187-189] delivery. Particularly, CS has been used in the 
preparation of mucoadhesive formulations [190, 191], improving the dissolution rate of 
the poorly soluble drugs [192], drug targeting [193, 194] and enhancement of peptide 
absorption [195]. 
Presently, a variety of CS-based drug delivery materials in the forms of gels [196], tablets 
[197], beads [198, 199], films [200] and particles [201, 202] have been developed and 
studied. Different types of CS-based drug delivery systems are summarized in Table 1.2. 
For example, Azab et al. developed a CS-based hydrogel cross-linked with glutaraldehyde 
and loaded with 131I-norcholesterol radioisotope for cancer therapy. CS hydrogels were 
tested in a breast cancer xenograft mouse model showing a reduction in the progression 
rate of the tumor, and preventing 69% of tumor recurrence and metastatic spread. 
Importantly, little or no systemic distribution of the radioisotope after hydrogel 
implantation was observed [203]. In another study, Senel et al. designed CS gels (at 1 or 
2% concentration) or film forms for local delivery of chlorhexidine gluconate, an 
antifungal agent, to the oral cavity. Due to bioadhesive property and high viscosity of the 
selected natural polymer, CS drug delivery systems were found to remain in the oral 
cavity and release the drug for a long period of time, thus enhancing the clinical effect. 
Release of the chlorhexidine gluconate from gel (2% concentration) and film was 
maintained for 3 hours and a higher antifungal agent release was observed from gels 
compared to film [204]. 
Among the different typologies of drug delivery system, CS based 
microspheres/nanoparticles are widely studied for controlled release of drugs, antibiotics, 
proteins, peptide drugs anti-inflammatory, steroids, antidiabetic, diuretics, amino acid 
and vaccines. Emulsion, chemical or ionic gelation [205], coacervation/precipitation [206, 
207] and spray-drying [208] have been used for CS- based drug delivery system 
fabrication;  these techniques were selected since they reduce the risk of drug, peptide 
and gene denaturation. Method selection depends upon factors such as particle size 
requirement, thermal and chemical stability of the active drug molecule, reproducibility 
of the release kinetic profiles, stability of the final product and residual toxicity associated 
with the final product. Pan et al. prepared insulin-loaded CS nanoparticles by ionotropic 
gelation of CS with tripolyphosphate (TPP) anions. The positively charged, stable CS 
nanoparticles showed particle size in the range of 250-400 nm. Insulin association was up 
to 80%. In vitro release experiments indicated initial burst release which is pH-sensitive. 
CS nanoparticles enhanced the intestinal absorption of insulin to a greater extent than 
the aqueous solution of CS in vivo. After administration of 21 iu/kg insulin in the CS 
nanoparticles, hypoglycemia was prolonged over 15 hours. The average pharmacological 
bioavailability relative to subcutaneous injection of insulin solution was up to 14.9 [209]. 
Preparations of CS nanoparticles loaded with plasmid DNA encoding surface protein of 
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Hepatitis B virus using the complex coacervation technique have been reported [207]. 
The attempt of this work was to provide plasmid DNA carrier system for nasal mucosal 
immunization against hepatitis B. The loading efficiency, the transfection efficacy and the 
ability of CS nanoparticles to protect DNA against nuclease digestion were demonstrated. 
Huang et al. prepared CS microspheres by the spray-drying method using type-A gelatin 
and ethylene oxide–propylene oxide block copolymer as modifiers. Shape, size and 
surface morphology of the microspheres were significantly influenced by the 
concentration of gelatin. Betamethasone disodium phosphate-loaded microspheres 
demonstrated a good drug stability (less 1% hydrolysis product), high entrapment 
efficiency (95%) and positive surface charge (37.5 mV) [210]. 
Self- assembly technique is a feasible and cost effective strategy to prepare CS drug 
carriers. The self assembly process of CS is similar to many other biological molecules 
(DNA, RNA and proteins) that occur in water phase normal conditions. This process leads 
to the formation of polyelectrolyte-complexes by electrostatic interaction, which is 
optically homogeneous, stable nano-dispersion at colloidal level. Self-assembled 
nanostructures display excellent properties such as protein encapsulation efficiency and 
prolonged drug release process [211]. Moreover, through self-assembly CS-based micelles 
have gained attention owing to their ability to solubilize many poorly water-soluble drug 
[211]. Therefore, various CS derivatives have been prepared via modifications to enhance 
CS solubility in aqueous solution as well as to provide a hydrophobic portion for the core 
and a hydrophilic portion for the shell by micelle formation [212-214]. Many studies have 
reported that CS based self-assembled nanostructures significantly improved the delivery 
efficiency of therapeutic proteins [215], genes [216] and small molecules [217, 218]. For 
example, CS self-assembly nanostructures have shown to significantly enhance insulin 
delivery [215, 219]. Mukhopadhyay et al. prepared CS/insulin nanoparticles by self-
assembly method and showed self assembled nanoparticles were 200–550 nm in size 
with almost 85% insulin encapsulation efficiency. Additionally, the in vivo oral 
administration of nanoparticles in diabetic mice indicated significant intestinal absorption 
of insulin, reducing the blood glucose level within 4 hours in comparison with 
subcutaneous injections [220]. In another study, Bisht et al. reported an easy method to 
encapsulate doxorubicin-dextran in CS self assembly nanoparticles for cancer therapy. 
Thanks to the conjuction with dextran and the enclosure in CS nanoparticles, the 
cardiotoxicity of doxorubicin was alleviated in normal heart cells [221]. 
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Table 1.2. CS based drug delivery systems prepared by different methods for various kinds of 
drugs 
Type of system Method of preparation Drug 
Tablets matrix diclofenac sodium, 
pentoxyphylline, salicylic acid, 
theophylline 
 coating propranolol HCl 
Microspheres/ 
Microparticles 
emulsion cross-linking theophylline, cisplatin, 
pentazocine, phenobarbitone, 
theophylline, insulin, 5-
fluorouracil, diclofenac sodium, 
griseofulvin, aspirin, diphtheria 
toxoid, pamidronate, 
suberoylbisphosphonate, 
mitoxantrone, progesterone 
 coacervation/precipitation prednisolone, interleukin-2, 
propranolol-HCl 
 spray-drying cimetidine, famotidine, 
nizatidine, vitamin D-2, 
diclofenac sodium, ketoprofen, 
metoclopramide-HCl, bovine 
serum albumin, ampicillin, 
cetylpyridinium chloride, 
oxytetracycline, betamethasone 
 ionic gelation felodipine 
Nanoparticles emulsion-droplet 
coalescence 
gadopentetic acid 
 coacervation/precipitation 
  
DNA, doxorubicin 
 ionic gelation nsulin, ricin, bovine serum 
albumin, cyclosporin A 
 reverse micellar method doxorubicin 
Beads coacervation/precipitation adriamycin, nifedipine, bovine 
serum albumin, salbutamol 
sulfate, lidocaine–HCl, riboflavin 
Films Solution casting sosorbide dinitrate, 
chlorhexidine gluconate, 
trypsin, granulocyte-
macrophage colony-stimulating 
factor, acyclovir, riboflavine, 
testosterone, progesterone, 
beta-oestradiol 
Gel Crosslinking chlorpheniramine maleate, 
aspirin, theophylline, caffeine, 
lidocaine–HCl, hydrocortisone 
acetate, 5-fluorouracil 
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1.6 Thesis goal 
The main purpose of this work is the development of chitosan (CS) based membranes for 
human and veterinary soft tissue regeneration and repair. In this work, different 
typologies of CS scaffolds are prepared varying the chemical composition by using 
different crosslinking mechanisms and the membrane structure through different 
fabrication techniques. 
CS has been selected as a candidate material for the development of bioartifical 
constructs in the field of soft TE because of its attractive properties in terms of 
biocompatibility, biodegradability, non-antigenicity, antibacterial activity and low cost 
[222]. Moreover, CS matrices of various forms such as films [75] porous scaffolds [223], 
hydrogels [15], nanofibers [224-226] can be easily fabricated. However, the main 
limitations of CS for TE applications are its inadeguate mechanical strength and low 
stability in biological environment. The improvement of CS properties can be achieved by 
modifying CS with ionic or covalent crosslinking agents (i.e. glutaraldehyde, γ-
glycidoxypropyltrimethoxysilane, tripolyphosphate, genipin) [227-230]. 
In the first part of this thesis, CS based compact films are crosslinked using different 
compounds with the aim to provide the basis for the selection of a crosslinking strategy 
able to impart the required properties to CS membranes in the design of a biomaterial. 
Three non cytotoxic compounds, genipin (GP), γ-glycidoxypropyltrimethoxysilane 
(GPTMS), dibasic sodium phosphate (DSP), widely used as CS crosslinking agents, have 
been selected. GP is a biocompatible crosslinking agent, and it is less-toxic than 
traditional chemical agents, such as formaldehyde, glutaraldehyde and epoxy compounds 
[227, 228]. GPTMS is a silane coupling selected for its oxygen permeability [231], 
biocompatibility and biodegradability [229]. DSP is a non-toxic polyanion which can 
interact with CS via electrostatic forces to form ionic crosslinked membrane [230]. The 
effect of crosslinking on CS based biomaterials and scaffolds performances in terms of 
physico-chemical, thermal and mechanical properties, as well as degradation and water 
stability is described in the first part of this thesis. 
The aim of the second part of the thesis is the development of different CS based 
membranes for peripheral nerve TE in human applications. Membranes chemical 
composition is selected in order to i) provide suitable mechanical and physico-chemical 
properties (ii), favour wrapping and suturing at the implant site, (iii) avoid the risk of 
compression of the regenerating nerve and (iv) ensure the supply of oxygen and 
nutrients. Different CS based scaffold morphologies are obtained by varying the 
fabrication methods. Two alternatives for CS based hollow nerve guide channels (coded 
as CS flat membrane and bi-layer CS membrane) and a CS based nanostructured as 
internal filler are prepared. 
- CS flat membranes crosslinked with DSP alone (CS/DSP) or in association with the 
GPTMS (CS/GPTMS_DSP) are fabricated with a solvent casting technique. The 
constituent ratio of crosslinking agents and CS are selected in the first part of this 
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thesis to obtain a composite material having both proper mechanical properties and 
good biocompatibility. At first, permeability study on the crosslinked flat samples is 
necessary to ensure the diffusion of nutrients through the CS/DSP and CS/GPTMS_DSP 
flat films. Then, the cellular response of glial-like cells, the rolling up and the 
suturability are evaluated on CS/GPTMS_DSP and CS/DSP flat membranes. In vivo tests 
are carried out on both the two types of nerve scaffolds for bridge implantation across 
10-mm long median nerve defects in rats, and the outcome of peripheral nerve repair 
at 12 weeks post-implantation is investigated. 
- Bi-layer CS membranes are prepared by a two-step coating technique. By this method, 
two kinds of CS flat membranes crosslinked with different compounds (optimized in 
the first part of the thesis) are combined to produce scaffold structures with good 
biocompatibility in the inner layer and with the desired mechanical strength protruded 
by the outer one. In detail, CS/DSP is selected as inner layer due to its biocompatibility 
and its capability to promote peripheral nerve functional recovery (results confirmed 
by in vivo test performed on CS flat membranes), while CS/GPTMS_DSP (GPTMS 25 % 
wt./wt.) is used for the realization of the outer layer. GPTMS addition increases 
mechanical strength and water stability of samples. The amount of GPTMS is optimized 
to allow the rolling up, suturability of bi-layer membranes and to reduce the risk of 
distal detachment. The two steps coating technique allows to control the wall 
thickness and to achieve a tight connection between the two layers. The initial studies 
are focused on a general physico-chemical, mechanical, dissolution and water uptake 
analysis of the CS bi-layered membranes. Permeability to nutrients using model 
molecules is evaluated and confirmed. Preliminary in vivo analysis of peripheral nerve 
recovery is carried out by rolling the developed membranes to form hollow conduits 
used to bridge 10 mm median nerve defects in rats. 
- Chitosan electrospun nanofibres are obtained starting from a 0.5 M acetic acid 
solution and using the electrospinning equipment. A first part of this work is focused 
on the optimization of the processing parameters to obtain CS based nanofibres from 
CS acetic acid solutions. Polyethylene oxide (PEO) and dimethylsulphoxide (DMSO) are 
added to the CS solution: PEO is a biocompatible synthetic polymer used to allow the 
spinnability of CS solutions at high polymer concentration with controllable fiber size; 
DMSO is introduced into the CS/PEO solution as a cosolvent to improve processing 
conditions and increase fiber yields by relaxing CS chain entanglement [226]. Process 
parameters are selected to prepare nanofibres in the range of 100-200 nm that have 
been reported to be advantageous for glial cell adhesion and proliferation as 
compared to fibres with 700 nm dimensions [232]. The use of DSP (the constituent 
ratio has been selected in the first part of this thesis) as a crosslinker of the nanofibres 
allows to neutralize CS/PEO_DMSO solution and does not influence the nanofibre 
structure. After preliminary morphological, physico-chemical and mechanical 
characterisation of DSP crosslinked CS based nanofibres (CS/PEO_DMSO_DSP), the 
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structural integrity of nanofibres in physiological solution is examined under 
physiological conditions. 
The aim of the third part of this thesis is the development of CS based porous 
membranes for the treatment of wound injuries in veterinary applications. Due to the 
similarity of animal wound healing process with humans, skin TE seems to be a promising 
alternative approach to treat wound injuries compared to conventional treatments 
adopted by veterinarians. The developed membranes should: i) absorb exudates and toxic 
components from the wound surface; ii) maintain a high humidity at the wound/dressing 
interface in order to avoid dessication and to promote re-epithelialization and cellular 
migration; iii) protect the wound from bacterial penetration; iv) allow gaseous exchange, 
necessary for the introduction of oxygen to the wound site as well as the elimination of 
carbon dioxide and v) be biodegradable, avoiding to periodically remove the device 
causing trauma to the wound.  
CS has been selected for the current study because of its widely use in wound 
management both in humans and animals: CS stimulates the migration of PMNs and 
macrophages [233], explicating an anti-inflammatory effect and is a hemostatic effect 
[234-238]. 
The goal of this part of the thesis is the design of CS porous membranes with improved 
antimicrobial properties able to promote the wound healing process and to reduce the 
bacterial proliferation in chelonian shell injury site. On the basis of the results obtained in 
the first part of the thesis, CS membranes are crosslinked with GPTMS and DSP and are 
fabricated by freeze-drying. Silver nanoparticles (AgNPs) and gentamicin sulphate (GS) are 
incorporated into the CS matrices to impart the proper antibacterial properties and to 
guarantee drug controlled release in time and in space avoiding the risk of systemic 
toxicity. Three different concentrations for the incorporation of AgNPs (5%, 10% and 15% 
wt./wt) are investigated while GS dosage is selected according to the conventional 
veterinary treatment for chelonian carapace healing. After a preliminary analysis on 
morphological, mechanical and water absorption properties, AgNPs with intermediate 
concentration is selected as ideal candidate. GS release analysis from CS porous 
membranes loaded with the antibiotics is evaluated. Antibacterial efficacy against Gram+ 
and Gram- bacteria is investigated. Finally preliminary in vivo tests on Testudo Hermanni 
are conducted. 
This thesis work addresses the research activities of: BICONERVE (“Biomimetic constructs 
for nerve regeneration”) financed Regional project, and a collaboration with the 
Department of Veterinary Sciences, Università di Torino and the “Clinica per animali 
esotici” in Roma. 
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Chapter 2 
Chitosan membranes for tissue 
engineering: comparison of different 
crosslinkers 
 
Abstract 
Chitosan (CS), a derivative of the naturally occurring biopolymer chitin, is an attractive 
material for biomedical applications because of its biocompatibility, biodegradability and 
immunological, antibacterial and wound-healing properties. However, the physical and 
mechanical stability of CS based materials are strongly influenced by the crosslinking 
method. In this work, the effect of the three crosslinking agents genipin (GP), γ-
glycidoxypropyltrimethoxysilane (GPTMS), dibasic sodium phosphate (DSP) and a 
combination of GPTMS and DSP (GPTMS_DSP) on CS physicochemical, thermal, 
morphological, mechanical properties, swelling and degradation behavior at physiological 
condition was investigated. The possibility to tailor the final properties of CS scaffolds 
through crosslinking is a key strategy to apply CS in different biomedical and tissue 
engineering applications. The obtained results reveal that the optimization of the 
crosslinking mechanism provide CS membrane properties required in different biomedical 
applications. 
2.1 Introduction 
Tissue engineering (TE) provides a novel way to assist and accelerate the regeneration 
and repairing of defective and damaged tissues based on the natural healing potential of 
humans. A major goal of TE is the design of biomaterial-based scaffolds containing cells 
and signaling molecules, as transplantable constructs, to enable the recovery of 
physiological functions in the host alternatively to conventional surgical techniques. In 
this context, biomaterial composition and processing technologies play a pivotal role in 
the field of TE. Among the various biomaterials, polysaccharides have recently gained 
interest as materials for scaffold fabrication, since their carbohydrate moieties interact 
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with or are integral component of several matrix glycoproteins and cell adhesion 
molecules [1]. Chitosan (CS), a copolymer of glucosamine and N-acetyl-glucosamine, is 
obtained by alkaline deacetylation of chitin, which is the main component of the 
exoskeleton of crustaceans, such as shrimps [2]. CS has attracted considerable interests 
for biomedical applications due to its attractive properties in terms of biocompatibility, 
biodegradability, non-antigenicity, antibacterial activity and low cost [3]. Moreover, CS 
offers several advantages that make it particularly enticing for TE applications: CS can be 
easily molded into matrices of various forms such as films [4], porous scaffolds [5], 
hydrogels [6], nanofibers [7-9] and drug carriers [10]. As a result of the protonation of 
free amino groups under acidic conditions (pH <6), CS exhibits a pH-dependent cationic 
nature and has the ability to interact with anionic components (glycosaminoglycans and 
proteins) [11, 12]. 
For most medical application, CS has been crosslinked in order to improve its mechanical 
strength and its structural integrity under physiological conditions. Commonly used 
chemical crosslinkers in literature include epoxy compounds [13], aldehydes 
(formaldehyde, glyceraldehyde and glutaraldehyde) [14, 15] and carbodiimides [16, 17]. 
They all exhibit a certain degree of cytotoxicity and may therefore impair biocompatibility 
of CS scaffolds. For this reason, increasing interest has been recently gained by less 
cytotoxic crosslinking agents such as enzymes [18] or naturally derived crosslinking 
agents, having a lower toxicity [19-22]. The effect of crosslinking strongly influences the in 
vivo performance of the scaffolds in terms of mechanical properties, degradation, water 
stability and cellular response. An analysis and comparison of different CS crosslinkers is 
however not currently available and is the aim of this study. Three compounds, widely 
used as CS crosslinkers, were selected. Genipin (GP), a natural cross-linker, is an aglucone 
of geniposide extracted from Gardenia jasminoides and obtained from geniposide via 
enzymatic hydrolysis. GP is 10,000 times less toxic than glutaraldehyde [20, 23] although 
its crosslinking mechanism is similar to other synthetic chemical crosslinking agents. 
Glycidoxypropyltrimethoxysilane (GPTMS) is a silane coupling agent, which has epoxy and 
methoxysilane groups. The epoxy groups react with the amino groups of CS molecules 
while the methoxysilane groups are hydrolyzed and form silanol groups [24]. GPTMS has 
been largely used to crosslink CS films and membranes for different TE applications [25, 
26]. Introduction of silica into the biomaterials has been shown to increase its oxygen 
permeability [27], biocompatibility, biodegradability [28] and to improve the flexibility of 
the CS based samples [25]. Dibasic sodium phosphate (DSP) is a non-toxic polyanion 
which can interact with CS via electrostatic forces to form ionic crosslinked membrane 
[29]. A novel in situ forming CS formulation has been recently developed via coupled ionic 
and covalent co-cross-linking [30]. The addition of DSP (as ionic crossilinker) neutralizes 
CS based samples avoiding the need of a rinsing step in sodium hydroxide solution. By 
combining DSP with GP, porous scaffolds were also fabricated by chemical cross-linking 
showing higher mechanical and chemical properties compared to those obtained using 
the single crosslinkers [30]. 
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Despite the numerous reports on the potential applications of CS scaffolds as biomaterials 
in clinics and pharmaceutical field, reports that compare the effect of different 
crosslinkers on the physicochemical, thermal and mechanical properties are still lacking. 
For this reason, this work compares the effects of various crosslinking methods (through 
covalent or ionic bonding) on the physicochemical, thermal and mechanical properties of 
CS flat membranes. The crosslinking agents used included GP, GPTMS, dibasic sodium 
phosphate (DSP), and a combination of GPTMS and DSP. The GP, GPTMS and DSP 
amounts were selected on the basis of data from literature analysing the use of different 
crosslinking agents [19, 25, 30]. 
2.2 Experimental 
2.2.1 Materials 
CS (medium molecular weight, 75%-85% deacetylation degree), GPTMS and DSP were 
supplied from Sigma Aldrich. GP was purchased from Challenge Bioproducts Ltd. Taiwan. 
All solvents used were of analytical grade and used without further purification. 
2.2.2 Methods 
CS was dissolved in acetic acid solution 0.5 M at room temperature by continuous stirring 
to obtain a 2.5 % (w/v) solution. The crosslinked membranes were prepared according to 
the following procedures: 
I. GP-crosslinked samples (CS/GP) were obtained by adding GP (2.5% w/w) to the CS 
solution. The resulting solution was kept under moderate stirring until a green-bluish 
gel started to form as suggested by visual inspection and by the viscosity increase of 
the mixture. 
II. GPTMS-crosslinked samples (CS/GPTMS) were prepared by adding GPTMS (75% w/w) 
to CS solution. The amount of GPTMS was selected according to literature [25] in 
order both to obtain the maximum crosslinking degree of CS chains and to increase 
the mechanical properties. The resulting solution was kept under stirring at room 
temperature for 1 hour. 
III. DSP-crosslinked samples (CS/DSP) were obtained by adding DSP 1M (one drop per 
second) to the CS solution with a concentration of 7.5 % v/v with respect to the 
natural polymer solution volume. The mixed solution was kept under stirring at room 
temperature for about 10 minutes.  
IV. GPTMS_DSP-crosslinked samples (CS/GPTMS_DSP) were obtained adding GPTMS 
(50% w/w) to the CS solution. The resulting CS/GPTMS solution was kept under 
stirring for 1 hour, followed by the dropwise addition (one drop per second) of DSP 
1M (concentration 7.5 % v/v) and maintained under moderate stirring for 10 
minutes. 
Then, 10 ml of each solution (CS/GP , CS/ GPTMS, CS/DSP and CS/GPTMS) was poured 
into 6 cm Petri dishes and air-dried for 48 h to obtain ﬂat membranes. All crosslinked 
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dried samples were dipped into demineralised water for 10 minutes and then the water 
pH values were measured to evaluate the presence of acidic residues. Uncrossilinked CS 
flat membranes were prepared as control following the procedures described above 
without adding any crosslinker. Acid pH were obtained for CS, CS/GP, CS/GPTMS films. 
Consequently, CS, CS/GP, CS/GPTMS samples were neutralized by rinsing in a 0.1M NaOH 
solution followed by 5 washing in distilled water to obtain physiological pH.  
2.2.3 Sample characterization 
2.2.3.1 Fourier transform infrared-attenuated total reflectance spectroscopy (FTIR-ATR) 
The FTIR-ATR spectra of CS, CS/GP, CS/GPTMS, CS/DSP, CS/GPTMS_DSP samples were 
recorded at room temperature in a Perkin Elmer Spectrometer in the range 2000-600 cm-
1 at a resolution of 4 cm-1. 
2.2.3.2 Surface wettability 
The static contact angle of CS, CS/GP, CS/GPTMS, CS/DSP and CS/GPTMS_DSP films were 
measured at room temperature using a KSV instrument equipped with a CAM 200 
software for data acquisition. Sessile drop method was applied, using a 5 μL double 
distilled water droplet. For each angle reported, at least five measurements on different 
surface locations were measured and results were expressed as average value ± standard 
deviation. 
2.2.3.3 Swelling and dissolution test 
The swelling and dissolution behavior of the uncrosslinked and crosslinked CS samples 
were evaluated by immerging the samples in PBS (pH 7.4) at 37°C. The swelling degree 
was measured after 1, 3, 6, 9 and 24 hours while the dissolution degree was evaluated 
after 1, 3, 5, 7, 14, 28 and 56 days. The swelling percentage was calculated as: 
ΔWs (%) = (Ws-W0)/W0*100 
where W0 and WS are the sample weights before and after swelling respectively. The 
dissolution percentage was calculated as: 
ΔWd (%) = (W0-Wd)/W0*100 
where Wd is the dried sample weight after dissolution. The solution pH was measured at 
the same time intervals during the swelling and the dissolution tests, and its stable value 
at around 7 (physiological pH) was verified. For each experimental time, three samples 
were measured and the results were expressed as averages value  standard deviation. 
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2.2.3.4 Morphological characterization and element distribution 
The external surface morphology of CS, CS/GPTMS, CS/DSP and CS/GPTMS_DSP flat 
membranes was observed by scanning electron microscopy (SEM LEO – 1430, Zeiss). 
Using an energy dispersive spectrometer (EDS), qualitative compositional analysis was 
performed and punctual elemental composition of materials with high spatial resolution 
was accomplished. Samples were sputter coated with gold in a undervacuum chamber 
prior to SEM-EDS examination. 
2.2.3.5 Thermogravimetric analysis (TGA) 
Thermal degradation was measured using a TA INSTRUMENT Q500 equipment. The 
experiments were performed with a 10-15 mg sample in aluminum pans under a dynamic 
nitrogen atmosphere between 40°C and 800 C. The experiments were run at a scanning 
rate of 10°C/min and obtained results were analyzed using TA Universal Analysis 
software. 
2.2.3.6 Differential scanning calorimetry (DSC) 
DSC was performed on CS based membranes using a TA INSTRUMENT DSC Q20. 
Accurately weighted (6-10 mg) samples were placed into aluminum cups and sealed. A 
small hole was done at the top of the cup in order to allow the release of water. An empty 
cup was used as reference. The samples were detected in the ﬁrst heating scan run in the 
temperature range of 30–200 °C. The experiments were run at a scanning rate of 
10°C/min. Water evaporation temperature (Twe) and enthalpy (ΔHwe) were calculated as 
the temperature of the maximum value of the endotherm and the peak area, 
respectively. For CS/GP, CS/GPTMS, CS/DSP and CS/GPTMS_DSP samples, the enthalpy 
values were normalized based on the contents of uncrosslinked CS.  
2.2.3.7 Mechanical properties 
The tensile mechanical properties were performed on dry and wet flat membranes using 
MTS QTest/10 device equipped with load cells of 50N and of 10N, respectively. 
Rectangular strips of 30 mm x 10 mm size were cut from each films and strained to break 
at a constant crosshead speed of 2 mm/min. Using the associated software Test Works, 
break stress and strain were determined. The elastic modulus was calculated from the 
slope of the linear portion of the stress–strain curve. To measure the thickness of the 
films, digital calibrator was used. Prior to tensile testing in wet state, samples were 
immersed in phosphate buffered saline (PBS, pH 7.4) for 10 min at 25°C. Four specimens 
for each kind of material were tested. The results were expressed as average values ± 
standard deviation. 
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2.2.3.8 Statistics 
Experiments were repeated three times and results expressed as an mean ± standard 
deviation. Statistical significance was calculated using analysis of variance (ANOVA). A 
comparison between two means was analyzed using Tukey's test with statistical 
significance level set at p <0.05. 
2.3 Results and discussion 
2.3.1 Membrane preparation 
Crosslinked CS membranes were obtained from casting the CS acetic acid aqueous 
solution containing GP, GPTMS, DSP or a combination of GPTMS and DSP respectively. In 
all processes, in situ crosslinking and sample preparation were performed with the 
conventional fabrication technique in order to provide a convenient way of preparing 
crosslinked CS membranes. Fig. 2.1 schematizes the different crosslinking mechanisms. 
The GP reaction is influence by the pH value. In acetic acid solution (acidic condition), a 
nucleophilic attack by the amino groups of CS on the olefinic carbon atom at C-3 occurs, 
followed by opening the dihydropyran ring and attachment of the secondary amino group 
on the newly formed aldehyde group while the short chains of condensed GP act as 
crosslinking bridges. The dark-blue coloration that appears in the samples exposed to air 
is associated with the oxygen radical induced polymerization of GP as well as its reaction 
with amino groups (Fig. 2.1A). GPTMS reacts with the amino groups of CS chains through 
its oxirane ring. Meanwhile the hydratation of the trimethoxy groups of GPTMS moiety 
forms silantriol pendent through acid-catalyzed reaction. Dehydration reaction among the 
silantriol groups occurs during the drying process and forms inter-chain linkages between 
CS chains [20] (Fig. 2.1B). DSP is a sodium salt of phosphoric acid able to increase the pH 
value of CS solution to around neutrality (pH≈7). DSP is negatively charged in solution and 
thus may interact with CS via electrostatic forces to form ionic crosslinked membrane 
(Fig. 2.1C). The combination of GPTMS and DSP exploit both the chemical and ionic co-
crosslinking mechanism (Fig. 2.1D). 
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Fig. 2.1. Chemical structure of CS crosslinked with: GP (A), GPTMS (B), DSP (C) and a combination 
of GPTMS and DSP (D). 
2.3.2 Fourier transform infrared-attenuated total reflectance spectroscopy (FTIR-ATR) 
In Fig. 2.2, the FTIR-ATR spectra of CS, CS/GP, CS/GPTMS, CS/DSP and CS/GPTMS_DSP are 
reported. The five spectra showed the typical adsorption bands of CS: peaks at 1151 cm-1 
(C-O-C stretching) and at 1019 cm-1 (C-O stretching) were associated to vibrational modes 
typical of the saccharide structure of CS [31]; absorption bands at 1637 cm-1 and 1542 cm-
1 resulted from axial stretching of C=O in amide group (amide I band) and NH2 bending 
vibration of amino groups and N-H bending of amide groups, respectively; the vibration 
modes at 1414 cm-1 and at 1319 cm-1 were assigned to O-H bending (originating from CS 
deacetylation) and C-H bending vibrations [31]. No significant differences were detected 
between the CS and CS/GP spectra, as also described by Mi et al. [32]. The introduction of 
silane groups by GPTMS crosslinker (CS/GPTMS samples), caused the appearance of new 
bands at 920 cm-1, at 1020 cm-1 and 1150 cm-1 in FTIR spectra, associated with the 
stretching of Si-OH bonds and Si-O-Si vibrations, respectively [25, 26]. In addtion, the peak 
at 1000- 1100 cm-1 broadened and increased its intensity owing to the absorption from Si-
O-C stretching bonds [33]. As regard the CS/DSP FTIR spectra, new peaks were detected 
at 1150 cm-1 and 1000 cm-1 which could be attributed to the PO3 out-of-phase stretching. 
Bands at 989 cm-1 and 943 cm-1 were associated with PO3 in-phase-stretching. The 
detected peaks at 861 cm-1 and at 814 cm-1 were associated with P-OH stretching and P-
O-P asymmetric stretching vibration respectively [34]. The FTIR spectra of CS/GPTMS_DSP 
hybrid sample showed the typical adsorption bands of both the ionic and covalent 
crosslinkers: bands at 1200 cm-1, due to the Si-O-Si bonds, confirmed the crosslinking of 
CS by GPTMS; peaks at 1150 cm-1 and 1000 cm-1 (PO3 out-of-phase stretching), 861 cm
-1 
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(P-OH stretching) and 814 cm-1 (P-O-P) asymmetric groups evidenced the presence of 
DSP. The absorption band at 1720 cm-1 was observed in CS/GPTMS, CS/DSP and 
CS/GPTMS_DSP spectra and could be attributed to the stretching vibration of C=O groups, 
probably due to acetic acid residuals [35]. 
 
Fig. 2.2. FTIR-ATR spectra of CS, CS/GP, CS/GPTMS, CS/DSP and CS/GPTMS-DSP films. 
2.3.3 Surface wettability 
The static water contact angles of both crosslinked and uncrosslinked CS flat membranes 
are reported in Fig. 2.3. Uncrosslinked CS samples displayed a slightly hydrophilic 
behavior with a contact angle in the 83°–88° range. Crosslinking with GP or GPTMS did 
not change the surface wettability significantly (85.1°±0.9° for CS/GP and 85.8°±1.0° for 
CS/GPTMS). On the other hand, CS/DSP based samples presented a significant higher 
hydrophilicity respect to the CS, CS/GP and CS/GPTMS samples. The enhanced 
hydrophilicity caused by the addition of DSP is attributed to the presence of hydrophilic 
phosphate groups in DSP. Water contact angles of CS/DSP and CS/GPTMS_DSP film 
samples were not significantly different (66.0°±9.7° for CS/DSP and 57.7±9.2° for 
CS/GPTMS_DSP). The presence of DSP is expected to effort in vitro and in vivo cells 
response since cell adhesion, which depends on various parameters, is known to be 
maximised on surfaces with an intermediate wettability (with 50–70° water contact 
angle) [36, 37]. 
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Fig. 2.3. Static water contact angle of CS, CS/GP. CS/GPTMS, CS/DSP and CS/GPTMS_DSP film 
samples. Histograms reported the  average values and the standard deviations. **p <0.001 and 
***p < 0.0001. 
2.3.4 Swelling and dissolution tests 
The swelling and dissolution of CS network greatly depend on the internal structural 
parameters of the swelling network such as the amounts of constituent polymers present, 
crosslink density of the membrane, presence of hydrophilic and/or hydrophobic 
functional groups, etc. Fig. 2.4A reports the swelling degrees of CS, CS/GP, CS/GPTMS, 
CS/DSP and CS/GPTMS_DSP samples, respectively. A comparison of the swelling 
percentage of CS crosslinked samples reveals that the water uptake of uncrosslinked 
samples is significantly higher than for all CS crosslinked specimens at each time point 
(***p<0.0001). CS is a hydrophilic, cationic polymer, which causes CS flat membranes to 
have a higher water uptake respect to ionic and covalent crosslinked samples: CS/GP, 
CS/DSP, CS/GPTMS and CS/GPTMS_DSP contain less free NH3
+ moieties and decrease the 
ability of CS to form hydrogen bonds with water molecules. Moreover, the presence of 
GPTMS causes a maximum reduction in the swelling degree of CS associated to the 
formation of a well-organized polymer structure [25]. In detail, CS and CS/DSP films 
increased considerably their weight immediately after 1 h of immersion in PBS solution 
showing a significantly higher degree of water uptake of 1366±189% and 532±25%, 
respectively (***p<0.0001). By contrast, the swelling degree of CS/GPTMS and 
CS/GPTMS_DSP reached values of 7±4% and 29±12% respectively, after 1 h incubation in 
PBS. Both films achieved equilibrium swelling degree after immersion for 3 h and the 
maximum degree of water uptake was about 30±2% for CS/GPTMS and 48±2% for 
CS/GPTMS_DSP after 24 h. No significant differences were observed between CS/GPTMS 
and CS/GPTMS_DSP samples at each time step. The presence of many Si-OH and Si-O-Si 
groups, which depends on the degree of polymerization of GPTMS has been shown to 
influence water uptake: an increase in the GPTMS content contributes to an increase in 
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number of hydrophilic silicate units, and reduces as a consequence CS water uptake [25]. 
An increase of swelling degree was observed by adding DSP to CS/GPTMS and could be 
attributed to the presence of hydrophilic phosphate groups in DSP. This behaviour is 
confirmed for CS/DSP samples where a higher water uptake is observed. An intermediate 
behavior was observed for CS/GP specimens reaching a stable value swelling degree of 
280±30% after 1 h of immersion in PBS. CS/GP crosslinked films showed low swelling ratio 
as compared to uncrosslinked CS that could be due to the formation of molecular linkages 
(heterocyclic amino linkage) by GP.  
Dissolution tests were performed on crosslinked CS films, with the aim to study their 
stability in aqueous environment. The degradation profiles of crosslinked CS samples after 
56 days of immersion in PBS are presented in Fig 2.4B. The stability of the CS based 
samples in PBS solution increased when GPTMS and GP were used as crosslinking agents. 
Analyzing the weight loss degree, CS/GPTMS_DSP and CS/DSP membranes presented a 
significant dissolution after 1 day immersion in PBS reaching values of 38% and 44%, 
respectively. CS/GPTMS and CS/GP films showed lower weight loss respect to CS/DSP and 
CS/GPTMS_DSP specimens, with 15% and 18% degradation respectively after 1 day and 
reached a final value of about 35% and 21% after 56 days incubation in PBS. Compared to 
the CS/DSP and CS/GPTMS_DSP samples that lost the 67% and 50% of the initial weight 
after 8 weeks, chemical crosslinking by the addition of GPTMS or GP agents enhanced the 
stability in aqueous media. CS/GP samples reached a stable value of weight loss after 1 
day in immersion in PBS solution. On the contrary, the presence of DSP as ionic 
crosslinking increased the weight loss 1 day after immersion in PBS and was associated to 
the release of salts into the PBS solution.  
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Fig. 2.4. Swelling (A) and dissolution (B) degrees for CS/GP, CS/GPTMS, CS/DSP and 
CS/GPTMS_DSP films. Measurements were carried out in PBS at pH 7.4, at 37 °C. Column heights 
correspond to the mean values. Bars indicate standard deviations (n = 3). *p< 0.05, **p < 0.001 
and ***p < 0.0001. 
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2.3.5 Morphological characterization and chemical composition 
SEM-EDS analysis was performed on the surfaces of films to evaluate the effect of the 
different crosslinking methods on sample morphology and chemical composition. EDS 
elemental mapping is a powerful method to identify the elemental composition in distinct 
region of a material [38, 39]. No phase separation between CS and crosslinking agents 
was observed (data not shown). Fig. 2.5 reports the EDS element-mapping on the surface 
for CS/GP, CS/GPTMS, CS/DSP and CS/GPTMS_DSP films. EDS spectra of crosslinked 
samples (insert in Fig. 2.5 A, B, C, D) showed the characteristic elements of CS: carbon (C) 
and oxygen (O) and also the peak relative to silicon (Si) for CS/GPTMS and to sodium (Na) 
and phosphate (P) for CS/DSP, respectively; moreover, characteristic peaks corresponding 
to Si, Na and P elements were found on the CS/GPTMS_DSP films and were associated 
both to the presence of both the ionic and covalent crosslinkers (insert in Fig. 2.5). No 
compositional differences were found between CS and CS/GP samples (data not shown). 
The green and the red spots corresponding to silicon (Si) and phosphorus (P) elements 
(Fig. 2.5) were found homogeneously distributed in the CS/GPTMS and CS/DSP samples, 
respectively while both spots were observed to be uniformly dispersed in CS/GPTMS_DSP 
films. The EDS mapping results suggested uniform CS crosslinking for all the analysed 
compositions.  
 
Fig. 2.5. EDS spectra of compact films: surface of (A) CS/GP, (B) CS/GPTMS, (C) CS/DSP and 
CS/GPTMS_DSP. 
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2.3.6 Thermogravimetric analysis (TGA) 
The decomposition profile of CS, CS/GP, CS/GPTMS, CS/DSP and CS/GPTMS_DSP 
membranes was evaluated by TGA analysis in a temperature range from 40°C to 800 °C. 
The derivative of TGA curves (DTG), as shown in Fig. 2.6, revealed two separate 
degradation phenomena both for crosslinked and uncrosslinked CS samples: the first 
decomposition step started from 50°C and continued to above 150 °C and was related to 
the water evaporation; the second weight loss was observed in the 180-400 °C 
temperature range and was attributed to the decomposition of CS main chains. Pure CS 
showed a first thermal degradation at around 103 °C and a second stage, associated to 
the thermal and oxidative decomposition of CS and to the vaporization and elimination of 
volatile products, starting at 181 °C and reaching a maximum at 265 °C with a total weight 
loss of 35% [40]. In CS/GP samples, the second degradation step started at about 190 °C 
and degradation was completed at 497 °C. The temperature of the maximum degradation 
rate was measured at 264 °C. No relevant differences in the weight loss associated to this 
second step were observed for CS/GP samples respect to pure CS. According to literature 
[41], the obtained result confirmed that GP addition had no influence on thermal stability 
of CS membranes. CS/GPTMS hybrids exhibited improved thermal stability respect to 
pure CS and CS/GP film samples. The initial weight loss of CS/GPTMS samples was 
attributed to water evaporation. The second degradation step resulted from the thermal 
degradation of the crosslinked material. The temperature of maximum rate of 
degradation was shifted to a higher value respect to CS and CS/GPTMS (281 °C) and 
associated with a weight loss of 27%. A new weight loss was observed in a temperature 
range between 330 °C and 550 °C. Such changes might indicate the hybridization between 
the organic and inorganic parts, as suggested by a previous study [42]. The weight loss at 
281 °C might be due to the cleavage of relatively unstable parts of the polymeric 
compound and the structural reorganization of the polysiloxane, while the third weight 
loss stage might correspond to the complete decomposition of the backbone of the 
polymeric matrix. In CS/DSP samples the first degradation step was observed at around 
80 °C and the corresponding weight loss was higher than CS, CS/GP and CS/GPTMS due to 
superior hydrophilicity of CS/DSP. Polymer pyrolysis was detected in the 250-500 °C range 
temperature with the maximum rate of degradation at 271 °C. During the degradation 
step, weight loss was also associated to DSP reactions: at higher temperatures than 
210°C, DSP starts to condense forming disodium pyrophosphate and above 300 °C 
metaphosphates form, leading to an additional weight loss [43] (31%). For 
CS/GPTMS_DSP the first degradation stage started at about 100 °C and the second stage 
showed a rapid weight at about 273 °C due to degradation of CS. Complete degradation 
occurred at 550 °C conﬁrming an increase of the thermal stability of CS films caused by 
the hybridization between the organic and inorganic parts of CS/GPTMS_DSP samples. 
The total weight loss of the crosslinked and uncrosslinked CS samples at about 550 °C was 
in a range between 50% and 58%. The remaining solid residue is mostly due to the 
formation of inorganic compounds containing C, N and O. Similar multi-degradation 
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behavior of CS film was reported in the literature [44, 45]. Table 2.1 collects the maximum 
degradation rate temperature (Td) of CS based samples and the corresponding weight 
losses. The Td values of CS and CS/GP films were similar, while for the other crosslinked 
samples, the Td was shifted to higher temperatures. Moreover, the final weight loss of the 
CS/GPTMS, CS/DSP and CS/GPTMS_DSP samples was lower than that of CS and CS/GP 
specimens. TGA analysis confirmed the improvement of the thermal stability of 
crosslinked CS, especially when both GPTMS and DSP crosslinking agents were used. 
 
Fig. 2.6. First derivative of TGA curves of CS, CS/GP, CS/GPTMS, CS/DSP and CS/GPTMS_DSP films. 
Table 2.1. Maximum degradation rate temperature (Td) and corresponding weight loss for CS and 
crosslinked CS. 
Sample Td (°C) Weight loss (%) 
CS 265 35 
CS/GP 264 34 
CS/GPTMS 281 28 
CS/DSP 271 31 
CS/GPTMS_DSP 273 32 
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2.3.7 Differential scanning calorimetry (DSC) 
DSC analysis was performed to analyze the thermal behavior of CS based materials as it is 
influenced by the different crosslinking treatments. The DSC thermograms, shown in Fig. 
2.7, compare the first heating traces for pure CS and CS crosslinked samples in the 
temperature range from 30°C to 200°C. The maximum temperature of 200°C was selected 
in order to limit possible CS degradation, as confirmed by thermogravimetric analysis (see 
paragraph 2.3.6). All DSC traces presented an endothermic event in the temperature 
range of 90°C-100°C which features were collected in Table 2.2. For all CS based 
membranes, the endothermic event was not directed in the second DSC run (data not 
shown in Fig. 2.7), confirming the hypothesis that water evaporation occurred during the 
first cycle [40, 46]. A detailed examination of Fig. 2.7 revealed differences among the 
samples in the endothermic peak enthalpy and temperature. This result is attributable to 
different water holding capacity and to water–material interactions ascribed to the 
physical and molecular changes as a consequence of the crosslinking process. CS heating 
trace showed an endothermic peak at 95°C while the DSC heating trace of CS/GPTMS was 
characterized by the presence of a splitted endothermic event at around 100°C. CS and 
CS/GPTMS possess polar groups, which are able to adsorb water and establish onto 
hydrogen bonds with it. According to literature [47], upon heating, the thermally 
activated water molecules tend to be released: water molecules which are bound to 
amino groups are removed easier than those bound to hydroxyl groups. In CS/GPTMS 
films, some amino groups reacted with the oxirane group of GPTMS and, thus the number 
of amine groups available to interact with the water molecules decreased. Therefore, the 
amount of released water was lower than CS. Furthermore, as the hydrogen bonds 
between water molecules and CS hydroxyl groups were stronger compared to the ones 
with CS amino groups, CS/GPTMS endothermic peak shifted to a higher temperature 
value compared to the case of pure CS. On the contrary, for CS/GP samples, the DSC 
endothermic peak was shifted to lower temperature compared to the case of pure CS, in 
agreement with scientific literature [48]. The DSC heating traces of CS/DSP and 
CS/GPTMS_DSP films were characterized by an endothermic peak centered at around 85-
88°C. This event, again associated with the evaporation of water molecules, was shifted 
to lower temperatures compared to uncrosslinked CS due to weaker water–material 
interactions caused by the addition of DSP. The enthalpy value measured for 
uncrosslinked CS was 140 J/g. CS/GP enthalpy value did not change significantly upon 
crosslinking showing that GP did not affect the water holding capacity of CS. Following the 
introduction of GPTMS, DSP and GPTMS_DSP, enthalpy value changed indicating a 
definite correlation between the water holding capacity and chemical and supramolecular 
structures of this natural polymer. CS/GPTMS showed the lowest enthalpy value (80.8 J/g) 
compared to other CS membranes (Table 2.2); the use of GPTMS as crosslinker forms 
ordered and organized structures that significantly contribute to the decrease in the 
content of adsorbed water. On the contrary, the presence of DSP in CS/DSP and 
CS/GPTMS_DSP films led to higher enthalpy values of about 208 J/g and 184 J/g 
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respectively, indicating a stronger interaction with water molecules (and consequently an 
higher water uptake) due to the higher hydrophilicity associated with the ionic 
crosslinker. 
 
Fig. 2.7. The first heating scan DSC curve of CS, CS/GP, CS/GPTMS, CS/DSP and CS/GPTMS_DSP. 
Table 2.2. Differential scanning calorimetry (DSC) measurements for cross-linked films. 
Sample Peak temperature (°C) Enthalpy (J/g) 
CS 95.0 140.0 
CS/GP 85.0 160.0 
CS/GPTMS 100.0 80.8 
CS/DSP 85.0 208.2 
CS/GPTMS_DSP 87.0 184.4 
 
2.3.8 Mechanical properties 
Tensile tests were performed on control and crosslinked CS flat films both in dry and in 
wet conditions to determine the effect of crosslinking on sample stiffness. Dried CS based 
samples had a uniform thickness in the range of 60-90 μm while wet CS samples showed 
an increase in thickness reaching values within 90-130 μm. For all samples, at low strains 
(lower than 6%) the stress increased linearly with an increase in the strain. In this region, 
the ɕ-ɛ slope was calculated to obtain the elastic modulus. At strains >6%, the stress 
increased slowly with increasing strain until failure occurred (data not shown). Table 2.3 
shows the elastic moduli of CS samples in dry and wet state. In dry condition, the Young’s 
modulus of CS was around 1900-2800 MPa and the typical ɕ- ɛ behavior of a brittle and 
rigid material was observed [49]. The elastic modulus for CS/GP films did not show 
significant difference compared to pure CS confirming the brittleness and the poor 
flexibility of the CS membranes crosslinked with GP. The introduction of GPTMS, DSP or a 
combination of both in CS samples significantly decreased the Young’s modulus compared 
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to CS (**p<0.001) by obtaining values of 1643±92 MPa, 1090±72 MPa and 1250±100 
MPa, respectively. These results revealed that the mechanical resistance and flexibility of 
CS based films were altered by the addition of different crosslinkers because of the 
reorganization of the polymer structure. Furthermore, more hydrophilic CS membranes 
(CS/DSP and CS/GPTMS_DSP) showed a less bridle behavior thanks to the ability of water 
to plasticise the CS matrix. In wet condition the elastic modulus of CS significantly 
decreased and an opposite trend was observed compared to dry samples. The Young’s 
modulus of wet CS samples was about 0.212 MPa suggested a dramatical loss of stiffness. 
On the contrary, the crosslinking of CS films enhanced the mechanical resistance in wet 
state, and the elastic modulus calculated was 5.7±0.8 MPa for CS/GP, 21.3±2.9 MPa for 
CS/GPTMS, 3.5±1.1 MPa for CS/DSP and 23.0±2.7 MPa for CS/GPTMS_DSP samples. The 
significant stiffening of the crosslinked specimens was associated to the formation of a 
more organized structure following the addition of GP and GPTMS (statistical significant 
compared to CS, CS/GP and CS/DSP samples, ***p<0.0001) respect to pure CS. By adding 
DSP, an improved deformability of the samples was observed probably due to a water 
adsorption behaviour. CS/GPTMS_DSP showed an intermediate behavior compared to 
CS/GPTMS and CS/DSP films and samples (statistical significance, *p<0.05 and 
***p<0.0001 respectively) were found to be both highly elastic and resistant. 
Table 2.3. Elastic modulus calculated from the corresponding stress-strain curves of dry and wet 
CS based samples (average value ± standard deviation). 
Sample Edry (MPa) Ewet (MPa) 
CS 2300±438 0.22±0.06 
CS/GP 2030±208 5.73±0.84 
CS/GPTMS 1465±172 18.10±4.14 
CS/DSP 1402±300 3.47±1.06 
CS/GPTMS_DSP 1300±126 23.03±2.62 
 
2.4 Conclusion 
The results obtained in the present study provides the basis for choosing a crosslinking 
reagent that could impart the requisite properties to the CS membranes in the design of a 
biomaterial for different biomedical application. CS based matrices were treated with 
different crosslinking agents (GP, GPTMS, DSP and a combination of GPTMS and DSP) to 
investigate the effect on the physical and mechanical properties of CS following the 
chemical or the ionic crosslinking treatment. In details: 
 GP and GPTMS did not affect the surface wettability and the thermal degradation 
kinetics of samples respect to uncrosslinked CS. Both GPTMS and GP based crosslinking 
treatments allowed to significantly reduce the CS swelling and dissolution behavior 
and to enhance its mechanical resistance under wet condition; 
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 DSP contributed to increase the hydrophilicity of CS/DSP and CS/GPTMS_DSP samples 
as compared to CS, CS/GP and CS/GPTMS. The stronger interaction existing between 
water and CS chains after ionic crosslinking was confirmed by a higher water uptake 
degree and higher enthalpy values. Moreover, the higher water–material interaction 
following the addition of DSP to CS and CS/GPTMS solutions allowed to obtain more 
flexible membranes. The simultaneous use of GPTMS and DSP permitted to combine 
the features obtained both from GPTMS and DSP crosslinkers. Lower degree of 
swelling and dissolution respect to pure CS and CS/DSP were associated to the addition 
of the covalent crosslinker while the improved surface wettability for CS/GPTMS_DSP 
samples was attributable to the ionic agent. Concerning the mechanical properties, 
GPTMS enhanced the resistance of CS while DSP allowed to obtain more flexible 
specimens. 
In summary, these different crosslinkers for CS based membranes could offer a broad 
range of choices to be potentially used in biomedical applications such as biomaterial, 
drug delivery vehicles and skin tissue engineering. 
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Chapter 3 
Peripheral nerve tissue engineering: 
state of the art and 
chitosan based biomaterials 
 
3.1 Introduction 
Regeneration in the peripheral nervous system offers unique opportunities and 
challenges to medicine. Compared to the central nervous system (CNS), peripheral axons 
can regenerate resulting in functional recovery, especially if the distance to target is 
shorter than 3 cm as in distal limb injuries. However, this regenerative capacity is often 
incomplete and functional recovery with proximal lesions is limited. Autologous nerve 
graft transplantation is a feasible treatment in several clinical cases, but it is limited by 
donor site morbidity and insufficient donor tissue, impairing complete functional 
recovery. TE has introduced innovative approaches to promote and guide peripheral 
nerve regeneration by using biomimetic constructs inducing favorable 
microenvironments for nervous ingrowth. Promising strategies using nanotechnology 
have been recently proposed, such as the use of scaffolds with functionalized cell-binding 
domains, the use of guidance channels with cell-scale internally oriented fibers, and the 
possibility of sustained release of GFs and encapsulation of SCs. This chapter addresses: i) 
an overview of the biology of peripheral nerve and type of injuries and ii), the most recent 
TE approaches in view of future solutions for peripheral nerve repair. 
3.2 Biology of the peripheral nerve and injuries 
3.2.1 Central and peripheral nervous systems 
The nervous system is composed of organized group of cells specialized for the 
conduction of electrochemical stimuli from sensory receptors through a network to the 
site at which a response occurs. The nervous system includes both the CNS and peripheral 
nervous system (PNS). The two systems work together to collect information from inside 
the body and from the environment outside it. The CNS and PNS process the collected 
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information and then dispatch instructions to the rest of the body, making it respond. The 
CNS is the primary control center for the body and is made up of the brain and spinal 
cord. Injuries in these locations have only a very limited capacity to heal, because nerve 
regeneration tends not to occur. The PNS consists of a network of nerves that connect the 
CNS to the limbs and peripheral organs. The PNS is divided into: 
- the sensory nervous system which sends information to the CNS from internal organs 
or from external stimuli;  
- the motor nervous system which carries information from the CNS to organs, muscles, 
and glands. This latter one is divided into: i) the somatic nervous system (responsible 
for coordinating the skeletal muscle movements, and also for controlling external 
sensory organs such as the skin; it is the system that regulates activities that are under 
conscious control); ii) the autonomic nervous system (responsible for coordinating 
involuntary functions, such as breathing and digestion). This system is also called the 
involuntary nervous system. The autonomic nervous system can further be separated 
into the parasympathetic and sympathetic divisions. The parasympathetic division 
controls various functions including inhibiting heart rate, constricting pupils, and 
contracting the bladder. The nerves of the sympathetic division often have an opposite 
effect when they are located within the same organs as parasympathetic nerves. 
The CNS is contained within the dorsal cavity, with the brain in the cranial cavity and the 
spinal cord in the spinal cavity. Both the brain and the spinal cord are protected by bones: 
the brain by the bones of the skull, and the spinal cord by a set of ring-shaped bones 
called vertebrae. Unlike the CNS, the PNS is not protected by bones, leaving it exposed to 
toxins and mechanical injuries. 
The PNS has a much greater capacity than the CNS for natural regeneration after an 
injury, in large part because the glial microenvironment both secretes inhibitory factors 
preventing myelin and neuronal regeneration and lacks the ability to express necessary 
GFs [1]. Therefore, in response to small injuries, peripheral nerves can regenerate on their 
own over relatively short distances under appropriate conditions. 
3.2.2 Nervous tissue cells types 
The nervous system is primarily composed of two categories of cells: neurons and glial 
cells. 
The neuron is the basic unit in the nervous system. It is a specialized conductor cell that 
receives and transmits electrochemical nerve impulses. Chemical signaling occurs via 
synapses, specialized connections with other cells. Neurons connect to each other to form 
networks. This type of cell is highly specialized and amitotic. Functionally, neurons are 
classified as: 
- motor (efferent) neurons transmit impulses from the CNS to the effector organs such 
as muscles and glands. They usually have short dendrites and long axons;  
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- sensory (afferent) neurons respond to touch, sound, light and numerous other stimuli 
effecting sensory organs and transfer impulses from peripheral sense receptors to the 
CNS. They usually have long dendrites and relatively short axons; 
- interneurons (association neurons) are located entirely within the CNS in which they 
form the connecting link between afferent and efferent neurons. They have short 
dendrites and they may have either short or long axon. 
A typical neuron possesses a cell body (often called the soma), dendrites, an axon, and 
synapses (Fig. 3.1). Dendrites are short extensions that arise from the cell body, often 
extending for hundreds of µms and branching multiple times, giving rise to a complex 
"dendritic tree". They receive information from another cell and transmit the message to 
the cell body. The soma ensures the vital functions of the neuron and integrates signals 
from the dendrites. The cell body has a nucleus with at least one nucleolus and contains 
many of the typical cytoplasmic organelles typical of eukaryotic cells. However, it lacks 
centriols. The axon is a special cellular protrusion that arises from the cell body at a site 
called the axon hillock and travels for a distance, as far as 1 m in humans or even more in 
other species. Its main function is to carry the electrical signals produced by the cell body. 
The cell body of a neuron frequently gives rise to multiple dendrites, but never to more 
than one axon, although the axon may branch hundreds of times before it terminates. 
The synapses are branched terminations responsible for the transmission of the signals 
from the axon of one neuron to a dendrite of another. They release neurotransmitters. 
Glial cells compose a voluminous support system that is essential to the proper operation 
of nervous tissue and the nervous system. Unlike neurons, glial cells do not conduct nerve 
impulses. Their main functions include providing support for the brain, assisting in 
nervous system repair and maintenance, assisting in the development of the nervous 
system, and providing metabolic functions for neurons. They are far more numerous than 
neurons (in the human brain glia are estimated to outnumber neurons by about 10 to 1) 
and, unlike neurons, are capable of mitosis. There are four types of glial cells in the 
human body depending on their location in the body and their function. The 
oligodendrocytes, the astrocytes and the microglia are three kind of glial cells located in 
the CNS. The astrocytes (also called astroglia) have numerous projections that anchor 
neurons to their blood supply. They regulate the external chemical environment of 
neurons by removing excess ions (notably potassium) and recycling neurotransmitters 
released during synaptic transmission. The current theory suggests that astrocytes may 
be the predominant "building blocks" of the blood-brain barrier. The microglia are 
extremely small cells of the central nervous system that remove cellular waste and 
protect against microorganisms. The oligodendrocytes are central nervous system 
structures that wrap some neuronal axons to form a specialized membrane called myelin, 
producing the so-called myelin sheath. The SCs are the glial cells located in the PNS. They 
surround the peripheral nerve axon and maintain the vitality of peripheral nerve fibers 
(both myelinated and unmyelinated). In myelinated axons, SCs form the myelin sheath.  
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The myelin sheath, both in the CNS and in the PNS, provides insulation to the axon that 
allows electrical signals to propagate more efficiently. This type of layer is not continous 
but interrupted (at intervals corresponding to the length of the SCs and the uncovered 
parts of the axon are called nodes of Ranvier. Due to the presence of the nodes of 
Ranvier, impulses propagate by saltation. 
 
-  
Fig. 3.1. Scheme of a neuron. Each neuron has three basic parts: cell body called soma, one or 
more dendrites and a single axon. SCs (in PNS) and oligodendrocytes (in CNS) surround the axon 
forming not continuous myelin sheath. 
3.2.3 Structure of the nerve 
The PNS is composed of nerves, which are cylindrical bundles of fibers that start at the 
brain and central cord and branch out to every other part of the body forming the 
communication network between the CNS and the surrounding (muscles, organs of the 
digestive system…). 
The primary function of a peripheral nerve is to transmit signals from the spinal cord to 
the rest of the body (motor nerves), or to transmit sensory information from the rest of 
the body to the spinal cord (sensory nerves). The peripheral nerve is made up of 
connective tissue and nerve components. These connective tissue structures the 
endoneurium, perineurium, and epineurium, all form the framework that organizes and 
protects the nerve fibers and the axons (Fig. 3.2). The epineurium is a layer of dense 
connective tissue that covers and holds together the outer surface of nerves. The main 
function of the epineurium is to maintain the structural continuity of the nerve and to 
protect the nerve. Each bundle of nerve fibers is called a fasciculus (set of 10-100 axons) 
and is enclosed by the perineurium, a connective tissue sheath formed mainly of 
collagenous fibers. Important functions of the perineurium are to maintain the 
intrafascicular pressure and to regulate the local environment in the intrafascicular space 
by acting as a diffusion barrier to several substances. Within the fasciculus, each 
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individual nerve fiber, with its myelin and neurolemma, is surrounded by connective 
tissue called the endoneurium. 
The peripheral nerve is supplied by both an external segment blood supply and an 
intrinsic longitudinal blood supply. The intrinsic blood supply exists in the epineurium, 
perineurium, and endoneurium. Whereas large vessels can be found in the epineurium 
and endoneurium, only capillaries are found in the endoneurium. 
A nerve conveys information in the form of electrochemical impulses (known as action 
potentials) carried by the individual neurons that make up the nerve. These impulses are 
extremely fast, with some myelinated neurons conducting at speeds up to 120 m/s. The 
impulses travel from one neuron to another by crossing a synapse, the message is 
converted from electrical to chemical and then back to electrical. 
 
Fig 3.2. Section of a spinal nerve: see the epineurium surrounding the nerve, each bundle of 
nerve is called fasciculus and is surrounded by the perineurium. Each nerve fiber of the fasciculus 
is surrounded by the endoneurium. 
3.2.4 Nerve injuries classification 
Nerve injuries can be produced by various mechanisms such as crush trauma, direct 
laceration, stretching and compression. The two most widely accepted classifications of 
nerve injuries are Seddon and coworker’s [2] and Sunderland’s classification [3]. The 
latter one expanded the previous classification of Seddon, which described three types of 
lesion named neuropraxia, axonotmesis, and neurotmesis, into a more detailed 
subdivison according to the connective and fibrous structures that are damaged. 
Neurapraxia and axonotmesis, or first- and second- degree Sunderland injury, have a 
good prognosis. Neurapraxia (Fig. 3.3A) involves a local conduction block at the site of 
injury along the course of the nerve, with normal conduction both proximal and distal to 
the site of injury. The nerve remains in continuity and no axonal injury is present. In more 
severe instances of neuropraxia, local myelin abnormalities or even segmental 
demyelination may be involved. This type of injury may result from exposure to a wide 
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range of conditions including heat, cold, irradiation or electrical injuries, but is most 
commonly due to mechanical stress, such as concussion, compression or traction injuries, 
and is often associated with some degree of ischemia. Full functional recovery is to be 
expected within a few days to a few weeks. Axonotmesis (Fig. 3.3B), involves severance 
or destruction to peripheral axons, but connective tissue structures remain intact thus 
facilitating nerve regeneration and functional recovery. The SCs enveloping the injured 
axons also remain intact, which allow regeneration to restore full motor and sensory 
function. The interruption of axons is often the result of nerve pinching, crushing or 
prolonged pressure. Recoveries in these injuries will occur at the classic rate of nerve 
regeneration of approximately 1mm/day to 1.5 mm/day [2]. 
The neurotmesis (Fig. 3.3C-E) is a complete transection of the nerve and can range from a 
disruption of a subset of endoneurial tubes to a complete transection of the nerve. 
Therefore, axons must regenerate through some degree of scar tissue. This can lead to 
incomplete regeneration, as some of the regenerating fibers do not achieve contacts 
with distal receptors or end organs because of interposed scarring within the 
endoneurium. The basal lamina of the SCs is also damaged in this type of injury which can 
lead to mismatching of regenerating nerve fibers to inappropriate distal receptors. In this 
case, the functional recovery does not easily occur because of the extent of endoneurial 
tube disruption. Nonetheless, successful regeneration into appropriate (or the original) 
endoneurial tubes might result in the re-establishment of target reinnervation. In 
neurotmesis the spontaneuos re-innervation is often incomplete and absent. 
 
Fig. 3.3. Schematic representation of the ﬁve degrees of nerve injury according to Sunderland [3]. 
Grade 1: conduction block indicated by red arrow (neurapraxia), Grade 2: transection of axon 
with an intact endoneurium (axonotmesis), Grade 3: transection of the nerve ﬁber (axon and 
endoneurium) within an intact perineurium (neurotmesis), Grade 4: transection of funiculi, 
epineurial tissue maintains nerve trunk continuity (neurotmesis +), Grade 5: transection of the 
whole nerve trunk (neurotmesis ++). 
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3.2.5 Peripheral nerve regeneration after injuries 
Functional recovery after nerve injury involves a complex series of pathophysiologic 
changes, including morphologic and metabolic alterations, each of which may delay or 
impair the neuronal regenerative process. These complex changes occur: i) in the nerve 
cell body, ii) in the segments proximal and distal to the injury site, iii) at the site of injury 
itself and iv) in the distal endings of both muscle end-plates and sensory receptors. The 
regeneration and repair phase following nerve injury may last for many months. In detail, 
following axonal disruption, degenerative changes, including axon and myelin 
breakdown, are initiated proximally and distally to the injury site (Fig. 3.4A). Retrograde 
axonal degeneration in the proximal nerve stump may extend for several millimeters, or 
even several centimeters following severe injuries. The remaining axons in the proximal 
nerve may also demonstrate a reduction in diameter, the extent of which depends on the 
time taken to re-establish functional connections (Fig. 3.4B). Pathophysiologic alteration 
can be seen in the nerve cell body as early as several hours after injury. The series of 
morphological changes that ensue in the cell body after injury are known as 
chromatolysis, and entail cell body and nucleolar swelling, and nuclear eccentricity. This 
is accompanied by the loss of Nissl substance from the cytoplasm (Fig 3.4B). Such 
changes represent reactive alterations in neuronal biochemistry and function and they 
are indispensable for subsequent axon regeneration. Chromatolytic changes involve an 
alteration of metabolic machinery from being primarily concerned with transmitting 
nerve impulses to fabricating structural components for reconstruction of the injured 
nerve. Recovery from such changes takes a number of weeks (or even months) and has 
been reported to depend on the re-establishment of appropriate functional connections 
in the periphery [4]. Failure of axotomised neurons to re-establish appropriate 
connections may result in them persisting in an atrophic, chromatolytic state (Fig. 3.4E) 
or even in their degeneration. After nerve transection, the distal nerve undergoes a slow 
process of degeneration known as Wallerian degeneration which starts immediately after 
injury and involves myelin breakdown and proliferation of SCs. SCs and macrophages are 
recruited to the injury site, and over a period of 3 to 6 weeks, they phagocytize all the 
myelin and cellular debris, and ultimately leave endoneurial tubes, which essentially 
consist of the basement membrane of these SCs (Figure 3.4A-B). The newly generated 
SCs, together with pre-existing SCs that survived the nerve injury form the bands of 
Bϋngner (Fig. 3.4C). The bands of Bϋngner in the distal nerve segment are highly aligned 
and this topographical property is thought to be crucial for the direction of axon growth. 
Apart from their orientated topography, the molecular characteristics of SCs afford them 
their axon-growth promoting properties. SCs produce a basal lamina, which is a 
specialized and complex network of ECM proteins capable of supporting axon regrowth. 
The growth cones of sprouting axons use these tubes, delineated by the continuous SC 
basal laminae, as a regenerative substrate through which they extend at an average rate 
of 1–3 mm/day. Changes in the levels of neurotrophins within both the proximal and 
distal stump occur, too. Neurotrophin 4/5 mRNA, nerve growth factor (NGF), brain 
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derived neurotrophic factor (BDNF) and in the distal stump are increased. NGF is known 
to be secreted by SCs after axotomy [5]. 
In neurotmesis (Fig. 3.4C-E), the severity of disorganisation to local ECM or cellular 
architecture can range from a disruption of a subset of endoneurial tubes to a complete 
transection of the nerve. In this case, endoneurial SCs and fibroblasts proliferate and 
migrate from both ends of the damaged nerve in an attempt to form a cellular and 
connective tissue bridge across the lesion site. Distal nerve stumps, as well as denervated 
target tissues, such as skeletal muscle, exert an attractive influence on axonal sprouts, 
presumably by providing chemotactic cues. However, functional recovery does not easily 
occur because of the extent of endoneurial tube disruption. Nonetheless, successful 
regeneration might result in the re-establishment of target reinnervation with, in the 
case of skeletal muscle, neurotransmission at the neuromuscular junction, reversal of 
muscle fiber atrophy as well as of motoneuronal chromatolysis (Fig. 3.4C). The maturing 
SC–axon interactions in the regenerated distal nerve stump include the formation of 
myelin with significantly shorter internodes (Fig. 3.4C). Since these types of peripheral 
nerve injuries also involve connective tissue scarring, regenerative attempts of severed 
axons are often destined to fail and aberrant sprouting is frequently observed, often 
leading to the development of a neuroma at the proximal nerve stump that causes 
neuropathic pain symptoms (Fig. 3.4E). 
 
Fig. 3.4. Schematic representation of the degenerative and regenerative events associated with 
peripheral nerve injury. A: During the early phase (ﬁrst few days) after axonal injury (arrowhead), 
local degenerative events are accompanied by both retrograde and anterograde degeneration of 
axon and myelin. B: During the intermediate phase (a few days to weeks), the anterograde 
pattern of Wallerian degeneration proceeds to completion with inﬁltrating macrophages 
contributing to the removal of tissue debris and SC undergoing mitosis. The axotomised neuronal 
cell body undergoes reactive, chromatolytic changes and the severed proximal end of the axon 
develops regenerative axonal sprouts. C: Of the numerous axonal sprouts that successfully 
traverse the injury site (during the ﬁrst fewweeks tomonths), some re-enter appropriate 
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endoneurial tubes and continue to extend through the distal nerve stump, supported by SC in the 
bands of Büngner. The target organ/tissue (in this case skeletalmuscle) undergoes disuse atrophy. 
D: Successful axon regeneration through the bands of Bungner and the re-establishment of 
neurotransmission at the neuromuscular junction results in the retraction or dying-back of 
unsuccessful axon sprouts, the reversal of muscle ﬁber atrophy, of neuronal cell body 
chromatolysis and the establishment of maturing SC–axon interactions (including reduced 
internodal spacing). E: Failure of regenerating axonal sprouts to cross the injury site (possibly due 
to the formation of a physical scarring barrier or the loss of a large segment of nerve) results in 
neuroma formation. The permanently denervated muscle ﬁbers demonstrate severe atrophy, 
loss of their characteristic striations and pyknotic nuclei. 
3.2.6 Surgical approaches 
Peripheral nerve injury greatly compromises the quality of life of affected individuals and 
has a significant socioeconomic impact [6]. Nerve gaps caused by neurotmesis is 
undoubtedly the most challenging type of peripheral nerve lesion repair and requires 
surgical intervention. Satisfactory results are obtained when the nerves are purely motor 
or purely sensory and when the amount of intraneural connective tissue is relatively 
small. For optimal nerve regeneration after repair, nerve stumps must be properly 
prepared, aligned without tension, and repaired atraumatically with minimal tissue 
damage and minimal number of sutures. For nerve gaps of a few millimeters in length, 
end to-end tension-free nerve suture repair is preferred clinically [7]. This surgical process 
consists of primary anastomosys of a divided nerve at the epineural or fascicular level, 
through end-to-end or end-to side and is applicable to short nerve gaps because the 
fascicular coaptation may cause excessive tension over the suture line, which would 
inhibit nerve regeneration [8]. In such cases, the regenerative process can be enhanced 
surgically through the use of nerve conduits, either using autologous or engineered 
tissue, that bridge the gap in the damaged nerve. Entubulization minimizes unregulated 
axonal growth at the site of injury by providing a distinct environment, and allows 
diffusion of trophic factors emitted from the distal stump to reach the proximal segment, 
which recreates the physiological conditions for nerve regeneration. Among the 
entubulization choices, autograft is still the gold standard technique in repairing injured 
peripheral nerve as it provides a scaffold containing both SCs and their basal lamina. The 
basal lamina contains many adhesion molecules, such as laminin, fibronectin, 
proteoglicans, that can promote neurite elongation. The sural, lateral antebrachial 
cutaneous, and terminal branch of the posterior interosseus nerve are common donor 
sites for nerve grafts. However, autograft is limited by the inherent drawbacks, such as 
limited availability of donor nerves, the need for a second surgery to obtain the donor 
nerve, donor site morbidity and secondary deformities, as well as mismatch between the 
injured nerve and the donor nerve [9]. Allografts and xenograft have also been used, but 
they are accompanied by the need for immunosuppression and have very poor success 
rate [10]. Autologous and autogenous blood vessel have also been used as conduits for 
nerve regeneration because of vein similarity to that of nerve tissue including the ability 
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to furnish important neurotrophic and neurotropic factors [11]. Although veins have 
shown good results, their parameters are limited and should be used only in sensory 
nerves with a defect of less than 30 mm [11]. Muscle-in-vein conduit (a vein segment 
filled with a skeletal muscle) has been developed to prevent the collapse of the lumen of 
the blood vessel [12]. The muscle offers strut to the vein and its basal lamina attract the 
regenerating axons. When the muscle degenerates, the gap is filled by the proliferation of 
SCs. Although such combined vein-muscle nerve conduits show the good biocompatible, 
the shortage of these materials limit the use of them in clinic, because these tissue must 
be removed from the patients. 
Avoiding the problems of availability and immune rejection, artificial nerve guidance 
channels (NGCs) seems to be a promising alternative to autologous choices for extending 
the length over which nerves can successfully regenerate. In the next paragraph, the 
current status and future development directions of TE NGCs will be discussed. 
3.2.7 Tissue engineering in peripheral nerve injury 
Developments in the field of TE offer the possibility to use artificial NGCs for 
reconstruction of nerve gaps. NGCs are small cylindric structures composed of either 
natural or synthetic biomaterials that are used to facilitate axon regeneration: the ends of 
the damaged nerve are inserted into either end of the cylinder, and the NGC acts both as 
a connecting bridge for the severed nerve ends as well as a protective shelter for the 
regenerating nerve. Artificial NGCs seems to be a promising alternative to conventional 
treatments since these conduits serve to: i) direct axons sprouting from the proximal to 
distal nerve stump; ii) maintain adequate mechanical support for the regenerating nerve 
ﬁbers; iii) provide a conduit channel for the diffusion of neurotropic and neurotrophic 
factors secreted by the damaged nerve stump and a conduit wall for the exchange of 
nutrients and waste products; iv) avoid the risk of fibroblasts infiltration and scar tissue 
formation that hinders axonal regeneration; and v) create an optimal microenvironment 
for nerve regeneration through the accumulation and release of exogenous and 
endogenous biochemical effects [10, 13]. In addition, the efficiency of NGCs can be 
improved by the presence of internal matrices inside the conduit which acts as physical 
guidance for axonal growth by providing a structured environment for cell regeneration 
and organization. Moreover, the conduits can also be functionalized with contact-
mediated cues, such as proteins and peptides, chemotactic cues, such as neurotrophic 
factors and biological or cellular cues, such as SCs, neural stem cells and astrocytes 
(satellite cells of the PNS and CNS) [14]. An ideal neural scaffold should satisfy many 
biological and physicochemical requirements, among which biocompatibility, 
biodegradability into nontoxic products, permeability to ensure supply of nutrients, low 
degree of swelling, sufficient mechanical stability during nerve regeneration, flexibility 
(with a Young’s modulus close to that of nerve tissues to prevent compression of the 
regenerating nerve) are the major concerns. Moreover, the neural scaffold is hoped to be 
easy to fabricate and sterilize, and simple to implant in the body by microsurgical 
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techniques. These required properties are mainly determined by the scaffold material and 
scaffold structure. As regard the former, a wide variety of biomaterials have been 
attempted, which are of either natural or synthetic origin. Moreover, both non-
degradable [15] and (bio)degradable [13] materials have been used for NGC fabrication. 
The main objection for using non-degradable conduits is that they remain in situ as 
foreign bodies after the nerve has regenerated showing a higher risk of infection, a 
possible chronic inflammatory response, and having the potential to compress the nerve 
after regeneration. A second surgery might then be necessary to remove the conduits, 
causing possible damage to the nerve. Biodegradable materials offer several advantages, 
such as the possibility of attaching bioactive molecules or cells on the biomaterial surface 
through physicochemical modifications and to deliver them during biodegradation. 
Biodegradable polymers, both synthetic and natural polymers, have been extensively 
investigated as biodegradable polymeric biomaterials. Biodegradation of polymeric 
biomaterials involves cleavage of hydrolilytically or enzymatically sensitive bonds in the 
polymer leading to polymer erosion. Depending on the mode of degradation, polymeric 
biomaterials can be further classiﬁed into hydrolytically degradable polymers and 
enzymatically degradable polymers. Hydrolytically degradable polymers are generally 
preferred as implants due to their minimal site-to-site and patient-to patient variations 
compared to enzymatically degradable polymers [16]. However, most of the naturally 
occurring polymers undergo enzymatic degradation. Natural biomaterials are useful for 
nerve TE as they stimulate adhesion, migration, growth and proliferation of cells, and 
enable avoidance of toxic effects [17, 18]. Although the use of these natural materials 
would be ideal, there are some inherent difficulties generally associated to the necessity 
of extensive purification and characterization of the extracted materials and to the lack of 
adequate mechanical strength and water stability of the natural based material [19]. 
Synthetic polymers constitute another class of promising biomaterials for fabricating 
neural scaffolds due to their tunable chemical and physical properties. However, some 
synthetic materials, shows poor biocompatibility in terms of cell adhesion and tissue 
repair. Some natural and synthetic based NGCs have been approved by regulatory 
authorities for use in human [20]; they include, e.g., NeuraGen® (Integra) and 
NeuroMatrix®/Neuroflex® (Stryker) both made of the cross-linked collagen, Neurotube® 
(Synovis) made of poly(glycolic acid), SaluBridge® and SaluTunnel® (SaluMedica) made of 
Salubria® hydrogel, and Neurolac® (Ascension) made of poly(d,l-lactide-co-caprolactone). 
The main advantages and disadvantages of the more commonly investigated polymers for 
NGCs (including both non-biodegradable and biodegradable synthetic and natural 
polymers) will be evidenced hereafter. In Table 3.1 biomaterials, both of synthetic or 
natural origin, used in peripheral nerve regeneration are reported. 
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3.2.7.1 Biomaterials in nerve regeneration 
3.2.7.1.1 Synthetic biomaterials used for NGCs 
Nonbiodegradable materials 
Silicone rubber has been studied since 1960s for peripheral nerve repair, and silicone 
tubes represent one of the ﬁrst and most frequently used NGCs prepared with synthetic 
materials because of the bioinert and elastic properties of silicone. Although they are 
nondegradable in the body and impermeable to large molecules, silicone tubes provide 
an important model system for studying nerve regeneration under controlled conditions 
of nerve tubulization, and have been applied in clinical trials to bridge short nerve gaps 
(few mm in length) with some success [21, 22]. Chen et al. have recently shown that 
silicone rubber tubes containing a gel of collagen, laminin and fibronectin led to a 
successful nerve regeneration across the gap as compared to a empty silicone tube [23]. 
Non-degradable scaffolds have also been fabricated using plastic such as acrylic polymer, 
polyethylene, elastomer, etc.[16, 24, 25]. Disadvantages of the use of nondegradable 
NGCs include chronic foreign body reaction, inﬂexibility, and lack of stability. Particularly, 
the inﬂammatory response of nonbiodegradable NGCs may lead to ﬁbrotic capsule 
formation around the guide and consequent nerve compression [26]. 
Biodegradable synthetic materials 
In order to overcome the disadvantages associated with non-degradable materials, 
research has been concentrated on biodegradable synthetic materials used to prepare 
neural scaffolds. Materials applied should degrade within the regeneration period and 
degradation products should be no toxic and they should be absorbed by the body with 
no foreign body reaction. Moreover, the physiochemical and biological properties of 
biodegradable synthetic materials can be tailored to match different application 
requirements, and some chemical modiﬁcations enable the materials effectively to 
entrap support cells or bioactive molecules for controlled delivery during nerve 
regeneration. Among the bioresorbable materials, aliphatic polyesters and copolyesters 
have been frequently used for nerve regeneration. Aliphatic polyesters represent a class 
of the common degradable synthetic polymers, among which poly(L-lactic acid) (PLLA) 
[27], poly(glycolic acid) (PGA) [28], polycaprolactone (PCL) [29, 30] and their copolymers, 
including poly(lactic acid-ɛ-caprolactone) [31], poly(L-lactic-co-glycolic acid) (PLGA) [32] 
and poly(1,3-trimethylenecarbonate-ɛ -caprolactone) [33], have become the U.S. FDA-
approved biomaterials used in the ﬁeld of medical devices. Thanks to the possibility of 
finely tuning their properties by varying the block structure, copolymers are gaining more 
and more attention. Several investigations have been also focused on other copolymers, 
such as poly(DL-lactic-co-ε-caprolactone) (poly(DLLA-CL)), synthesized poly(ester-
urethane)s (PU) with polyester macrodiols, poly(trimethylenecarbonate-co-ε-
caprolactone) (poly(TMC-CL)), and microbial polyhydroxyalkanoates (e.g., 
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poly(hydroxybutyrate-co-hydroxyhexanoate), PHBHHx). PGA, PLA, and PCL degrade 
primarily via hydrolysis in aqueous medium, but they can be cleaved enzymatically upon 
implantation by esterases as well. 
The biocompatibility of PLLA has been demonstrated in vitro by the survival of SCs that 
were seeded onto the polymer surface and their subsequent expression of a range of 
ECM-related proteins, e.g. collagen IV, laminins-I and –II [34]. PLLA NGCs degradation 
products, particularly crystalline debris and lactic acid , may adversely cause long-term 
problems, affecting axon growth and nerve function [35]. In a recent study, Koh et al. 
have developed a new functionalized scaffold by coupling laminin onto PLLA nanofibers. 
Laminin was successfully added to nanofibers using covalent binding, physical adsorption 
or blended electrospinning procedures. The new functionalized fibers were able to 
enhance axonal extension by PC12 cell viability and neurite outgrowth assays [36]. 
PCL has been widely used in medical devices and drug delivery systems. However, the 
relatively slow degradation rate has resulted being sub-optimal for some tissue-
engineering applications. The in vitro affinity of this polymer has been recently 
demonstrated toward the adhesion and proliferation of PC12 cells [37], SCs and rat 
cortical neurons [38]. In a recent study, Ciardelli et al. [30] have shown that PCL supports 
the in vitro adhesion and proliferation of S5Y5 neuroblastoma cells and neonatal 
olphactory bulb ensheating cells and can be shaped into tubular guides by dip-coating of 
a rotating mandrel. Interstingly, adding mesenchymial stem cells in a PCL conduit have 
been shown to enhance median-nerve regeneration, prevent decrease of creatine 
phosphokinase levels in muscle and improve functional recovery in mice [39]. 
PGA conduits ﬁlled with laminin-soaked collagen scaffolds have been shown to promote 
axonal regeneration over the 8 cm gaps with the same efficiency as the PGA-collagen 
fiber-filled conduits [40, 41]. Hollow guides made from PCL and poly(DLLA-CL) have also 
demonstrated promise of full morphometric and functional recovery at levels similar to 
autograft controls in 10-mm rat sciatic nerve defects [42]. In particular, poly(DLLA-CL) 
scaffolds have been found to be advantageous for peripheral nerve repair, as they are 
transparent and possess suitable mechanical properties allowing to accommodate 
movements over surrounding tissues. Poly(DLLA-CL) NGCs degrade completely within 1 
year from implantation; however, this type of  scaffold is suitable for the repair of short 
nerve gaps (e.g. digital nerves) because of their brief mechanical performance (negligible 
after only 2 months) and their high swelling during degradation , especially during the 
first 3 months [43]. Innovative biocompatible PUs have been investigated because they 
can be synthesized by a proper selection of block composition which allows a ﬁne tuning 
of their mechanical properties, degradation rate, biocompatibility, and biomimickly [44]. 
An alternative method of stimulating neuronal tissue regeneration includes the 
application of electrical stimulation treatments through nerve conduits made from 
electrically conductive materials. Hence some important electrically conducting 
polymers, including polypyrrole (Ppy), polyaniline and polythiophene, have been tried to 
prepare neural scaffolds due to their tailored electrical and antioxidant properties [45-
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47]. Ppy possesses good electrical conductivity, biocompatibility, high electrical stability, 
and it can be easily sinthetized. When electrically stimulated in vitro, Ppy may attract 
serum proteins, such as fibronectin, which promote neurite expression: this provides a 
means for controlled chemical stimulation. However, its poor mechanical properties, lack 
of biodegradability, and difﬁculties associated with processing it into complex three-
dimensional shape. In a recent study, Morover, Moroder et al. have investigated the 
mechanical and electrical properties of polycaprolactone fumarate–polypyrrole (PCLF–
Ppy) scaffolds under physiological conditions. PC12 cells cultured on PCLF–Ppys scaffolds 
were electrically stimulated with regimens of 10 μA of either a constant or a 20 Hz 
frequency current passed through the scaffolds for 1 h per day. PCLF–Ppy scaffolds 
exhibited excellent mechanical properties at 37°C which would allow suturing and 
ﬂexibility. The scaffolds were electrically stable during the application of ES. In vitro 
studies showed the capability to signiﬁcantly enhance and direct neurite extension by 
passing an electrical current through PCLF–PPy scaffolds [48]. 
3.2.7.1.2 Natural polymers for NGCs 
Natural polymers are advantageous materials for TE of nerves as they are biocompatible, 
favour the migration of supporting cells, and avoid the occurrence of toxic effects. 
However, the poor mechanical properties, the high swelling behavior, and the relatively 
fast in vivo biodegradation rate of natural polymers generally limit their applications as 
constituent materials of the external tubular structure of NGCs. In some cases, blends 
between natural and synthetic polymers have been proposed for neural guides, to 
combine the biocompatibility of the natural component with the advantageous 
processing properties and mechanical performance of the synthetic material. Insoluble 
ECM molecules, such as collagen, gelatin, laminin, and fibronectin, play an important role 
in the development and growth of axons [49, 50], and many other proteoglycans and 
glycosaminoglycans of the ECM can modulate neural activity and neuritis extension, 
providing either stimulatory or inhibitory effects [51, 52]. As a result, ECM components 
have become very important candidate materials for neural scaffolds, and they were 
predominantly processed into lumen fillers of NGCs in the form of fibers, channels, 
porous sponges, or hydrogels to serve as delivery vehicles for support cells, GFs, or drugs. 
Collagen is one of the major ECM proteins, accounting for up to 30% of the total body 
protein. In its native environment, collagen interacts with cells in connective tissues and 
transduces essential signals for the regulation of cell anchorage, migration, proliferation, 
differentiation, and survival [53]. Biomaterials made from collagen offer several 
advantages, including biocompatibility, non-toxic degradation and a weak antigenic 
activity, due to its phylogenetically conserved primary sequence and a helical structure. 
Disadvantages of collagen include its relatively high cost and mechanical weakness. 
Among the realized NGCs based on natural polymers, collagen conduits, such a 
NeuroMatrix®, Neuroﬂex® [Collagen Matrix Inc.], and NeuraGen® [Integra Life sciences 
Corp.] have been approved by FDA. Collagen conduits have been reported to be as 
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effective as autografts when repairing peripheral nerve defects as small as 4 mm in 
length [54]. However, Stang et al., showed that axon regeneration across the 2 cm 
resection injury was relatively poor in comparison to the autographs [55]. Collagen, in the 
form of a hydrogel, has been used to ﬁll the lumen of conduits made from a range of 
materials to promote improved axon regeneration and tissue repair [56]. Collagen gel 
ﬁlled conduits were found to improve the extent of functional recovery across 4 mm and 
6 mm lesions of the mouse sciatic nerve when compared to saline ﬁlled conduits. 
Interestingly, the concentration of the gel signiﬁcantly affected the extent of the repair 
process; lower concentration gels supported the best degree of functional recovery. 
Moreover, collagen filaments have been found to guide axon repair. Madison et al. 
reported bridging of nerve gap distances of 3 cm in rat sciatic nerve [57]. In a recent 
work, collagen-based microstructured three-dimensional NGC containing numerous 
longitudinal guidance channels with dimensions resembling natural endoneurial tubes 
have been produced [58]. The NGCs have been functionalized by SC seeding. Viable SCs 
within the guidance channels formed cellular columns reminiscent of bands of Bϋngner, 
which are crucial structures in the natural process of peripheral nerve regeneration 
during the Wallerian degeneration. The orientated 3D nerve guides (decorated with SCs) 
with their physical and molecular properties showed great promise in the repair of 
peripheral nerve lesion.  
Gelatin (GL) is a protein derived from collagen by thermal denaturation or physical and 
chemical degradation. GL does not express antigenicity in physiological conditions and is 
cheaper and easier to obtain in concentrated solutions than collagen. Other interesting 
properties of GL are its biocompatibility, biodegradability, and adhesiveness. The 
mechanical and chemical properties of GL can be modulated by proper crosslinking. GL 
conduits have been produced using crosslinked GL by photocuring [59] or genipin (GP) 
treatment [60, 61]. In both cases, NGCs have been implanted for the repair of a 10 mm 
nerve gap in the rat sciatic nerve. Neural regeneration was assessed in terms of 
functional recovery, electrophysiological responses, and tissue morphological 
regeneration. GL-based neural scaffolds can be covalently incorporated with additional 
bioactive cues, which are gradually released during the scaffold biodegradation [62]. 
Laminin is the ﬁrst ECM protein expressed during embryogenesis, and can guide 
developing neuritis and promote neurite outgrowth. Found in the basal lamina 
(basement membrane) and produced by SCs, it is an important adhesion molecule for 
growth and regeneration of neural tissue. Laminin plays a crucial role in the developing 
and maturing central nervous system, for example, in cell migration, differentiation, and 
axonal growth [63]. 
Fibronectin is an ECM protein that is dispersed in interstitial matrices. It is composed of 
several rod-like domains, one of which contains a repeating sequence of peptides that 
regulates cell adhesion, the RGDS sequence (L-arginine, L-glycine, L-aspartic acid, and L-
serine). Fibronectin has been found to play a role in axonal growth and cell migration. 
Tong et al. have shown that the presence of laminin and fibronectin in collagen grafts can 
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dramatically increase the ability of neural components to regenerate effectively over 
long nerve gaps [64]. In a recent study, the incorporation of fibronectin into hollow 
conduits was able to improve axon regeneration across 18 mm gaps of the adult rat 
sciatic nerve. Greater numbers of regenerated axons and more retrogradely labeled 
motoneurons and dorsal roat ganglia sensory neurons could be detected 4 months after 
implantation when compared to the saline ﬁlled hollow conduits. 
Other naturally derived molecules investigated for their application in nerve repair 
include hyaluronic acid, alginate, agarose, CS and silk fibroin. 
CS, has been investigated for a variety of TE applications because it is structurally similar 
to naturally occurring GAGs and it is degradable by enzymes in humans. It is a linear 
polysaccharide of (1–4)-linked d-glucosamine and N-acetyl-d-glucosamine residues 
derived from chitin. The similarity in the molecular structure between CS and 
glycosaminoglycans allows interactions between CS and ECM molecules including 
laminin, ﬁbronectin and collagen. CS possesses favorable TE properties as biomaterials. 
This is due to its antibacterial activity, biodegradability, and biocompatibility [65]. Since 
CS is fragile in its dry form, it has to undergo chemical crosslinking or to be used jointly 
with other materials before scaffold fabrication. The biocompatibility of CS-based 
biomaterials with the cells in CNS or PNS has been investigated [66, 67]. Yuan et al. 
showed that CS ﬁbers supported the adhesion, migration and proliferation of SCs [17]. 
Blending CS with a protein (or a peptide) has been proposed as an effective method to 
enhance nerve cell attachment and to make the mechanical properties of scaffolds more 
similar to those of nerve tissues. In a recent study, CS/poly(L-lysine) composite materials 
with various compositions have been prepared with the aim of enhancing CS nerve cell 
afﬁnity. PC12 cells cultured on the composite substrates showed an improved 
attachment, differentiation and growth when compared to cells cultured on CS 
membranes. The effectiveness of CS/poly(L-lysine) composite materials in the nerve 
regeneration ﬁeld has been attributed to the increased hydrophilicity and positive 
surface charge of blends with respect to pure CS [68]. Recently, NGCs have been 
obtained consisting of CS conduits filled with porous collagen sponges simulating the 3D 
structure of ECM [69]. The inner sponge was imbibed with NGF. Conduits have been 
tested for the repair of a 10 mm defect in the rabbit facial nerve: in one case, a 
suspension of neural stem cells (NSCs) has been injected into the tube during in vivo 
implantation, whereas, in the control test, a saline solution has been used. Autograft has 
been employed as a positive control. After 12 weeks from implantation, nerves treated 
with autografts have shown similar recovery as compared to the ones treated with NGCs 
containing NSCs. 
Alginate is a biodegradable polysaccharide with repeat units of mannuronic acid and 
glucuronic acid. It is extracted from brown sea-weed and bacteria [70]. The physical 
properties of alginate gels vary widely depending on the proportion of guluronic to 
mannuronic acid residues and the overall molecular weight of the polymer. Matsuura et 
al., have demonstrated the potential of alginate as a scaffold for promoting autonomic 
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nerve regeneration [71]. The alginate foam has been developed and implanted into a 7-
mm sciatic nerve gap in rats or a 50-mm sciatic nerve gap in cats [72]. The results suggest 
that alginate foams could promote peripheral nerve regeneration even without being 
sutured to nerve stumps. Recently, alginate has been also used to deliver GFs such as FGF 
over a number of weeks [73]. 
Agarose is a polysaccharide derived from red algae. Agarose hydrogel has been found to 
support neurite extension in vitro [74]. The advantage of agarose derives from the 
possibility to easily couple proteins and GAGs to the polymer, resulting in improved cell 
response. In a recent study polysulfone NGCs have been filled with anisotropic agarose 
hydrogels containing gradients of laminin and NGF and used for the repair of 2 cm 
defects in the rat sciatic nerve. The NGCs investigated were than compared with syngenic 
grafts and NGCs filled with isotropic agarose hydrogels with uniform concentration of 
NGF and laminin. After 4 months from surgery, NGCs containing anisotropic agarose 
hydrogels with gradients of both laminin and NGF have shown much better results than 
for isotropic fillers [75]. 
Silk ﬁbroin (SF), a core protein of natural silk, has found rapidly increasing applications in 
TE because of its biocompatibility, high resilience, and slow biodegradation. SF is water 
soluble and becomes water insoluble by physical induction of -sheet formation. Besides 
serving as a biochemical delivery substrate, SF has also been used to prepare NGCs for 
investigating the in vitro biocompatibility of SF with neural tissues and cells, and for 
bridging a sciatic nerve gap in a mouse model [76, 77]. Recently, Yang et al., have 
developed a novel biomimetic design of the SF-based nerve graft which was composed of 
a SF-NCG inserted with oriented SF ﬁlaments, serving as a skeleton for regrowing nerve 
tissues. The SF-NGC was used for bridge implantation across a 10-mm long sciatic nerve 
defect in rats, and the outcome of peripheral nerve repair at 6 months post-implantation 
was evaluated. The examined functional and morphological parameters show that SF 
grafts could promote peripheral nerve regeneration with effects approaching those 
elicited by nerve autografts. Just like silk ﬁbroin, keratins and other matrix proteins 
extracted from human hair, wool, nail and feather have also been tried as new scaffold 
materials in the clinical repair of damaged tissues. It has been reported that they are 
likely to become candidate materials for neural scaffolds as well [78]. 
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Table 3.1 Most widely studied materials for NGCs with related properties and selected studies 
where they were used. 
 
  
NGC material Characteristics Reference 
Synthetic   
Silicone  Highly elastomeric polymer, non-biodagrable, 
bioinert, impermeable, hydrophobic 
[21-23, 26] 
Poly(ε-
caprolactone) 
Aliphatic polyester, biodegradable by hydrolysis, 
commercial NGC (CultiGuide®) 
[29, 30, 37-
39] 
Poly(glycolic acid) Aliphatic polyester, biodegradable by hydrolysis, 
commercial NGC approved by FDA (Neurotube®) 
[28, 40, 41] 
Poly(DL-lactic-co-ɛ-
caprolactone) 
Aliphatic polyester, biodegradable by hydrolysis, 
commercial NGC approved by FDA (Neurolac®) 
[31, 43] 
Poly(L-lactic acid) Aliphatic polyester, very slowly biodegradable by 
hydrolysis 
[27, 34-36] 
Polyester urethane Elastomeric polymer, biodegradable [44] 
Polypyrrole Electrically conducting polymer, biocompatible, 
high electrical stability, lack of biodegradability 
[47] 
Natural   
Alginate Polysaccharide, water-soluble, biodegradable by 
hydrolysis 
[70-73] 
Agarose  Polysaccharide, water-soluble, biodegradable by 
hydrolysis 
[74, 75] 
Chitosan  Polysaccharide, enzymatically degradable, 
positively charged, good cell interactions 
[65-69, 79] 
Collagen ECM protein, enzimatically degradable, good cell 
interaction, commercial NGC approved by FDA 
(Neuroflex®, Neuromatrix®, Neurogen®) 
[53-58] 
Fibronectin ECM protein, enzimatically degradable, good cell 
interaction 
[64] 
Gelatin  ECM protein, enzimatically degradable, good cell 
interaction 
[59-62] 
Laminin ECM protein, enzimatically degradable, good cell 
interaction 
[63] 
Silk fibroin  Silk protein, enzimatically degradable [76, 77] 
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3.2.7.2 The structure of a neural scaffold 
The structure of a neural scaffold, as well as the scaffold material, is a critical factor that 
determines the efﬁcacy of neural guides to aid peripheral nerve regeneration. The neural 
scaffold can be simply fabricated into a basic structure, that is a tubular NGC with a single 
hollow lumen. Single hollow lumen NGCs are fabricated with natural or synthetic 
biomaterials by a range of polymer processing methods, among which a common 
technique is melt extrusion [30], the process of converting a thermostable polymer into a 
product by forcing it through a die of desired shape. Alternative techniques suitable for 
those polymers with low thermal stability are dipping spinning-mandrel into the polymer 
solution followed by air-drying to obtain a tube [80], injection molding, physical ﬁlm 
rolling, crosslinking braiding, and electrospinning. All these processes have been 
employed for preparing neural scaffolds with the basic structure, i. e., hollow NGCs [81, 
82]. Inappropriate target reinnervation following the dispersion of regenerating axons is 
the main drawback associated to hollow lumen NGC [83]. As a result, this type of conduit 
is mostly used for the repair of small injuries of sensory nerves with a less than 30-mm 
long nerve gap, such as digital nerve lesions [84]. Therefore, considerable efforts have 
been focused on the development of more complex scaffold structures in which the NGC 
lumen shows an intricate internal architecture, and then physical ﬁllers are introduced 
into the NGC lumen, or a multichannel NGC is created to replace a single hollow lumen 
NGC. These modiﬁcations to the basic structure, shown in Fig 3.5, attempt to generate a 
substrate able to reproduce several of the important physical and molecular 
characteristics of nerves observed during nerve spontaneous regeneration. 
The development of multichannel NGCs, through the incorporation of one or more 
intraluminal channels into the hollow conduit, is mainly based on the idea of mimicking 
the architecture of nerve fascicles. Multichannel NGCs are commonly fabricated by an 
injection-molding technique [85]. Multi-channel NGCs provide greater surface areas for 
cell attachment [86] and local release of GFs [87]. Multichannel conduits, fabricated from 
PLGA, have shown promising results in directing nerve growth over short observation 
times (six weeks) and limited gap size (7 mm) [86]. However, the extra internal structure 
may interfere with some important properties of the neural scaffold, such as 
permeability, bending and deformation properties, swelling, and degradation. Swelling 
has been shown in vitro and in vivo studies to close the conduit cavities and block axonal 
growth overlong-term study (12 weeks) and larger gap sizes (10 mm) [85, 88]. In a recent 
study, Yao et al. have investigated the inﬂuence of channel number on the axonal 
regeneration using a series of 1-,2-,4 , and 7-channel collagen conduits and commercial 
(NeuraGen®) single channel conduits. The multichannel collagen conduits were 
fabricated by molding and crosslinking (with 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS)). Crosslinking 
led to control the biodegradation rate and to limit swelling. The results of this study 
clearly demonstrated the potential inﬂuence that multichannel nerve tube structure have 
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on limiting axonal dispersion across the conduit without decreasing the quantitative 
results of regeneration [89]. 
The incorporation of physical lumen ﬁllers, typically supportive GFs or accessory cells, has 
been largely investigated with the aim to provide a permissive environment which mimic 
the endoneurial-like substructure by the presence of an adequate amount of SCs to 
support, through the release of neurotrophic factors and the formation of bands of 
Bϋngner, the axonal regeneration inside the NGCs. The failure of non-neuronal cells, such 
as SCs, to migrate across lesion gaps (longer >15 mm) is often the reason for the poor 
regeneration outcome in non-ﬁller-containing nerve conduits. An array of biomaterial-
based ﬁllers with different physical forms (such as ﬁbers, ﬁlaments, gel, or sponges) have 
been included into the lumen as topological cues [40, 41, 56, 74, 75]. For all these 
different types of biomaterial-based fillers, there seems to be a need to create an 
internal aligned architecture of matrix within the NGC lumen. To do this, a range of 
method including polymer extrusion or polymer alignment by magnetic ﬁelds, injection 
molding, phases separation and micropatterning have been used to orient the ﬁber, 
ﬁlament or gel ﬁllers inside the NGC lumen [57, 90, 91]. Magnetically aligned collagen (or 
other ECM protein) matrices within the NGC lumen have been shown to promote axonal 
outgrowth in vitro and in vivo as compared to random isotropic counterparts that are 
usually prepared in a handmade way [92, 93]. Moreover, the number of ﬁlaments or 
ﬁbers and the gel concentration introduced to the NGC lumen should be optimized 
because dense intraluminal matrices may impede the migration of regenerating axons 
and non neuronal cells, and occupy space within the NGC lumen where new initial 
regenerative cables are formed and distributed [56]. 
Longitudinally oriented ﬁlaments or ﬁber bundles, both of synthetic [32, 94, 95] or 
biological materials [57, 59], have been inserted into the NGC lumen to guide the 
longitudinally directed growth of regenerating axons. Several manufacture methods, 
including electrospinning, phase separation, and self-assembly, have been used for the 
fabrication of such biofunctional nanofibrous scaffolds. Wang et al. prepared a 
microporous CS NGC with internal oriented filaments of PGA. This NGC was used to 
bridge 30-mm dog sciatic nerve gap, achieving the repair outcome similar to that by 
autologous nerve grafting [96]. In vitro studies have demonstrated the inﬂuence of ﬁber 
diameter on the orientation of process outgrowth. The greater surface curvature of small 
diameter ﬁbers prompted an increasing tendency for neurite outgrowth to follow the 
longitudinal axis of the ﬁbers. Thus, small caliber ﬁbers (5–30 µm diameter) supported a 
greater degree of orientated process growth than large caliber ﬁbers (up to 500 µm 
diameter) [97]. Interstingly, Ribeiro-Resende et al. have reported that PCL NGCs inserted 
with laminin-coated PCL filaments (22 µm diameter) or with poly-D-lysine-coated fibers 
(22 µm diameter) could support nerve regeneration [90]. In this study, researchers have 
also shown that the alignment of SCs can be induced more efﬁciently by physical means, 
i.e. polymer ﬁlament topography, than by biological means such as the application of 
individual soluble factors. 
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Besides being processed into the physical form of ﬁbers or ﬁlaments, the ECM protein-
based intraluminal matrix is also shaped as gels or three-dimensional sponges due to the 
ease of fabrication. In a recent work, Tonda-Turo et al. have developed artificial NCGs 
consisting of porous PCL hollow tube and an internal GP-crosslinked GL sponge (GL/GP). 
GP crosslinking increased the GL-sponge stability in water and improved the mechanical 
properties under compression, as compared to uncrosslinked GL sponge. GL/GP films 
were found to support the in vitro adhesion, the survival and the proliferation of NOBEC 
and PC12 cells [98]. Hydrogels, serving both as space lumen filler and as delivery vehicles 
for bioactive molecules and cells, have been developed by using natural based 
biomaterial such as collagen, GL, and laminin gels, showing an improve in the recovery of 
neural gaps in rat or mouse sciatic nerve [40, 41, 68]. In a recent study, Pawar et al., have 
developed an alginate-based anisotropic hydrogels [99]. The incorporation of GL into 
hydrogel, by simple immersion of alginate gels in 2g/l GL solution, has been shown to 
promote directed axon outgrowth and SC migration in vitro. The author has recently 
collaborated to the development of a agar/gelatin based hydrogel for the loading and 
release of growth factors (Tonda Turo et al) The prepared developed showed shear-
thinning properties and was applied as filler of NGCs. In vitro experiments showed that 
the GL based hydrogel was able to promote Schwann- like cell adhesion, proliferation 
and migration.  
 
 
Fig. 3.5. Schematic representation of structural repair strategies used for improving existing 
hollow nerve guidance conduits. Repair strategies include the use of intraluminal guidance 
structures and multichannel designs to provide additional structure support and topographical 
guidance to regenerating axons and migrating SCs. 
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3.2.7.3 Cellular therapy: support cells 
The success of simple tubulization is dependent on the length of the gap between the 
two nerve stumps. When the length of nerve gaps is consistent (>30 mm in primate ulnar 
nerve), empty NGCs alone will not suffice unless support cells or GFs are incorporated 
into them [100]. Support cells implanted into the injury nerve may clearly act as the 
source of a range of particular neurotrophic factors, and may also generate beneficial, 
axon growth promoting environments by the production of important ECM molecules 
such as collagen, laminin and fibronectin. Moreover, the donor cells obtained from 
patients themselves may be acutely dissociated from the injured nerve and added to an 
implant or expanded in tissue culture prior to implantation [101]. SCs, neural stem cells 
(NSCs) and marrow stromal cells (MSCs) are the most studied candidates of support cells 
among others.  
SCs are the first and most widely used support cells in peripheral nerve TE because of 
their pivotal role in the neuronal process of regeneration (see paragraph  3.2.5) [102]. 
SCs are also able to produce a high level of different GFs, such as NGF, BDNF, and 
erythropoietin in the sensory system and glial derived GFs in the motor system [103, 
104]. SCs suspended in GL within PGA conduits and autogenous SC suspension in venous 
grafts have supported nerve regeneration over a 30 mm gap in rabbits [105]. Hadlock et 
al. developed artificial NGCs consisting of multichannel conduits seeded with SCs isolated 
from neonatal Fisher rats. The NGCs seeded with SCs increased the average fiber 
diameter in the polymer conduits, as compared to autografts, favouring regeneration of 
myelinated motor fibers [86]. As well, neural scaffolds with different structures are 
attempted to include SCs, it has been reported that SCs introduced into NGCs with lumen 
fillers or multiple channels, could form the ordered arrangement of SC columns to 
imitate Bands of Bunger [106]. However, the long-term effects have, so far, proved 
unremarkable [107].  
Since isolation and culture of primary SCs is a time-consuming process, the growing 
applicability of stem cells has opened new frontiers to nerve regeneration: the advantage 
of using these cell lines is that cell differentiation may be stimulated by advancing axons 
and pluripotency, allows multiple differentiation paths, which can create a positive 
environment for axonal regenerationhas been taken into account by researchers. Among 
the multipotent stem cells, NSCs have the potential to differentiate into three major 
cellular elements of the nervous system, including neurons, astrocytes and 
oligodendrocytes; moreover they can proliferate unlimitedly and undergo rapid cellular 
expansion in response to nerve injuries. Markedly increased functional and 
morphological recovery has been observed following the incorporation of NSCs into 
conduits [108]. In a recent study, CS based NGCs seeded with NSCs have been used as a 
nerve graft to bridge 10-mm facial nerve gaps in rabbits. Nerve regeneration at 12 weeks 
after implantation was similar to that by autologous nerve grafting [69]. MSCs are 
pluripotent stem cells easily obtained through the aspiration of the bone marrow and 
expanded in a large scale by in vitro culture [109]. Several in vitro studies have reported 
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that MSCs can be induced to differentiate into non-mesenchymal cells, such as SCs, 
improving myelin formation and nerve regeneration in vivo after their transplantation 
into different models of peripheral nerve injury [110-113]. Moreover, morphological and 
functional recovery have been observed following the tubulazation with a PCL conduit 
filled with MSC in a mouse median nerve [39]. 
3.2.7.4 Biomolecular therapy 
Because nerve regeneration is modulated by many complex interactions between cells, 
ECM molecules and GFs, the local presence of neurotrophic factors at the nerve injury 
sites plays a vital and complex role in controlling the survival, proliferation, migration and 
differentiation of various cell types involved in nerve regeneration. After nerve injury the 
endogenous GFs secreted by neural cells in the distal nerve stump can support axon 
regeneration, but this supportive action may not be sustained indeﬁnitely due to an 
obvious decline with time in cellular production of GFs [114]. Besides the neurotrophic 
actions that are indirectly provided by support cells within the neural scaffold, exogenous 
GFs may be ideally combined with a NGC. Nerve regeneration has been found to be 
enhanced by filling nerve guides with the neurotrophins, such as nerve growth factors 
(NGF) [75, 115-118], brain-derived neurotrophic factor (BDNF) [116, 119] and 
neurotrophin -3 (NT-3) [114, 116], the glial cell line-derived neurotrophic factor (GDNF) (a 
member of the glial cell line-derive neurotrophic factor family ligands)[117, 120], and 
cytokines as fibroblast growth factor-1 and -2 (FGF) [73]. Vascular endothelial growth 
factor (VEGF) has been fully investigated in terms of its promoting actions on peripheral 
nerve regeneration [121]. NGF and GDNF are two prominent used GFs. They differ in their 
spectrum of action when applied as a single factor. While NGF promotes primarily survival 
and axonal outgrowth of sensory neurons, both in vitro and in vivo [122], GDNF is a key 
factor for motor axonal regeneration [123]. Another striking difference between NGF and 
GDNF relates to their effects on axonal branching, as primarily induced by NGF, and 
axonal elongation, as mostly promoted by GDNF [124, 125]. However, the sustained 
delivery of either GDNF or NGF from synthetic NGC have been found to enhance nerve 
regeneration over long gaps in vivo [117]. In a recent work, Bloch et al. demonstrated the 
ability of ethylene-vinyl acetate based NGC to promote sensory nerve regeneration in the 
rat transected dorsal root by releasing bioactive NGF, BDNF, or NT-3. By comparing the 
effects of the three different types of neurotrophins, NGF was found to powerfully 
promote regeneration of both myelinated and unmyelinated axons after dorsal root 
axotomy, while NT-3 significantly increase regeneration of myelinated axons only; BDNF 
has no significant effect on either myelinated or unmyelinated axons [116]. 
GFs must be locally administered to ensure an adequate effect with little adverse 
reactions because the factors have several traits, including high biological activity, 
pleiotrophic effects (acting on various targets), short half-lives, slow tissue penetration, 
and potential toxicity at high systemic levels [126, 127]. Moreover, the inherent 
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instability of GFs is generally a very limiting factor so that denaturation and partial or 
complete loss of biological activity are frequently events observed in processing and 
formulating these compounds [128]. Therefore, GFs require mild processing conditions 
such as ambient or low temperatures, little exposure to organic solvents or chemical 
reagents, and presence of stabilizing additives. Moreover, to obtain sterile dosage forms 
or delivery systems for GFs, all processes have to be performed aseptically because 
terminal sterilization through γ-rays or heat would destroy the proteins. 
For all these reasons, a variety of delivery systems (Fig. 3.6) with sustained neurotrophic 
factors release have been tested in peripheral nerve injury models. Direct delivery of GFs 
from the NGC has been implemented by either conjugating [129] or physically adsorbing 
[130] the proteins to the NGC wall. For example, PLA-based NGCs for delivery of FGF-2 
fabricated with a relatively simple design consisting of an inner porous PLA layer loaded 
with FGF-2 and an outer densely structured PLA tube. The FGF-2 releasing NGCs 
promoted sciatic nerve regeneration in a 15 mm nerve gap in rats [131]. Prolonged 
delivery of GFs has been also achieved by embedding the drug substances into gel 
structures filled into the lumen of NGCs. Often used gel forming materials include 
alginate, Matrigel®, collagen, heparin, laminin, and fibronectin [132, 133]. Tonda Turo et 
al. developed an injectabale hydrogel based on GL for delivery of VEGF-A165 into the NGC 
lumen [134]. In vitro results confirmed a sustained VEGF-A165 release in a bioactive form, 
inducing capillary-like tube formation and axonal outgrowth ex vivo [135]. To control GF 
release independently of NGC wall type and structure, the proteins can be 
microencapsulated into microspheres embedded in the NGC wall or into elecrospun 
nanofibers. Kokai et al. developed double-walled PLGA microspheres for localized release 
of GDNF [136]. The microspheres were embedded into the wall of PCL based NGCs during 
fabrication. The NGCs with embedded microspheres sustained the GDNF release over the 
study period of 16 weeks and exhibited no initial burst release. The NGCs with improved 
release kinetics ameliorated also axonal regeneration and functional recovery. As regard 
the loading of nanofibres with proteins, the main advantage is based on the combination 
of localized release of growth promoting compounds and immediate axonal guidance. GFs 
can be added into the polymer solution prepared to produce nanofibres [137] or by co-
axial spinning [138], which affords embedding of GFs in the core of the fibres.  
Another approach for loading and releasing GFs in NGCs is by using the binding affinity of 
GFs to heparin or heparin sulfate and to ECM components like collagen or laminin. 
Recently, Sakiyama-Elbert et al. developed a drug delivery system consisted of heparin-
binding peptides covalently immobilized within a fibrin matrix. NGF was bound by affinity 
to the immobilized heparin [139]. Collagen or laminin binding domain were bound to NGF 
or CNTF domains and used as a delivery strategy to support sciatic nerve regeneration in 
rat [140, 141]. The scaffolds provided slow release of the GFs at the site of nerve injury. 
All the studies demonstrated that prolonged release of GFs over several days or weeks 
can be achieved by NGC-integrated, polymer-based delivery systems. 
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Table 3.2 GFs used in peripheral nerve regeneration are reported. 
Growth factor Major target References 
NGF  Sensory neurons, small axons [75, 115-118] 
NT-3 Sensory neurons, small-and medium size axons [114, 116] 
BDNF  Sensory neurons, large axons [116, 119] 
GDNF  Motor neurons [117, 120, 136] 
FGF-1 (acidic FGF) Vascular endothelial cells [142] 
FGF-2 (basic FGF) Vascular endothelial cells [73, 131] 
VEGF  Vascular endothelial cells [121, 143] 
IGF-1  Inflammatory cells (anti-inflammatory) [144] 
 
 
Fig. 3.6 Design of delivery systems for neurotrophic factors inside NCs: A) NGC empty wall; B) 
neurotrophic factors embedded in NC wall; C) neurotrophic factors  embedded in polymeric 
coatings of NGC wall; D) neurotrophic factors encapsulated in biodegradable microspheres 
embedded in NGC wall; E) neurotrophic factors embedded in ECM material in NGC lumen; F) 
neurotrophic factors entrapped in biodegradable nanofibres that are mounted on the NGC wall. 
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Chapter 4 
Chitosan crosslinked flat membranes 
as scaffolds for 
peripheral nerve regeneration 
 
Abstract 
Chitosan (CS) has been widely used in a variety of biomedical applications including 
peripheral nerve repair because of its excellent biocompatibility, biodegradability, readily 
availability and antibacterial activity. In this study, CS flat membranes, crosslinked with 
dibasic sodium phosphate (DSP) alone (CS/DSP) or in association with the γ-
glycidoxypropyltrimethoxysilane (CS/GPTMS_DSP) were fabricated with a solvent casting 
technique. The constituent ratio of crosslinking agents and CS was previously selected to 
obtain a composite material having both proper mechanical properties and good 
biocompatibility. Furthermore, the diffusion of nutrients through the CS/DSP and 
CS/GPTMS_DSP flat films were tested.  
In vitro cytotoxicity tests showed that CS membranes were not cytotoxic. CS/GPTMS_DSP 
provided a favorable environment for nerve RT4-D6P2T adhesion, proliferation, and 
function. Moreover, developed CS based membranes showed to direct cell attachment 
resulting in characteristic cell morphology typical of SCs and to support the neurite 
outgrowth of dorsal root ganglia (DRG) cultured on this biomaterial. Finally, in vivo tests 
were carried out on both the two types of nerve scaffolds made by CS/DSP and 
CS/GPTMS_DSP flat membranes due to their easily manipulation and suturability. 
During in vivo tests CS/GPTMS_DSP tubes were detached from the distal suturing site and 
functional recovery did not occurred. On the other hand, crushed nerve encircled with 
CS/DSP membranes, allowed nerve fiber regeneration and functional recovery, obtaining 
results comparable to median nerve repaired with reversed autologous graft, used as 
control. 
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4.1 Introduction 
Peripheral nerve injuries (PNI) are a serious health problem. Generally, an end-to-end 
anastomosis method can be used to bridge the PNI with small gaps, however, it is still 
difficult to completely cure the long nerve gaps [1]. Autologous nerve grafts is the “ gold 
standard” technique in bridging peripheral nerve defects [2]. However there are 
unavoidable drawbacks associated to it such as the limited availability and donor-site 
morbidity. In recent years, a variety of biomaterials for better recovery of nerve functions 
have been developed as previously described in chapter 3. CS, as a natural 
polysaccharide, has attracted more and more attention due to its good biocompatibility, 
biodegradability, non-toxicity, readily availability and unique physicochemical properties 
[3-5]. 
Recent in vitro studies revealed the suitability of CS membranes as substrate for survival 
and oriented SC growth [6] as well as survival and differentiation of neuronal cells [7, 8]. 
CS NGCs alone or in combination with other biomaterials have been found to efficiently 
bridge peripheral nerve defects [9]. For example, CS/gelatin nerve grafts have been 
developed for delivering SCs and NGF to explore the feasibility of improving sciatic nerve 
regeneration, the results showed that the nerve conduction velocity, average regenerated 
myelin area, and myelinated axon count were all promoted [10, 11]. In addition, the 
differentiation of induced pluripotent stem cells into neuron-like cells was found to be 
accelerated by the chitin–CS–gelatin scaffolds [12]. However, pure CS is brittle and 
degrades rapidly [13, 14]: improved technologies and different crosslinking methods have 
been developed to overcome the poor mechanical strength of CS nerve guide channel 
under physiological conditions, which is one of the main factors limiting the use of such 
for neural clinical applications until now [11]. In the first section of this thesis (Chapter 2), 
CS flat membranes, crosslinked with DSP and GPTMS_DSP were prepared and 
characterized to have suitable properties for peripheral nerve TE. 
In this work, DSP and GPTMS _DSP crosslinked CS flat membranes were prepared by 
solvent casting technique and biologically characterized by in vitro and preliminary in vivo 
tests. Permeability to nutrients was evaluated using FITC-dextran as a model of nutrients 
having a Stokes radius of 14 Å that is superior to glucose Stokes radius (3.8 Å) [15] and 
NaCl Stokes radius (1.4 Å) [16]. Culture studies of RT4-D6P2T cells were also performed 
on these degradable CS based flat membranes to ensure their potential applicability as 
nerve repair conduits.  
In addition to the fine-tuned manufacturing of the CS samples and their evaluation with 
regard to biocompatibility, CS flat membranes were used to bridge a 10 mm defect in rat 
sciatic nerves: in vivo studies were performed by analyzing the outcome of peripheral 
nerve repair at 12 weeks post-implantation through a combination of electrophysiological 
assessment, immunohistochemical and histological investigations. 
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4.2  Experimental 
4.2.1 Materials 
CS (medium molecular weight, 75%-85% deacetylation degree), GPTMS and DSP were 
supplied from Sigma Aldrich. All solvents used were of analytical grade and used without 
further purification. RT4-D6P2T schwannoma cell line was purchased from American Type 
Culture Collection (ATCC- catalog number CRL-2768) and cultured following 
manufacturer’s instruction. 
4.2.2 Methods 
CS was dissolved in acetic acid solution 0.5M at room temperature by continuous stirring 
to obtain a 2.5 % (w/v) solution. The crosslinked membranes were prepared according to 
the following procedures as previously described in chapter 2. Briefly: 
I. DSP-crosslinked samples (CS/DSP) were obtained by adding DSP 1M (one drop per 
second) to the CS solution with a concentration of 7.5 % v/v with respect to the 
natural polymer solution volume. The mixed solution was kept under stirring at 
room temperature for about 10 minutes.  
II. GPTMS_DSP crosslinked samples (CS/GPTMS_DSP) were obtained adding GPTMS 
(50% w/w) to the CS solution. The resulting CS/GPTMS solution was kept under 
stirring for 1 hour, followed by the dropwise addition (one drop per second) of 
DSP 1M (concentration 7.5 % v/v) and maintained under moderate stirring for 10 
minutes. 
Then, 10 ml of each solution (CS/DSP and CS/GPTMS_DSP) was poured into 6 cm Petri 
dishes and air-dried for 48 h to obtain ﬂat membranes. All crosslinked dried samples were 
dipped into demineralised water for 10 minutes and then the water pH values were 
measured to evaluate the presence of acidic residues. 
4.2.3 Sample characterization 
4.2.3.1 Evaluation of CS based membranes permeability 
Permeability of CS flat membranes for FITC-labelled dextrans (Sigma Aldrich) of 4400 Da 
(FD-4) was determined in the following way. First, CS/DSP and CS/GPTMS_DSP 
membranes were rolled and glued to obtained a tube having a 3 mm diameter and a 1.5 
cm length, then one end of the tube was closed with cyanoacrylate glue. A 10% w/v 
solution of FD-4 in phosphate buffer saline (PBS) was prepared, and 180 µl of FD-4 
solution were inserted into the lumen, then the second opening was closed with a 
cyanoacrylate glue. The tube was then placed in 3 ml of PBS at pH 7.4, and FITC–dextran 
concentration in the incubation medium was measured through UV spettroscopy (CARY 
500 SCAN UV-VIS-NIR Spectrophotometer) after 1, 3, 6, 24, 48 and 96 hours. The FD-4 
release concentration in the external PBS solution was reported as a percentage respect 
96 
 
to the initial concentration (10% w/v) in the tube (Fig. 4.1). Five measures for samples 
were used and the data were reported as mean value and standard deviation. The 
concentration of FD-4 was calculated from the absorption values using the calibration 
curves that was prepared starting from FD-4 solution of known concentrations. 
 
Fig. 4.1. Sample preparation for permeability test: A) solution of FD-4 in PBS was prepared, B) 
CS/DSP and CS/GPTMS_DSP films were rolled and glued to obtained a tube and one end of the 
tube was closed with cyanoacrylate glue; FD-4 solution was inserted into the lumen, then the 
second opening was closed with a cyanoacrylate glue; C) the tubes was placed in PBS. 
4.2.3.2 In vitro cell tests on CS based samples 
In vitro cell tests were performed using RT4-D6P2T, a schwannoma cell line derived from 
N-ethyl-N-nitrosourea (ENU) induced rat peripheral neurotumor RT4 [17]. Cytotoxicity 
test was carried out on both CS/DSP and CS/GPTMS_DSP while, RT4-D6P2T adhesion, 
proliferation and function were evaluated on CS/GPTMS_DSP due to the higher 
mechanical stability of the biomaterial under physiological condition and because they 
were considered as “the worst case” (biomaterials employed for CS/GPTMS_DSP 
fabrication were the same of CS/DSP supplemented with GPTMS). Neurite outgrowth of 
dorsal root ganglia (DRG) cultured on CS/GPTMS_DSP was examined. 
4.2.3.2.1 Cytotoxicity study on CS/GPTMS_DSP and CS/DSP 
The effect of the CS based material extracts was studied on RT4-D6P2T. CS/DSP and 
CS/GPTMS_DSP samples were first sterilized with a 20 minutes exposure to ultraviolet 
(UV) irradiation (UV lamp, wavelength 254 nm; Technoscientific Co., El- Haram Giza - 
Egypt). Material extracts were prepared by incubating both crosslinked CS samples in 
Dulbecco’s Modified Eagle Medium (DMEM, Sigma Aldrich) supplemented with 100 U/ml 
penicillin (Sigma), 0.1 mg/ml streptomycin (Sigma), 1 mM sodiumpyruvate (Sigma), 4 mM 
L-glutamine (Sigma) and 10% heat-inactivated fetal bovine serum (FBS; all from 
Invitrogen) and stored at 37 °C in a humidified atmosphere of 5% CO2 for 13 days. As 
control media, samples of culture medium without CS were maintained in the same 
conditions of CS/DSP and CS/GPTMS_DSP samples and then collected after 13 days. Then 
proliferation assay on cell line was carried out using media collected. In details, RT4-
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D6P2T cells were seeded in the previous prepared extract media, at a density of 2x103 
cells/cm2 on Petri dishes. After 2, 3, 5 and 7 days in vitro (DIV), cells were trypsinized and 
counted in a Burker’s hemocytometer chamber. Experiments were performed as 
technical and biological triplicates. The counts obtained from assays were analysed, 
averaged and expressed as logarithmic scale of viable cells/mm2 ± SD. 
4.2.3.2.2 Cell adhesion on CS/GPTMS_DSP samples 
Immunocytochemistry analysis was performed to qualitatively evaluate cell adhesion and 
morphology. RT4-D6P2T were seeded at a density of 1.05x104/cm2 on films and control 
glass slides. After 24 hours of culture, culture medium was removed, substrates with 
attached cells were rinsed with PBS and fixed by the addition of 4% paraformaldehyde 
solution (PAF; Sigma-Aldrich). After 20 min the PAF was removed and each plate was 
washed with PBS. Fixed cells were permeabilized with 0.1% Triton X-100 and blocked with 
1% Normal goat serum in 0.01M PBS (pH 7.4) for 1 h at room temperature. F-actin was 
detected using fluorescein isothiocyanate (FITC)- conjugated phalloidin diluted 1:1000 in 
blocking solution (Chemicon-Millipore) by 1 h incubation at room temperature following 
three wash steps of 5 min each. Vinculin was detected by overnight incubation with 
vinculin monoclonal antibody (Millipore) diluted 1:200 in PBS followed by 1-h incubation 
with goat-anti-mouse Alexa 488 secondary antibody (Invitrogen) diluted 1:200 in PBS. All 
the fluorescently-labeled cells were examined under a LSM 510 confocal laser microscopy 
system (Zeiss, Jena), which incorporates two lasers (argon and HeNe) and is equipped 
with an inverted Axiovert 100 M microscope. 
4.2.3.2.3 Proliferation assay on CS/GPTMS_DSP samples 
RT4-D6P2T cells were seeded in DMEM containing 10% FBS, at a density of 2.5x103 
cells/cm2 on both CS/GPTMS_DSP and poly-d-lysine coated glass plates (positive control). 
After 1, 3 and 4 DIV, culture medium was removed, substrates with attached cells were 
rinsed with PBS and fixed by the addition of 4% PAF. After 20 min the PAF was removed 
and each plate was washed with PBS. RT4-D6P2T cells were stained with 1% crystal violet 
(a deep purple nucleic acid stain) solution in 200 mM boric solution (pH 9) for 10 min at 
room temperature. Cells were photographed at DFC 320 Leica microscope with a 30 
images were taken at a low magnification (10X) for each sample. The images were then 
acquired through the program Image Manager IM50 (Leica). The counts obtained from 
proliferation assay were analysed, averaged and expressed as logarithmic scale of viable 
cells/mm2 ± SD. 
4.2.3.2.4 Real Time Reverse-Transcriptase-Polymerase-Chain-Reaction (Real Time RT-
PCR) analysis on CS/GPTMS_DSP 
RT4-D6P2Ts were cultured in DMEM containing 10% FBS on polystyrene plates and 
CS/GPTMS_DSP flat membranes and were allowed to reach confluence. The total RNA 
was isolated from the confluent culture by extraction with TRIzol (Invitrogen). The RNA 
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concentration was quantified by measuring the absorbance at 260/280 nm. The total RNA 
(1 µg per sample) was reverse-transcribed in a reaction volume of 25 µl with 7.5 mM of 
random hexamers (Thermo Scientific). Each reaction consisted of cDNA synthesis buffer 
(50x10-3 M Tris-HCl, pH 8.3, 75x10-3 M KCl, 3x10-3 M MgCl2), 1 mM deoxynucleotide 
triphosphate (dNTP), Thermo Scientific), 1.3 U/µl ribonuclease inhibitor (RNAsin, Ribolock 
Thermo Scientific) and 8 U/µl Moloney murine leukaemia virus (M-MLV) reverse 
transcriptase (RevertAid Thermo Scientific). The samples were then exposed to a first 
cycle: 25°C for 10 min, 42°C for 90 min and 90°C for 10 min. Specific primers designed to 
amplify B cell lymphoma 2 (Bcl2)-associated X protein (BAX), Bcl2 (two proteins involved 
in the cascade of caspases, which regulates cellular apoptosis), superoxide dismutase 
(SOD, an important antioxidant defense in nearly all living cells exposed to oxygen) and 
mammalian target of rapamycin (mTor, a protein encoded by the MTOR gene involved in 
the regulation of cell growth, cell proliferation, cell motility, cell survival, protein 
synthesis, and transcription) are listed in Table 4.1. For normalisation to multiple 
housekeeping genes, ubiquitin gene C (UBC) and TATA-binding protein (TBP) were used. 
The reaction mixture of PCR included 7.5μg forward and reverse primers, 12.5 μl SYBR 
Green (Life Technologies) and 5 μl cDNA. The PCR conditions were as following: initial 
step at 95°C for 25 s, then 40 cycles at 95 °C for 15 s, 60 °C for 1 min. The results were 
obtained from three independent experiments. 
Table 4.1. Primers designed to amplify BAX, Bcl2 and G3PDH cDNA. 
cDNA Primer Oligonucleotide primers 
Annealing temperature 
(°C) 
BAX 
Forward 5’-TTGCTGATGGCAACTTCAAC-3’ 
60 
Reverse 5’-GATCAGCTCGGGCACTTTAG-3’ 
Bcl2 
Forward 5’-GCATCTGCACACCTGGATC-3’ 
60 Reverse 5’-GGGCCATATAGTTCCACAAAGG-3’ 
SOD 
Forward 5’-GAGGCCATCCCTTATCCAAG 
60 Reverse 5’-GATGCCACAGGCCAACC-3’ 
mTOR 
Forward 5’-GCAGCAACAGTGAAAGTGAAG-3’ 
60 Reverse 5’-GCCTCTCGACAAGGAGATAG-3’ 
UBC 
Forward 5’-CCACCAAGAAGGTCAAACAGG-3’ 
60 Reverse 5’-CCCATCACACCCAAGAACAAG-3’ 
TBP 
Forward 5’-GATCAAACCCAGAATTGTTCTCC-3’ 
60 
Reverse 5’-GGGGTAGATGTTTTCAAATGCTTC-3’ 
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4.2.3.2.5 Neurite outgrowth assay on CS/GPTMS_DSP 
DRGs explants were harvested from adult female Wistar rats, weighing approximately 250 
g, reduced and maintained in Ham’s nutrient mixture F12 (Gibco) for 1 hour under sterile 
conditions. Experiment was performed in technical and biological triplicate. Rats were 
sacrificed by a lethal i.m. injection of tiletamine + zoletil, according with the Ethics 
Committee and the European Communities Council Directive of 24 November 1986 
(86/609/ EEC). Adequate measures were taken to minimize pain and discomfort taking 
into account human endpoints for animal suffering and distress. DRG explants were 
cultured onto matrigel-coated coverslips (BD Biosciences) and CS/GPTMS_DSP flat 
membranes and incubated at 37 °C for 1 hour. The matrigel was diluted 1:1 in the culture 
medium. Explants were maintained for 4 days in defined serum-free medium (SFM) at 37 
°C with 5% CO2 [18] supplemented with 50 ng/ml of NGF. As control no 50 ng of NGF/ml 
of medium were added according to literature data [19, 20]. After 4 days, explants were 
fixed with 4% PAF for 15 minutes at room temperature. For the immunohistochemistry, 
briefly, the specimens were incubated overnight in a solution containing both anti-
neurofilament-H (anti-NF-H, monoclonal mouse, 1:200, Sigma) that specifically recognizes 
both phosphorylated and non-phosphorylated NF-H subunits, and anti-peripherin 
(polyclonal rabbit, 1:1000, Chemicon International) primary antibodies. After washing in 
PBS, double immunolabeling was carried out by incubating sections for 1 h in a solution 
containing two secondary antibodies: anti-rabbit IgG Cy3 (Jackson Immunoresearch 
Laboratory) and anti-mouse IgG Alexa-Fluor-488-conjugated (Molecular Probes). All 
samples were observed with a LSM 510 confocal laser microscopy system (Zeiss, Jena), 
which incorporates two lasers (argon and HeNe) and is equipped with an inverted 
Axiovert 100 M microscope. For quantification, the whole explants were acquired through 
an optical video-confocal microscope and the supporting software ImageJ. 
4.2.3.3 In vivo tests on CS/GPTMS_DSP and CS/DSP 
All procedures were performed in accordance with the Ethics Committee and the 
European Communities Council Directive of 24 November 1986 (86/609/ EEC). 
4.2.3.3.1 In vivo qualitative analysis on: biocompatibility, rolling up and suturability 
Prior to their use on crushed median nerves, the biocompatibility, the rolling up and the 
suturability of CS/DSP and CS/GPTMS_DSP flat membranes were tested in vivo in 2 adult 
female Wistar rats, weighing approximately 250 g. First, CS/DSP and CS/GPTMS_DSP 
membranes were immersed in PBS solution, rolled up and glued with biomedical 
cyanoacrylate glue to obtain a tube having a 1.1 mm diameter and a 1 cm length (Fig 4.2 
A, B,C, D). Under general anesthesia, 1-cm-long incisions was made on the median nerve 
of the left forelimb and CS tubes were implanted (Fig. 4.2 E,F). Throughout the 8-week 
follow-up time, animals remained healthy, and none developed local or systemic signs of 
infection and/or inflammation. 
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Fig. 4.2 Sample preparation for in vivo qualitative analysis on biocompatibility, rolling up and 
suturability: A) CS/DSP film was immersed in PBS solution, B), C), D) CS/DSP film was rolled and 
glued with a cyanoacrylate glue to obtain a tube; E) F) CS/DSP tube immediately before and after 
implantation. 
4.2.3.3.2 Animals and surgery 
In vivo nerve regeneration assays were carried out with both CS/DSP and CS/GPTMS_DSP 
membranes because of their higher elasticity which proved to facilitate surgery. A total of 
12 adult female Wistar rats weighing approximately 250 g at the start of the experiment 
were used. The animals were divided by three experimental groups of 4 animals each. 
The experimental groups were set according to treatment after nerve median crush 
injury. In two groups, the crushed median nerve was encircled by CS/DSP or 
CS/GPTMS_DSP films. Finally, in an additional group, the median nerve was repaired with 
reversed autologous graft. The surgery procedure was the one previously described by 
Tos et al. [21]. Similar to the procedure used for rats [22], in order to prevent 
interferences with the grasping test device during testing due to the use of the contra-
lateral forepaw, the contra-lateral median nerve was transected at the middle third of the 
brachium and its proximal stump was sutured in the pectoralis major muscle to avoid 
spontaneous reinnervation. After 12-weeks post-operative, rats were sacrificed: 
CS/GPTMS_DSP were found to be detached from the distal suturing site (Fig. 4.3E). For 
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this reason, light and transmission electron microscope analysis was carried out on 
CS/DSP samples. 
 
Fig. 4.3 Pictures taken from CS/DSP (A, D), CS/GPTMS_DSP(B,E) and autograft (C, F) in situ 
immediately after post-operatory (A, B, C) and 12 weeks post-injury (D, E, F). 
4.2.3.3.3 Postoperative assessment of functional recovery 
Grasping test sessions were carried out every 3 weeks until week 12. Grasping test was 
performed following the same procedure previously described [22] using the BS-GRIP 
Grip Meter (2Biological Instruments, Varese, Italy). Equipment for grasping test is 
basically represented by a precision balance connected to a grid. The test is carried out by 
holding the mouse by the tail and lowering it towards the device and then, when the 
animal grips the grid, pulling it upward until it loses its grip. When the median nerve 
function is impaired, the animal’s paw approaches the grid in complete finger extension. 
The balance records the maximum weight that the animal manages to hold up before 
losing the grip. Each animal was tested three times and the average value was recorded. 
Since assessment of animal welfare was one of the main objectives of this study, a careful 
daily animal surveillance was adopted for passive and active movement, auto-mutilation 
and joint contracture, especially during early post-operative times. 
4.2.3.3.4 Resin embedding and electron microscopy 
After the 12-week follow-up time, animals were euthanatized and a 10-mm long segment 
of the median nerve distal to the site of lesion was collected, fixed, and prepared for 
design-based stereological analysis of myelinated nerve fibers and for electron 
microscopy. The week-12 end-point was chosen since functional recovery measured by 
the grasping test was stabilized by this post-operative time. Nerve samples were fixed by 
immediate immersion in 2.5% purified glutaraldehyde and 0.5% saccarose in 0.1 M 
Sorensen phosphate buffer for 6–8 hours. Specimens were then washed in a solution 
containing 1.5% saccarose in 0.1 M Sorensen phosphate buffer, post-fixed in 1% osmium 
tetroxide, dehydrated and embedded in resin. From each nerve, series of semi-thin 
102 
 
transverse sections (2-μm thickness) were cut starting from the distal stump of each 
median nerve specimen, using an Ultracut UCT ultramicrotome (Leica Microsystems, 
Wetzlar, Germany) and stained using Toluidine blue for high resolution light microscopy 
examination and design-based stereology. For transmission electron microscopy, ultra-
thin sections (50–90-nm thick) were cut using the same ultramicrotome and stained with 
saturated aqueous solution of uranyl acetate and lead citrate. Ultra-thin sections were 
analyzed using a JEM-1010 transmission electron microscope (JEOL, Tokyo, Japan). 
4.2.3.3.5 Design-based quantitative morphology of nerve fiber regeneration 
In each nerve treated with reversed autograft or encircled with CS/DSP, design-based 
stereological analysis was carried out using one randomly selected toluidine blue stained 
semithin section. A DM4000B microscope equipped with a DFC320 digital camera and an 
IM50 image manager system (Leica Microsystems, Wetzlar, Germany) was used for 
stereology. The final magnification was 6600X enabling accurate identification and 
morphometry analysis of myelinated nerve fibers. One semi-thin section from each nerve 
was randomly selected and the total cross-sectional area of the nerve was measured. The 
sample of fibers in each nerve was then randomly selected using a previously described 
stereological method [23]. Mean fiber density was then calculated by dividing the total 
number of nerve fibers within the sampling field by its area (N/mm2). Total fibers number 
(N) was finally estimated by multiplying the mean fiber density by the total cross-
sectional area of the whole nerve cross section. 
Two-dimensional disector probes were also used to select an unbiased representative 
sample of myelinated nerve fibers. In each fiber, both fiber and axon area were measured 
and the circle-fitting diameter of fiber (D) and axon (d) were calculated. These data were 
used to calculate myelin thickness [(D−d)/2], myelin thickness/axon diameter ratio 
[(D−d)/2d], and axon/fiber diameter ratio, the g-ratio (D/d). The precision of the 
estimates was evaluated by calculating the coefficient of error (CE) as previously 
described [24, 25]. The sampling scheme was designed in order to keep the CE below 
0.10, which assures enough accuracy for neuromorphological studies [26]. 
4.2.3.3.6 Immunohistochemistry and confocal laser microscopy 
From all animals, a 3-mm long nerve specimen withdrawn proximal to the segment was 
used for resin embedding, was fixed in PAF 4% and PBS and routinely embedded in 
paraffin for immunohistochemistry and confocal laser microscopy. Series of 8–10 μm 
thick sections were cut by a RM2135 microtome (Leica Microsystems, Wetzlar, Germany). 
Sections were then incubated overnight in a solution containing anti-neurofilament-
200kD (α-NF) primary antibody (monoclonal, mouse, which recognizes the 200 kD subunit 
of neurofilaments, dilution 1:200, Sigma) and then, after washing in PBS, incubated for 1 
hour in a solution containing TRITC-conjugated anti-rabbit IgG (dilution 1:200, Dako). The 
sections were finally mounted with a Dako fluorescent mounting medium and analyzed 
by a LSM 510 confocal laser microscopy system (Zeiss, Jena, Germany), which 
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incorporates two lasers (Argon and HeNe) and is equipped with an inverted Axiovert 
100M microscope. To visualize TRITC, we used excitation from 543 nm HeNe laser line 
and emission passing through a high-pass (LP) 560 filter which passes wavelengths 
superior to 560 nm to the detector. 
4.2.3.4 Statistics 
For vitro experiments, data were expressed as mean ± SEM. For in vivo studies, the 
number of animals used in the experiments (12) was calculated in order to meet the 
Ethical Committee requirements for a minimum number of animals used with the ‘Three 
Rs’ (replacement, reduction and refinement of animal studies) concept put forward by 
Russel and Burch and adopted by the European Community. Statistical analysis was 
carried out using single-factor analysis of variance (ANOVA) post hoc Bonferroni. Values 
of *p≤0.05, **p≤ 0.01, ***p≤0.001 were considered as statistically significant. 
4.3 Results and discussion 
4.3.1 Evaluation of CS based membranes permeability 
One critical properties of NGCs is the wall permeability for solutes and nutrients. The 
NGCs have to facilitate the permeation of small molecules from the outside to the inside 
of the tube and viceversa to allow cell metabolism and growth. The FD-4 was used as a 
model of nutrients having a Stokes radius of 14 Å that is superior to glucose Stokes radius 
(3.8 Å) [15] and NaCl Stokes radius (1.4 Å) [16]. In Fig. 4.4 the release concentration of the 
FD-4 in the PBS after 1, 3, 6, 24, 48 and 96 hours are reported. Results showed that the 
release of FD-4 from CS crosslinked tubes increased with time: an initial burst release 
(about 50%) from the inside to the outside of CS/DSP and CS/GPTMS_DSP conduits was 
followed by a sustained release stage of FD-4 contained into CS tubes, reaching a final 
value of 80% of model molecule released in 96 hours. The prolonged release observed 
after the initial burst release can be ascribed to the penetration of the FD-4 inside the 
tubes after PBS absorption during CS swelling. Moreover, different crosslinking method 
slightly influenced the FD-4 release kinetics. CS/DSP showed an easier permeation of the 
model molecules from the inside to the outside of the tube respect to CS crosslinked with 
both covalent (GPTMS) and ionic (DSP) agents. In detail, after 3 hours, a higher 
permeation of FD-4 was observed for CS/DSP compared to CS/GPTMS_DSP. This trend is 
also confirmed after 6, 24, 48 and 96 hours where a higher release was observed for 
CS/DSP. The addition of the covalent crosslinker in CS/GPTMS_DSP could slow down the 
FD-4 release in time for the hydrophobic properties of the GPTMS and for formation of a 
more organized structure as a consequence of a double crosslinker. 
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Figure 4.4. FITC–dextran release concentration in the incubation medium reported as a 
percentage respect to the dextran initially loaded into CS/DSP and CS/GPTMS_DSP tubes. 
4.3.2 In vitro cell tests on CS based samples 
4.3.2.1 Cytotoxicity study on CS/GPTMS_DSP and CS/DSP 
The effect of the CS based material extracts was studied by RT4-D6P2T proliferation assay 
counting the number of proliferating cells after 2, 3, 5 and 7 DIV (Fig 4.5). RT4-D6P2Ts 
treated with extracts of CS/DSP and CS/GPTMS_DSP showed no cytotoxic effects as no 
significant differences in the cells numbers were evidenced in these two culture 
conditions compared to the control used as reference. 
 
Fig.4.5. Logarithmic scale of RT4-D6P2Ts/mm2 proliferated after 1, 3, 5 and 7 DIV seeded in 
control, CS/DSP and CS/GPTMS_DSP extract media. Cells were counted in a Burker’s 
hemocytometer chamber. 
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4.3.2.2 Cell adhesion on CS/GPTMS_DSP samples 
RT4-D6P2Ts were seeded on CS/GPTMS_DSP and on control glass; immunocytochemistry 
analysis was performed after 24 hours of culture to qualitatively evaluate cell adhesion 
and morphology. The actin cytoskeleton is a highly dynamic network composed of actin 
polymers and a large variety of associated proteins. The function of the actin cytoskeleton 
is to mediate a variety of essential biological functions, including intracellular and 
extracellular movement and structural support. The orientation distribution of actin 
filaments within a cell is, therefore, an important determinant of cellular shape, adhesion 
and motility. In order to obtain a more detailed evaluation of cell adhesion, the actin 
cytoskeleton and focal adhesion complex were stained using FITC-conjugated phalloidin 
and antivinculin antibody, respectively. RT4-D6P2T cells interacted and integrated well 
with both the control and CS/GPTMS_DSP substrates. However, differing morphologies 
and dimensions were seen when RT4-D6P2T cells were cultured on control glass and 
CS/GPTMS_DSP (Fig. 4.6). Cells on control glass displayed a higher dimension and more 
spreading with no particular orientation of the actin cytoskeleton (Fig. 4.6A and C), while 
RT4-D6P2Ts cultured on CS/GPTMS_DSP displayed a more condensed and elongated 
morphology characterized by a typical oval-shaped cell body with long extensions, giving 
an overall spindle shape that is typical with SCs morphology (Fig. 4.6B and D). Vinculin 
immunostaining was performed for RT4-D6P2T cells to visualize the exact location of focal 
adhesion sites. Vinculin-positive sites were observed on cells seeded both on control and 
CS/GPTMS_DSP. However CS/GPTMS_DSP presented an higher accumulation of vinculin 
around the nucleus of RT4-D6P2T cells (Fig. 4.6F) while protein accumulation at the edges 
of cells was also showed in control (Fig. 4.6E). 
These data provide qualitative information about cell adhesion, morphology and 
spreading on the biomaterial surface: 24 hours after seeding cells are still attached to the 
CS/GPTMS_DSP and display a different morphology and vinculin accumulation compared 
to RT4-D6P2Ts cultured on control glass, allowing to hypothesize a lower adhesion and a 
higher motility of cells on the developed biomaterial. 
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Fig. 4.6. Confocal fluorescence microscopy images of RT4-D6P2T cells attached on control glass (A, 
C, E) and CS/GPTMS_DSP (B, D, F) after 24 hours of cell culture. Representative pictures of RT4-
D6P2T, cultured after phalloidin staining (A, B, C, D) and anti-vinculin (E, F). Scale bar 20 μm. 
4.3.2.3 Proliferation assay on CS/GPTMS_DSP samples 
As for cell adhesion (paragraph 4.3.1.2.2), proliferation assay was performed on 
CS/GPTMS_DSP samples. RT4-D6P2T cells were cultured on both CS/GPTMS_DSP and 
poly-d-lysine coated glass plates (positive control). The number of proliferating cells was 
then counted after 1, 3 and 4 DIV. RT4-D6P2Ts seeded on CS/GPTMS_DSP showed lower 
cell proliferation rate and significant differences in the cells numbers were evidenced in 
this culture condition after 3 (**p<0.01) and 4 DIV (***p<0.001) compared to the positive 
control. However, an increase in cell number on CS/GPTMS_DSP samples was observed at 
each time point. The obtained results are probably correlated with the lower adhesion 
and higher motility of RT4-D6P2T on the biomaterial at initial culture time. 
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Fig.4.7 RT4-D6P2T proliferation ratio after 1, 3 and 4 DIV on poly-d-lysine coated glass plates 
(control) and on CS/GPTMS_DSP films. RT4-D6P2T significant differences between CS/GPTMS_DSP 
substrates and control samples were observed (**p<0.01; ***p<0.001). 
4.3.2.4 Real Time Reverse-Transcriptase-Polymerase-Chain-Reaction (Real Time RT-PCR) 
analysis on CS/GPTMS_DSP 
Bax, Bcl2, mTOR and SOD mRNA expression changes were evaluated to study 
proapoptotic and cell survival signaling after 3 and 6 days of culture. Bax is a cytosolic 
protein that plays a pro-apoptotic role, whereas Bcl2 is a pro-survival protein that has 
been shown to heterodimerize with BAX, which counters the death-repressor activity of 
Bcl2 [27]. SOD enzyme participates in the first line of defence against superoxide anions 
(O2−) generated in different cell compartments. mTOR is a protein encoded by the MTOR 
gene involved in the regulation of cell growth, cell proliferation, cell motility, cell survival, 
protein synthesis, and transcription. 
The relative values of BAX, mTOR and SOD mRNA expression were not significantly 
different to RT4_D6P2T cells seeded on the CS/GPTMS_DSP samples and control 
condition both after 3 and 6 days of culture, providing confirmation of the viability of the 
cells cultured on CS/GPTMS_DSP (Fig. 4.8A, B, E, F, G and H). Significant difference in the 
Bcl2 mRNA expression was evidenced in the culture condition after 3 days of culture 
(*p<0.05) compared to the positive control. However, this difference was not observed 
after 6 days. 
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Fig.4.8. RT PCR expression proﬁles of BAX (A, B), Bcl2 (C, D), SOD (E, F) and mTOR (G, H) 
messengers in RT4-D6P2T seeded respectively on control plates, and CS/GPTMS_DSP films after 3 
and 6 days of culture. Signiﬁcative difference between the biomaterial and control was observed 
for Bcl2 after 3 days of culture (*p<0.05). 
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4.3.2.5 Neurite outgrowth assay on CS/GPTMS_DSP 
DRG explants were harvested from adult female Winstar rats and cultured for 4 days onto 
matrigel-coated coverslips and CS/GPTMS_DSP flat membranes. The cultures were fixed 
and immunostained for neurofilaments NF-H (yellow) and pheriperin (red) and then 
analyzed in toto using the laser confocal microscopy. Neurofilaments are the 
intermediate filaments of neurons and in mature neurons comprise neurofilament light, 
middle and heavy chains (NF-L, NF-M and NF-H) as their major proteins; peripherin is a 57 
kDa type III neuronal intermediate filament protein particularly expressed in the 
peripheral nervous system [28-30]. In common with other members of the intermediate 
filament protein family, each neurofilament subunit comprises a central α-helical rod 
domain of 310–352 amino acids that is flanked by an N-terminal globular head domain 
and non-α-helical C-terminal domains. The C-terminal domains are the most variable with 
those of NF-H being the longest and forming side-arms that project from the filament and 
which appear to form crossbridges between neurofilaments and between neurofilaments 
and other cytoskeletal organelles. Moreover, previous data in literature have suggested 
that all DRG neurons express NF-H [31]. Peripherin immunolabeling has been employed 
for the study of peripheral nerve development and regeneration, since this intermediate 
filament protein is highly over-expressed during axon elongation [32]. Both peripherin 
and all NF-H have been reported to co-existing in several neuronal types [31, 33, 34]. A 
double labeling in immunofluorescence revealed that these two neuronal intermediate 
filament proteins were both expressed within the DRG stained neurons (Fig. 4.9). High 
magnification showed that the axonal outgrowth onto CS/GPTMS_DSP flat membranes 
(Fig. 4.9D) apparently exceeds in length compared to that of the matrigel-coated 
coverslips (Fig. 4.9C). 
 
Fig. 4.9 Representative immunostaining image of axonal outgrowth at 4 days after co-culture onto 
matrigel-coated coverslips (A, C) and CS/GPTMS_DSP flat membranes (B, D) using anti-NF-H 
antibody (yellow) and anti-peripherin (red). Scale bar 100 μm. 
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4.3.3 In vivo tests on CS/GPTMS_DSP and CS/DSP 
4.3.3.1 Postoperative assessment of functional recovery 
In vivo nerve regeneration experiments were carried out with both CS/DSP and 
CS/GPTMS_DSP flat membranes. The crushed median nerve of female Winstar rats were 
encircled by CS/DSP or CS/GPTMS_DSP films or repaired with reversed autologous graft, 
used as control. Functional recovery of the left forepaw was assessed every 3 weeks until 
the end of the experiment at week-12 postoperative using the grasping test. Grasping test 
was performed following the same procedure previously described [22] using the BS-GRIP 
Grip Meter (2Biological Instruments, Varese, Italy). Fig. 4.10 reports the post traumatic 
time course of functional recovery for rats treated using CS/DSP and autologous graft. At 
week-3 post-crush, animal performance in the behavioral test dropped to zero confirming 
a complete nerve fiber transection from the crush lesion. The function of finger flexor 
muscles innervated by the median nerve started to recover faster for autograft reaching a 
performance statistically different from CS/DSP at week-6 after lesion (*p<0.05). 
However, functional recovery also started for CS/DSP at week-9 and progressively 
increased arriving at 60% and 80% of the pre-operative values by week-9 and until the 
end of the experiment (week-12), respectively. No significant differences were evidenced 
between autograft and CS/DSP treatment at these time points (week-9 and 12). 
CS/GPTMS_DSP tubes were detached from the distal suturing site and functional recovery 
of finger flexor muscles did not occurred. 
 
Fig. 4.10 Line graph reporting the posttraumatic time course of functional recovery as assessed by 
the grasping test. Values are mean ± standard deviation. Signiﬁcant difference between CS/DSP 
and autograft treated functional recovery was observed after 6 weeks (*p<0.05). 
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4.3.3.2 Light and transmission electron microscope analysis 
Fig. 4.11 shows high-resolution light photomicrographs of rat median nerves injured, 
treated with reversed autologous graft or encircled by CS/DSP film and harvested at 12 
weeks post-operative. Distal median nerves treated with CS/GPTMS_DSP were not 
harvested because conduits were found to be detached from the distal suturing site 
(Fig.4.3E). From each nerve, series of semi-thin transverse sections (2-μm thickness) were 
cut starting from the distal stump of each median nerve specimen and stained using 
Toluidine blue. Small myelinated axons and microfasciculation typical of regenerated 
nerve fibers was detected both on samples treated with CS/DSP (Fig. 4.11A, B) and 
autologous graft (Fig. 4.11C, D) through light microscopy observation. 
Small nerve fibers at different myelinization stages (unmyelinated in Fig. 4.12C, D; in early 
stages of myelinization in Fig. 4.12E, F and myelinated in Fig. 4.12 G, H) were detected 
both on the median nerve encircled with the biomaterial or repaired with reversed 
autologous graft through transmission electron microscopy observations. The presence of 
fibers that were still in the very early phase of myelinazation (Fig. 4.12E, F) suggested that 
at week-12 post-crush injury the process of maturation of regenerated nerve fibers is still 
incomplete. 
 
Fig. 4.11 Photomicrographs of semi-thin sections cut transversely to the main axis of treated 
median nerves using CS/DSP (A,B) and autologous graft (C, D) after 12 weeks post- operative. 
Scale bar: 20 µm. 
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Fig. 4.12 Electron microscope images of regenerated nerves treated using CS/DSP (A, C, E, G) and 
autologous graft (B, D, F, H) after 12 weeks post- operative. Scale bars: A, B, C, D, E, G and H = 1 
µm: F=0.5 µm. 
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4.3.3.3 Design-based quantitative morphology of nerve fiber regeneration 
At 12-week post injury, design-based stereological analysis of regenerated median nerves 
using CS/DSP tubes or reversed autologous grafts (Table 4.2) showed comparable results 
in terms of total number of myelinated fibers, fiber diameters and myelin thickness . 
Regarding density of fibers and axon diameters, both parameters decreased significantly 
(*p<0.05) for median nerve encircled with CS/DSP tubes compared to control. 
Interestingly, the mean g-ratio was not significantly different from both the surgical 
approaches. 
Table 4.2. Comparison of stereological parameters of myelinated nerve fibers in regenerated 
median nerve (12-week post-injury) using autograft and CS/DSP tubes. Values are expressed as 
mean ± S.D. Signiﬁcant differences between the bioengineered and the gold standard approach 
were observed for the density of fibres and axons diameter (*p<0.05). 
Regenerated median nerve Autograft CS/DSP 
Total number of myelinated fibers 6916±817 7059±219 
Density of fibers (#/mm2) 37763±2450 26677±2766* 
Fibers diameter (µm) 2.98±0.11 2.62±0.14 
Axons diameter (µm) 2.08±0.09 1.68±0.04* 
Myelin thickness (µm) 0.45±0.02 0.47±0.05 
g-ratio 0.68±0.01 0.63±0.02 
 
4.3.3.4 Immunohistochemistry and confocal laser microscopy 
Axonal regeneration onto CS/GPTMS_DSP and CS/DSP conduits was examined by 
confocal laser microscopy on longitudinal nerve frozen sections (Fig. 4.11) after 
neurofilaments staining. After 12-week post-injury, in middle segments of regenerated 
nerves, CS/DSP conduit exhibited NF200-positive axons that were linearly oriented in the 
longitudinal sections (Fig. 4.13B). The CS/GPTMS_DSP treated rats displayed poor axonal 
regeneration, irregular orientation, or disordered but NF positive staining for axons in the 
longitudinal sections (Fig. 4.13A). 
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Fig. 4.13 Neurofilament staining on longitudinal sections at 12 weeks revealed that CS/DSP and 
CS/GPTMS_DSP were densely populated with axons. Properly linearly aligned NF axons were 
found in CS/DSP (B) while CS/GPTMS_DSP displayed axons that were haphazardly oriented and 
disorder (A). 
4.4 Conclusion 
In this chapter CS/GPTMS_DSP and CS/DSP flat membranes were studied in vitro and in 
vivo for the development of CS based nerve conduit scaffolds. Both the crosslinked films 
were fabricated by solvent casting technique and they can be easily enwrapped to form a 
NGC in wet state. CS/DSP and CS/GPTMS_DSP showed a good permeability to molecules 
having a Stokes radius around 14 Å guarantying the permeation of nutrients and 
metabolites from the outside to the inside of the tube and viceversa. 
In vitro characterization performed on model membranes showed that CS/DSP and 
CS/GPTMS_DSP do not exert any cytotoxic effects on RT4-D6P2T. The higher mechanical 
stability of CS/GPTMS_DSP under physiological condition allowed to evaluate the RT4-
D6P2T proliferation on the CS materials: a high tendency to RT4-D6P2T to migrate 
emerged, phenomenon that is crucial in the lesion site for promoting nerve regeneration. 
Moreover, the compatibility of CS/GPTMS_DSP with axonal regrowth was tested culturing 
explants of rat dorsal root ganglia (DRG): the presence of neurite outgrowth in the 
samples grown on the CS films was assessed after only four days of culture with 
pheripherin and neurofilament positive axons. 
Finally, in vivo tests were carried out on both the two types of nerve scaffolds made by 
CS/DSP and CS/GPTMS_DSP flat membranes due to their easily manipulation and 
suturability. CS/DSP and CS/GPTMS_DSP nerve membranes were used for bridge 
implantation across 10-mm long median nerve defects in rats, and the outcome of 
peripheral nerve repair at 12 weeks post-implantation was evaluated by a combination of 
electrophysiological assessment, immunohistochemical and histological investigation. 
During in vivo tests CS/GPTMS_DSP tubes were detached from the distal suturing site and 
functional recovery did not occurred. This result was confirmed by confocal laser 
microscopy which displayed poor axonal regeneration and irregular orientation but NF 
positive staining for axons in the longitudinal nerve sections. However, the examined 
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functional and morphological parameters showed that CS/DSP grafts could promote 
peripheral nerve regeneration with effects approaching those elicited by nerve autografts 
which are generally considered as the gold standard for treating large peripheral nerve 
defects, thus raising a potential possibility of using these newly developed nerve grafts as 
a promising alternative to nerve autografts. 
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Chapter 5 
Bi-layer CS membranes for 
nerve tissue engineering 
 
Abstract 
The purpose of this study was to develop bi-layer CS flat membranes that can be easily 
manipulated and rolled to obtain flexible nerve guidance channels (NGCs). These bi-layer 
membranes were prepared via solvent casting technique and their chemical composition 
was optimized to realize malleable membranes to be enwrapped for NGC formation.Two 
kinds of CS films crosslinked with different crosslinking agents were combined to produce 
scaffold structures with good biocompatibility in the inner layer and with the desired 
mechanical strength imparted by the outer. A tight connection between the two layers 
was achieved and the physicochemical, thermal, mechanical properties of CS bi-layer 
membranes were investigated. Additionally, bi-layer membranes were used for bridge 
implantation across 10-mm long median nerve defects in rats, and the outcome of 
peripheral nerve repair at 12 weeks post-implantation was evaluated by a combination of 
electrophysiological assessment, immunohistochemical and histological investigations. 
5.1 Introduction 
Despite over 150 years of experience in modern surgical management of the peripheral 
nerve, repair of a nerve gap remains a problem in microsurgery [1]. Usually, peripheral 
nerve injuries that result in gaps or defects require surgical implantation of a bridge or 
guidance channel between the proximal nerve end and the distal stump in order to 
restore full function and organ regeneration [2]. Autologous nerve grafts have been 
commonly used in bridging peripheral nerve defects [3, 4]. However, unavoidable 
disadvantages, such as the limited availability and donor-site morbidity of autografts, still 
remained. Although allografts have also been used, these were accompanied by the usual 
need for immunosuppression and have lower success rates [5]. Due to the shortcomings 
associated with these approaches to nerve repair, artificial NGCs have been widely 
accepted as a method to create a favorable micro-environment for nerve regeneration. 
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However, there are many requirements for an ideal nerve scaffold, including proper 
mechanical strength to avoid local guide collapse and detachment at guide/nerve 
interface, porosity in the range of few microns to allow nutrients exchange minimizing the 
infiltration of fibrous tissue, good biocompatibility to avoid inflammation and other 
adverse reactions, desirable degradable rate to avoid long-term foreign body existence 
and internal porous structures to encourage nerve fibers or cells to grow inside [6]. To 
satisfy these requires, a bi-layer CS flat membrane with CS/DSP film as inner layer and 
CS/GPTMS_DSP as outer layer was developed. The two layers were selected on the basis 
of results reported in the second section of this thesis. In chapter 4, CS/DSP films were 
proved to enhance nerve fibre regeneration and functional recovery, obtaining results 
comparable to the autologous graft which is consider the gold standard technique, while 
CS/GPTMS_DSP samples showed improved mechanical resistance under wet condition 
due to the presence of the covalent crosslinker (see chapter 2) and were found to be 
permeable to nutrients and biocompatible (see chapter 4). The composition of the bi-
layer membrane was selected since the CS/DSP provides a substrate to promote cell 
adhesion, proliferation and migration as a template to guide the formation of new neural 
tissue and the CS/GPTMS_DSP membrane works as a temporary scaffold, which imparts 
the desired mechanical strength to the conduits.  
In this chapter the development of CS bi-layer membranes was described. The obtained 
membranes were analyzed for their physicochemical properties by FT-IR analysis and 
static contact angle measurements, their water stability was studied by swelling and 
dissolution tests in PBS, their mechanical properties were evaluated by tensile tests. 
Finally, conduits were fabricated by rolling the developed membranes to bridge the 10 
mm defects in the median nerve of female Winstar rats, and autograft nerves were taken 
as positive controls. 
5.2 Experimental 
5.2.1 Materials 
CS (medium molecular weight, 75%-85% deacetylation degree), GPTMS and DSP were 
supplied from Sigma Aldrich. All solvents used were of analytical grade and used without 
further purification. 
5.2.2 Methods 
CS was dissolved in acetic acid solution 0.5 M at room temperature by continuous stirring 
to obtain a 2.5% (w/v) solution. Single (CS/DSP and CS/GPTMS25_DSP) layer membranes 
were prepared according to the procedures described in paragraph 2.2.2. For the 
realization of CS/GPTMS25_DSP membrane, the amount of GPTMS was decreased from 
50% to 25% w/w compared to CS/GPTMS_DSP samples (developed in chapter 2) with the 
final aim to reduce compositional differences and optimize the adhesion among the inner 
and outer side in the bi-layer structure. 
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Bi-layer flat membranes were prepared by a two-step coating technique. CS/DSP samples 
were obtained following the procedures described in chapter 2 and were used as the base 
component of the bi-layer films, whereas CS/GPTMS25_DSP solutions were poured on 
top of them. Finally, samples were air-dried for 48 hours to obtain bi-layered membranes. 
5.2.3 Sample characterization 
5.2.3.1 Fourier transform infrared-attenuated total reflectance spectroscopy (FTIR-
ATR) 
The FTIR-ATR spectra of CS/GPTMS25_DSP, CS/DSP and bi-layer samples were recorded 
at room temperature in a Perkin Elmer Spectrometer in the range 2000-600 cm-1 at a 
resolution of 4 cm-1. 
5.2.3.2 Surface wettability 
The static contact angle of CS/DSP, CS/GPTMS25_DSP and bi-layer films were measured 
at room temperature using a KSV instrument equipped with a CAM 200 software for data 
acquisition. Sessile drop method was applied, using a 5 μL double distilled water droplet. 
For each angle reported, at least five measurements on different surface locations were 
measured and results were expressed as average value ± standard deviation. 
5.2.3.3 Mechanical properties 
The tensile mechanical properties were performed on wet flat membranes using MTS 
QTest/10 device equipped with load cells of 10 N, respectively. Rectangular strips of 
30x10 mm size were cut from each films and strained to break at a constant crosshead 
speed of 2 mm/min. Prior to tensile testing, samples were immersed in PBS for 10 min at 
25°C. Using the associated software Test Works, break stress and strain were determined. 
The elastic modulus was calculated from the slope of the linear portion of the stress–
strain curve. To measure the thickness of the films, digital calibrator was used. Four 
specimens for each kind of material were tested. The results were expressed as average 
values ± standard deviation. 
5.2.3.4 Swelling and dissolution tests 
The swelling and dissolution behavior of single and double layer samples were evaluated 
by immerging the samples in PBS (pH 7.4) at 37°C. The swelling degree was measured 
after 1, 3, 6, 9 and 24 hours while the dissolution degree was evaluated after 1, 3, 5, 7, 14, 
28 and 56 days. The swelling percentage was calculated as: 
ΔWs (%) = (Ws-W0)/W0*100 
where W0 and WS are the sample weights before and after swelling respectively. The 
dissolution percentage was calculated as: 
ΔWd (%) = (W0-Wd)/W0*100 
121 
 
where Wd is the dried sample weight after dissolution. The solution pH was measured at 
the same time intervals during the swelling and the dissolution tests, and its stable value 
at around 7 (physiological pH) was verified. For each experimental time, three samples 
were measured and the results were expressed as averages value  standard deviation. 
5.2.3.5 Permeability of bi-layer CS based membranes 
Permeability of CS/DSP, CS/GPTMS25_DSP25 and bi-layer membranes for FITC-labelled 
dextrans (Sigma Aldrich) of 4400 Da (FD-4) was determined following the procedure 
described in paragraph 4.2.3.1. Briefly, all samples were rolled and glued with a 
cyanoacrylate glue to obtained a tube closed to one end. A 10% w/v solution of FD-4 in 
PBS was prepared, and 180 µl of the solution were inserted into the lumen, then the 
second opening was with a cyanoacrylate glue. The tube was then placed in 3 ml of PBS at 
pH 7.4, and FITC–dextran concentration in the incubation medium was assayed 
fluorimetrically (CARY 500 SCAN UV-VIS-NIR Spectrophotometer) after 1, 3, 6, 24, 48 and 
96 hours. The FD-4 release concentration in the external PBS solution was reported as a 
percentage respect to the initial concentration (10% w/v) in the tube (Fig. 5.1). Five 
measures for samples were used and the data were reported as mean value and standard 
deviation. The concentration of FD-4 was calculated from the absorption values using the 
calibration curves that was prepared starting from FD-4 solution of known 
concentrations. 
 
Figure 5.1. Sample preparation for permeability test: A) solution of FD-4 in PBS was prepared, B) 
CS/DSP, CS/GPTMS25_DSP and bi-layer membranes were rolled and glued to obtained a tube and 
one end of the tube was closed with cyanoacrylate glue; FD-4 solution was inserted into the 
lumen, then the second opening was closed with a cyanoacrylate glue; C) the tubes was placed in 
PBS. 
5.2.3.6 Preliminary in vivo tests 
5.2.3.6.1 Animals and surgery 
In vivo nerve regeneration assay was carried out with CS/DSP, CS/GPTMS25_DSP and bi-
layer membranes. A total of 16 adult female Wistar rats weighing approximately 250 g at 
the start of the experiment were used. The animals were divided by three experimental 
groups of 4 animals each. The experimental groups were set according to treatment after 
nerve median crush injury. In three groups, the crushed median nerve was encircled by 
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CS/DSP, CS/GPTMS25_DSP and bi-layered films. Finally, in an additional group, the 
median nerve was repaired with reversed autologous graft. The surgery procedure was 
the one previously described by Tos et al. [7]. After 12-weeks post-operative, rats were 
sacrificed: CS/GPTMS_DSP25 were found to be detached from the distal suturing site (Fig. 
5.2F). For this reason, light and transmission electron microscope analysis was carried out 
on CS/DSP and bi-layer samples. 
 
Fig. 5.2 Pictures taken from CS/DSP (A, E), CS/GPTMS25_DSP (B, F) and bi-layer (C, G) nerve 
conduits and autograft (D, F) in situ immediately after post-operatory (A, B, C, D) and 12 weeks 
post-injury (E, F, G, H). 
5.2.3.6.2 Resin embedding and electron microscopy 
After the 12-week follow-up time, animals were euthanatized and a 10-mm long segment 
of the median nerve distal to the site of lesion was collected, fixed, and prepared for 
design-based stereological analysis of myelinated nerve fibers and for electron 
microscopy. Nerve samples were fixed by immediate immersion in 2.5% purified 
glutaraldehyde and 0.5% saccarose in 0.1 M Sorensen phosphate buffer for 6–8 hours. 
Specimens were then washed in a solution containing 1.5% saccarose in 0.1 M Sorensen 
phosphate buffer, post-fixed in 1% osmium tetroxide, dehydrated and embedded in resin. 
From each nerve, series of semi-thin transverse sections (2-μm thickness) were cut 
starting from the distal stump of each median nerve specimen, using an Ultracut UCT 
ultramicrotome (Leica Microsystems, Wetzlar, Germany) and stained using Toluidine blue 
for high resolution light microscopy examination and design-based stereology. For 
transmission electron microscopy, ultra-thin sections (50–90-nm thick) were cut using the 
same ultramicrotome and stained with saturated aqueous solution of uranyl acetate and 
lead citrate. Ultra-thin sections were analyzed using a JEM-1010 transmission electron 
microscope (JEOL, Tokyo, Japan). 
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5.2.3.6.3 Immunohistochemistry and confocal laser microscopy 
From all animals, a 3-mm long nerve specimen withdrawn proximal to the segment was 
used for resin embedding, was fixed in PAF 4% and PBS and routinely embedded in 
paraffin for immunohistochemistry and confocal laser microscopy. Series of 8–10 μm 
thick sections were cut by a RM2135 microtome (Leica Microsystems, Wetzlar, Germany). 
Sections were then incubated overnight in a solution containing α-NF-200kD primary 
antibody (monoclonal, mouse, which recognizes the 200 kD subunit of neurofilaments, 
dilution 1:200, Sigma) and then, after washing in PBS, incubated for 1h in a solution 
containing TRITC-conjugated anti-rabbit IgG (dilution 1:200, Dako). The sections were 
finally mounted with a Dako fluorescent mounting medium and analyzed by a LSM 510 
confocal laser microscopy system (Zeiss, Jena, Germany), which incorporates two lasers 
(Argon and HeNe) and is equipped with an inverted Axiovert 100M microscope. To 
visualize TRITC, we used excitation from 543 nm HeNe laser line and emission passing 
through a high-pass (LP) 560 filter which passes wavelengths superior to 560 nm to the 
detector. 
5.2.3.7 Statistics 
Experiments were repeated three times and results expressed as a mean ± standard 
deviation. Statistical analysis was carried out using single-factor analysis of variance 
(ANOVA) post hoc Bonferroni. Values of *p≤0.05, **p≤ 0.01, ***p≤0.001 were considered 
as statistically significant. For in vivo tests, the number of animals used in the experiments 
(16) was calculated in order to meet the Ethical Committee requirements for a minimum 
number of animals used with the ‘Three Rs’ (replacement, reduction and refinement of 
animal studies) concept put forward by Russel and Burch and adopted by the European 
Community. 
5.3 Results and discussion 
5.3.1 Fourier transform infrared-attenuated total reflectance spectroscopy (FTIR-ATR) 
In fig. 5.3 the FTIR-ATR spectra of CS based film samples are reported. CS/DSP, 
CS/GPTMS25_DSP, internal and external side bi-layer spectra showed the characteristics 
bands of both CS and DSP, as described at paragraphs 2.3.2. In details, the peak at 1674 
cm-1, 1542 cm-1and 1414 cm-1 were associated respectively to the C=O stretching bond, 
the amide and amine bending vibrations and O-H bending vibrations typical of CS. DSP 
crosslinking was confirmed by the detection of bands at 1000 cm-1 and at 989 cm-1 and 
943 cm-1 due to the PO3 out-of-phase and in-phase stretching; typical absorption peaks at 
861 cm-1 and at 814 cm-1 were associated with P-OH stretching and P-O-P asymmetric 
stretching vibration, respectively [8]. Moreover, the CS/GPTMS25_DSP and external side 
of the bi-layer FTIR-ATR spectrum showed bands at 1196 cm-1 due to the Si–O–Si bonds of 
the covalent crosslinking chains, confirming the successful crosslinking of CS by GPTMS. 
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The absorption band at 1720 cm-1 was observed in all spectra and could be attributed to 
the stretching vibration of C=O groups, probably due to acetic acid residuals [9]. 
 
Fig. 5.3. FTIR-ATR spectra of CS/DSP (A), CS/GPTMS25_DSP (B), external (C) and internal side (D) 
bilayer membrane. 
5.3.2 Surface wettability 
The static water contact angles of model CS/DSP, CS/GPTMS25_DSP, internal and external 
side of bi-layer samples are reported in Fig. 5.4. The average contact angles of CS/DSP and 
CS/GPTMS_DSP were 66°±9° and 65°±11°, respectively. The development of a double 
layer flat membranes significantly modified the wettability of the inner layer as compared 
to CS/DSP and CS/GPTMS_DSP25 films. Static water contact angles of the internal and 
external side of the bi-layer samples were also significantly different (41°±9° for inner and 
64°±16° for outer layer). 
The enhanced hydrophilicity of the internal part of the double layer membrane could be 
attributed to the physicochemical interactions between the inner and outer layer that 
occurs during the fabrication process that increased the amount of phosphate groups and 
consequently the surface wettability. The measured contact angle of the bi-layer flat 
membrane could favour cell attachment on the studied materials [10, 11]. 
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Fig. 5.4 Static water contact angle of CS/DSP, CS/GPTMS25_DSP, internal and external side of bi-
layered film samples. Histograms reported the average values and the standard deviations. 
**p<0.01. 
5.3.3 Mechanical properties 
CS based samples were tested under wet state since wet membranes are flexible enough 
to be rolled up to fabricate hollow guide. All specimens showed an elasto-plastic 
behaviour; the ɕ-ɛ slope was calculated to obtain the elastic modulus. Wet 
CS/GPTMS25_DSP and CS/DSP samples had a uniform thickness in the range of 90-130 
μm while bi-layer membrane showed thickness values within 300-350 μm. The presence 
of GPTMS enhanced the E values (E, from 3.47±1.06 MPa for CS/DSP to 9.29±0.85 MPa 
and 11.01±2.08 MPa for CS/GPTMS25_DSP and bi-layer respectively): the increment of 
the elastic modulus of CS/GPTMS25_DSP and bi-layer samples (statistical significant 
compared to CS/DSP samples, **p<0.01 and ***p<0.001) was a consequence of the 
mechanical reinforcement associated with covalent crosslinking process and indicated the 
superior elastic behaviour of CS/GPTMS25_DSP and double layer membranes compared 
to the ionic crosslinked samples. No significant differences were observed between 
CS/GPTMS25_DSP and bi-layer. Moreover, the developed bi-layer samples showed an 
intermediate behaviour in terms of elongation at break compared to CS/GPTMS25_DSP 
and CS/DSP (Fig. 5.5), indicating that the double layer is a highly elastic and resistant 
membrane, properties imparted by the CS/DSP internal side and CS/GPTMS25_DSP 
external side respectively. 
Biomaterials used to fabricate NGCs are expected to possess mechanical flexibility to 
favour their surgical application and the in vivo permanence in the body and to not 
collapse under compression during axonal outgrowth. The elastic modulus of the mouse 
sciatic nerve has been reported to be 7 MPa [12]. A nerve guide able to mimic the 
behaviour of the natural nerve tissue should possess a similar elastic modulus. In this 
work, elastic modulus values of around 10 MPa were measured for CS/GPTMS25_DSP and 
bi-layer samples and showed superior mechanical properties respect to CS/DSP samples. 
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Moreover, the development of a bi-layer membranes allowed to improve the elongation 
at break compared with CS/GPTMS25_DSP. Additionally, all the crosslinked scaffolds 
could be easily wrapped around the trunked nerve stumps, allowing the use of the 
different typologies of membranes for the preparation of NGCs during the surgical 
intervention and with the appropriate diameter size depending on the treated nerve size 
(data not shown). 
 
Fig. 5.5 Stress-strain curves of the CS/DSP, CS/GPTMS25_DSP and bi-layer flat membranes tested 
in wet state. 
5.3.4 Swelling and dissolution tests 
The CS based membranes prepared by solvent casting increased their weight when 
immersed in PBS and after 1 hour the water uptake was around 530%, 70% and 135% for 
CS/DSP, CS/GPTMS25_DSP and bi-layer samples, respectively (Fig. 5.6). The 
CS/GPTMS25_DSP and CS/DSP swelling values stabilized after 3 hours, while a slightly and 
continuous increase was measured for the bi-layer membranes reaching a water uptake 
value of around 130% after 24 hours. This gradual increase in swelling degree could be 
attributed to the higher thickness of the double layer membranes compared to single 
layers which slows down the water absorption in time. Moreover, an intermediate value 
of water uptake for the bi-layer membranes was observed and could be associated to the 
combination of single component behaviour: the high swelling degree attributed to the 
presence of phosphate groups for the inner layer and the moderate water absortion 
capacity of the external layer due to the presence of a GPTMS (see paragraphs 2.3.4). A 
comparison of the swelling percentage of CS based samples revealed that the water 
uptake of CS/DSP samples was significantly higher than for CS/GPTMS25_DSP and bi-layer 
specimens at each time point (***p<0.001).  
The dissolution profiles of CS based samples after 56 days of immersion in PBS are 
presented in Fig. 5.7. All membranes decreased their weight of 44.6±5.6 %, 34.5±1.9 % 
and 38.2±5.2 % for the CS/DSP, the CS/GPTMS25_DSP and the bi-layer after 1 day 
incubation in PBS. CS/GPTMS25_DSP samples showed significant lower weight loss 
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respect to CS/DSP specimens at this time point. The initial high weight loss was due to the 
release of salts into PBS solution, as described in chapter 2. CS/DSP, CS/GPTMS25_DSP 
and bi-layer weight loss reached final values of 67.3±6.6%, 54.7±1.5 % and 54.2±3.6% 
after 56 days incubation in PBS. Compared to the CS/DSP membranes, chemical 
crosslinking by the addition of GPTMS agents enhanced the stability in aqueous media of 
CS/GPTMS25_DSP and bi-layer membranes.  
 
Fig. 5.6. Swelling degree of CS/DSP, CS/GPTMS25_DSP and bi-layer flat membranes in PBS as a 
function of time. Column heights correspond to the mean values. Bars indicate standard 
deviations (n = 3). *p< 0.05, **p < 0.001. 
 
Fig. 5.7. Dissolution degree of CS/DSP, CS/GPTMS25_DSP and bi-layer samples in PBS as a function 
of time. Columns are the average values; bars represent the standard deviation. *p< 0.05, **p < 
0.001 and ***p < 0.001. 
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5.3.5 Permeability of bi-layer CS based membranes 
Fig. 5.8 reports the release concentration of the FD-4 in the PBS after 1, 3, 6, 24, 48 and 
96 hours. Results showed that the different structures (single or bi-layer) influenced the 
FD-4 release kinetics. The release of FD-4 from CS/DSP and CS/GPTMS25_DSP tubes was 
characterized by an initial burst release (about 50% and 65% for CD/DSP and 
CS/GPTMS25_DSP respectively) from the inside to the outside of conduits which was 
followed by a sustained release stage of FD-4 contained into CS tubes, reaching a final 
value of around 80% of model molecule released in 96 hours for both the single layer 
samples. No significant differences were observed between CS/DSP and 
CS/GPTMS25_DSP membranes at each time point. As regard bi-layer samples, a more 
gradual and controlled release of FD-4 was observed in time. In detail, multi-layer tubes 
released about 28% of the model molecule in the earlier time (6 hours) of incubation in 
PBS. Then, a burst release was observed from 24 hours reaching a FD-4 release value of 
about 72% after 4 days (96 hours). This behavior can be ascribed to the higher thickness 
of double layer specimens compared to CS/DSP and CS/GPTMS25_DSP conduits which 
slows down the penetration of the FD-4 inside the bi-layer tubes after PBS absorption 
during CS swelling, as observed in paragraph 5.3.4. However, no significant difference of 
model molecule release was observed between the different typologies of structure 
(single and by-layer) after 96 hours of immersion in PBS confirming the permeability of 
the bi-layer membrane for solutes and nutrients. 
 
Fig. 5.8. FITC–dextran release concentration in the incubation medium reported as a percentage 
respect to the dextran initially loaded into the tube. Columns are the average values; bars 
represent the standard deviation (n = 4). *p< 0.05, **p < 0.01 and ***p < 0.001. 
5.3.6 Preliminary in vivo tests 
All procedures were performed in accordance with the Ethics Committee and the 
European Communities Council Directive of 24 November 1986 (86/609/ EEC). 
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5.3.6.1 Light and transmission electron microscope analysis 
Fig. 5.9 shows high-resolution light photomicrographs of rat median nerves injured, 
treated with reversed autologous graft or encircled by CS/DSP (previously described in 
paragraph 4.3.1.2.6.2) or by bi-layer flat membranes and harvested at 12 weeks post-
operative. From each nerve, series of semi-thin transverse sections (2-μm thickness) were 
cut starting from the distal stump of each median nerve specimen and stained using 
Toluidine blue. Distal median nerves treated with CS/GPTMS25_DSP were not harvested 
because conduits were found to be detached from the distal suturing site (Fig. 5.2F). 
Small myelinated axons and microfasciculation typical of regenerated nerve fibers were 
detected on samples treated with bi-layer membranes through light microscopy 
observation. These results were comparable to nerve regenerated using autologous graft 
(Fig. 5.9A, B) and CS/DSP (Fig. 5.9C, D) (see chapter 4). As described in paragraph 
4.3.1.2.6.2, small nerve fibers at different myelinization stages were detected both on the 
median nerve encircled with CS/DSP (Fig 5.10A, D, H) or repaired with reversed 
autologous graft (Fig. 5.10B, E, H) through transmission electron microscopy 
observations. Nerve treated with bi-layer membranes showed unmyelinated (Fig. 5.10F) 
and myelinated fibers (Fig.5.10I) which organized into small bundles following the 
perineural cells activity (Fig. 5.10 C, I). 
 
Fig. 5.9 Photomicrographs of semi-thin sections cut transversely to the main axis of treated 
median nerves using autologous graft (A,B), CS/DSP (C, D) and bi-layer membranes (E, F) after 12 
weeks post- operative. White arrows indicated the presence of myelinated axons.Scale bar: 20 
µm. 
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Fig. 5.10 Electron microscope images of regenerated nerves treated using CS/DSP (A, D, G), 
autologous graft (B, E, H) and bi-layer membranes (C, F, I) after 12 weeks post- operative. Scale 
bars: 1 µm. 
5.3.6.2 Immunohistochemistry and confocal laser microscopy 
Axonal regeneration onto bi-layer, CS/DSP and CS/GPTMS25_DSP conduits was examined 
by confocal laser microscopy on longitudinal nerve frozen sections (Fig. 5.11) after NF 
staining. After 12-week post-operative, in middle segments of regenerated nerves, all 
samples exhibited a densely population of NF axons. Properly linearly alignment of NF 
axons was observed in CS/DSP (Fig. 5.11B) and bi-layer (Fig. 5.11C) while 
CS/GPTMS25_DSP treated rats (Fig. 5.11A) displayed poor axonal regeneration and 
disordered orientation in the longitudinal sections. Moreover, an increase of axon 
alignment was observed for bi-layer membranes compared to CS/DSP single layer. These 
results allows to confirm that the presence of CS/DSP internal side of the bi-layer 
structure could be beneficial for axon regeneration from the proximal to the distal stump.  
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Fig. 5.11 Neurofilament staining on longitudinal sections at 12 weeks revealed that bi-layer, 
CS/DSP and CS/GPTMS_DSP were densely populated with axons. Properly linearly aligned NF 
axons were found in CS/DSP (B) and bi-layer (C) while CS/GPTMS25_DSP displayed axons that 
were haphazardly oriented and disorder (A). 
5.4 Conclusion 
In the present study, a novel bi-layer flat membrane based on CS was developed to 
enhance peripheral nerve regeneration. The bi-layer was composed of a CS/DSP inner 
layer and a CS/GPTMS25_DSP outer layer with the aim to improve nerve regeneration at 
the internal site and to impart the desired mechanical strength to the membrane. The 
scaffold was fabricated by a two-step coating technique where one layer was formed for 
solvent casting and then the polymer solution of the second layer is poured directly on 
top of the previously dried layer. In the present case, CS/DSP film was used as the base 
component of the bi-layer membrane, whereas CS/GPTMS25_DSP solution was poured 
on top of it and left dried. CS/DSP and CS/GPTMS25_DSP single layer were used as 
controls. 
The physico-chemical results showed that the two single layers interacts during the 
double-layer fabrication process: an increase in the surface wettability of the structure 
was observed and could be associated to the strong hydrogen bonding and the higher 
amount of phosphate groups. The bi-layer samples tested under wet condition showed 
improved mechanical properties compared with the CS/DSP and higher elongation at 
break characteristic of CS/DSP film was also observed. Bi-layer samples permeation to 
small molecules and an intermediate swelling degree compared to the single layers. 
Finally, preliminary in vivo tests were carried out on the bi-layers fat membranes for 
bridge implantation across 10-mm long median nerve defects in rats. After 12 weeks 
post-operative, nerves treated with bi-layer tubes displayed regenerated and aligned 
fibers at the injury site through light and transmission electron microscopy and 
observation as well as immunohistochemistry analysis. 
These attractive results, together with all the previous reported positive characteristics of 
CS/DSP and CS/GPTMS_DSP based conduit (see chapter 2 and 4) indicate that the double-
layer CS based conduit should be investigated further as a guide conduit for promoting 
peripheral nerve regeneration. 
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Chapter 6 
CS electrospun nanofibres 
for nerve tissue engineering 
 
Abstract 
Polymeric nanofibres that mimic the structure and function of the native extracellular 
matrix (ECM) are of great interest in tissue engineering as scaffolding materials. Chitosan 
(CS) has been investigated for biomedical applications because of its good 
biocompatibility, biodegradability, and wound healing effect. In this work, CS based 
nanofibers were fabricated by electrospinning solutions containing CS, polyethylene oxide 
(PEO), and dimethyl sulfoxide (DMSO). Spinnable CS-based solution was prepared by 
dissolving CS and PEO in 0.5M acetic acid with a concentration of 5% and 3% (w/v), 
respectively. Then, the two solutions (CS and PEO) were mixed in order to obtain blends 
with volume ratios of 50/50 and finally 5% (v/v) of DMSO was added. The set of 
electrospinning parameters composed by a voltage of 30 kV, a 30 μL/min flow rate and a 
temperature of 37 – 39 °C allowed to obtain homogenous nanofibres with an average 
fiber diameter of 120 nm. Lastly, dibasic sodium phosphate (DSP) was introduced into CS 
based solution as ionic crosslinker to improve the mechanical and physiological stability 
of the developed nanofibres and to neutralize the electrospun membranes. Crosslinked 
nanofibres showed an increase in the mechanical strength (E, from 63±10 MPa to 113±8 
MPa) and on water stability until 7 days in aqueous environment compared to 
uncrosslinked CS nanofibres. 
6.1 Introduction 
In artificial nerve guidance conduits (NGCs) designed, it is essential to introduce an 
internal filler for large nerve gaps (> 30 mm in humans). Internal fillers act as a physical 
axonal guidance enhancing the regeneration process and the functional recovery of 
injured nerves [1]. Fibrous substrates have gained increased interested in recent years 
since they mimic the structure of the ECM. Random or aligned fibrous matrices with fibre 
diameters ranging from tens of nanometres to several microns can be easily prepared by 
electrospinning [2-4] which is a simple and versatile method, which allows the deposition 
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of nanofibrous mats through the extrusion of the solution from a needle by an high 
voltage electric field. By tuning electrospinning processing parameters is possible to 
modify fibres morphology and dimension to maximize the morphology- mediated cellular 
response [3].  
In nerve regeneration, the choice of an appropriate biomaterial is essential to satisfy the 
requirements of a proper biological response and scaffold processability. Among currently 
available polymers, natural polymers, such as proteins (gelatin, collagen and silk fibroin) 
and polysaccharides (chitosan, hyaluronic acid and cellulose) are functionally superior to 
non- informational synthetic polymers: as components of natural ECM or having a similar 
composition to ECM components, natural polymers provide chemical cues which facilitate 
cell attachment [5]. 
As discussed in previous chapters, CS offers many advantages and it is a promising 
material for TE applications (see chapter 1 and 3). The possibility to fabricate nanofibrous 
scaffold through electrospinning using CS have few drawbacks since processing conditions 
have to be carefully selected as the use of high temperatures and organic solvents may 
cause CS denaturation [6]. On the other hand, CS electrospinning is also critical due to the 
relative high viscosity of CS solutions, which limits the spinnability [7]. 
Studies reported in literature strongly suggest that nanofibre-based scaffolds hold a great 
potential as a new class of synthetic NGCs for repairing peripheral nerve injuries and 
defects in vivo since CS nanofibers not only promoted the adhesion of Schwann cells, but 
also helped to maintain their characteristic cell morphology and cell phenotype, providing 
a new class of scaffolds for neural tissue engineering [8]. 
Although many studies have been reported, the use of electrospun nanofibres remains 
largely unexplored and further experiments are necessary to define the effect of CS 
nanofibres on peripheral nerve repair. 
In this work, CS based solution were electrospun to produce internal filler for NGCs. Low 
amounts of acetic acid (0.5M) were applied for CS solubilization in order to reduce the 
risk of polymer degradation and citotoxicity. Different blends of medical grade highly 
deacetileted chitosan (CS M.G.) and polyethylene oxide (PEO) were analyzed in order to 
identify the ideal solution for the deposition of homogeneous and uniform nanofibres 
suitable for peripheral nerve regeneration. PEO solution (3% w/v) and CS solutions 
(ranging from 3 to 7% w/v) were prepared separately by dissolving CS and PEO in 0.5M 
acetic acid. Then, the two solutions (CS M.G. and PEO) were mixed in order to obtain 
blends with volume ratios of 50/50. Among the mixtures analysed, the optimal 
nanofibrous scaffolds were obtained electrospinning the blend CS/PEO 50/50 vol/vol with 
a CS concentration of 5% w/v. Furthermore, the influence of different process parameters 
on fibre deposition and morphology was analyzed. Moreover, dibasic sodium phosphate 
(DSP) was used as CS crosslinker to increase the nanofibres stability in aqueous 
environment and to neutralize the electrospun membrane. The crosslinked nanofibrous 
mats developed were characterized from a physicochemical point of view, through 
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infrared spectroscopy (FTIR) analysis, then thermal, mechanical and dissolution properties 
were studied by thermogravimetric analysis, tensile and dissolution tests. 
6.2 Experimental 
6.2.1 Materials 
Medical grade CS (molecular weight 200 – 400 kDa, deacetylation degree ≥ 92.6 % ) was 
purchased by Kraeber GmbH & Co. PEO (Mw 900000 Da), DSP, DMSO and solvents were 
supplied from Sigma Aldrich. All solvents used were of analytical grade and used without 
further purification. 
6.2.2 Electrospun membrane preparation 
6.2.2.1 Preparation of solutions for electrospinning 
3, 5 or 7 % (wt/vol) CS and 3% (wt/vol) PEO solutions were prepared separately by 
dissolving CS or PEO in 0.5M acetic acid solution at room temperature by continuous 
stirring. After complete solubilisation of each components, a 50/50 (v/v) CS/PEO solution 
was prepared by mixing equal volumes of CS and PEO solutions to obtain the mixtures 
with weight ratios of CS to PEO of 50/50, 62/38 and 70/30; the resultant mixtures were 
kept under stirring for about 2 hours. A 5% (v/v) of DMSO was added to the CS/PEO 
solution as a cosolvent to relax CS chain entanglements and increase the fiber yields and 
consequently improving the spinnability of the CS-based solution [9]. Finally, ionically 
crosslinked samples were prepared by adding DSP 1M (one drop per second) to the 
CS/PEO solution with a concentration of 7.5 % vol./vol. with respect to the natural 
polymer solution volume as previously described (Chapter 2). The CS/PEO_DSP mixed 
solution was maintained under magnetic stirring at room temperature for about 10 
minutes. Not crosslinked solutions were prepared as control. 
6.2.2.2 Electrospinning of CS nanofibres 
The electrospinning system used for fibre preparation was previously described [10]. 
Briefly, the system consists of a high voltage generator (PS/EL30R01.5-22 Glassman High 
Voltage), providing a voltage of 0 to 30 kV; a volumetric pump (KDS210 of KD Scientific); a 
mobile syringe support and a 1.5 mm-thick flat aluminium collector for random fibres. 
6.2.3 Membrane preparation and optimization of solution and process parameters 
6.2.3.1 Solution parameters and viscosity tests 
Preliminary tests were performed to optimize CS based solution concentration. Different 
CS concentrations were tested (3%, 5% and 7%) using a MCR302, Anton Paar GmbH 
rheometer having 50 mm parallel plate and a temperature controller. Measurements 
were performed by pouring 5 ml of solution on pre-heated plate (40°C), then the shear 
rate was set in the range of 1 to 100 s-1. 
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6.2.3.2 Process parameters 
Continuous nanofibres were obtained only for 5% CS solution concentration while process 
parameters (62/38 w/w CS/PEO mixture) were varied to reduce fibre defects and 
maximize the amount of collected fibres. The parameter values allowing spinnability 
were: (i) temperature from 25 °C to 39°C, (ii) flow rate of 25 µl min-1 to 50 µl min-1, (iii) 
nozzle-collector distance of 12 cm and (iv) voltage of 30 kV. The effect of temperature 
and flow rate was evaluated to optimize the process and the fibre morphology. 
6.2.3.3 Fibres morphology and element distribution 
The surface morphology of crosslinked and uncrosslinked CS based nanofibrous 
membranes was observed by scanning electron microscopy (SEM LEO – 1430, Zeiss). 
Qualitative compositional analysis and punctual elemental composition of materials were 
performed using an energy dispersive spectrometer (EDS). Samples were sputter coated 
with gold in a undervacuum chamber prior to SEM-EDS examination. SEM micrographs 
were then analysed through ImageJ software. Fibre diameters and pore size were 
measured on three different images and they were reported as average value ± standard 
deviation. 
6.2.4 Electrospun membranes characterization 
6.2.4.1 Fourier transform infrared-attenuated total reflectance spectroscopy (FTIR-
ATR) 
FTIR-ATR spectra of CS, PEO, CS/PEO, CS/PEO_DSP electrospun matrices were recorded at 
room temperature in a Perkin Elmer Spectrometer in the range 4000-600 cm-1 at a 
resolution of 4 cm-1. 
6.2.4.2 Thermogravimetric analysis (TGA) 
Thermogravimetric analysis was performed using a TA INSTRUMENT Q500 equipment. 
Thermal degradation was measured on a 10-15 mg sample in aluminum pans under a 
dynamic nitrogen atmosphere between 40°C and 800 C. The experiments were run at a 
scanning rate of 10°C/min and obtained results were analyzed using TA Universal Analysis 
software. Three samples were analyzed both compositions. 
6.2.4.3 Mechanical properties 
The tensile mechanical properties were evaluated on crosslinked and uncrosslinked CS-
based nanofibrous scaffolds in dry condition using a MTS QTest/10 device equipped with 
load cells of 10N. Rectangular speciments of 30x5 mm size were cut from each 
membranes and their thickness were measured using a digital calibrator. Samples were 
then strained at a constant crosshead speed of 1 mm/min until breaking. Break stress and 
strain were determined using the associated software Test Works 4 while the elastic 
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moduli (E) were calculated from the slope of the linear portion of the stress–strain curve 
of each sample. Five specimens for each kind of material were tested. The results were 
expressed as an average values ± standard deviation 
6.2.4.4 Fibres dissolution 
The dissolution behavior of the uncrosslinked and crosslinked CS samples was evaluated 
by immerging the samples in PBS (pH 7.4) at 37°C. Qualitative tests after immersion were 
performed analyzing the nanofibres morphology by SEM. For each sample, five 
rectangular nanofibrous membranes deposited on the rectangular metal collector (1 cm x 
3 cm) were soaked in 5 ml of PBS and maintained at 37°C. After 1, 24 and 168 hours, 
samples were collected, freeze-dried and then analyzed by SEM. 
Quantitative analysis were performed on crosslinked CS based nanofibres. After 1, 3, 5, 7 
days immersions, samples were dried and the dissolution percentage was calculated as: 
ΔWd (%) = (W0-Wd)/W0*100 
where W0 and Wd are the sample weights before and after degradation respectively.  
The solution pH was measured at the same time intervals during the dissolution tests 
confirming a stable value at around 7.2 (physiological pH). For each experimental time, 
three samples were measured and the results were expressed as averages value ± 
 standard deviation. 
6.2.5 Statistical Analysis 
Statistical analysis was performed applying t-Student for two group comparisons and one-
way ANOVA for multiple analysis using GraphPad Prism 6.0 software. Data were 
considered statistically difference for p value < 0.05. 
6.3 Results and discussion 
6.3.1 Optimization of the electrospinning parameters 
6.3.1.1 Solution viscosity and its effect on electrospun nanofibres 
The effect of CS solution concentration on viscosity and, consequently, spinnability was 
evaluated. The three mixed solutions showed a non-newtonian behavior and an increase 
in viscosity for more concentrate CS solutions (Fig.6.1). Homogenous nanofibres were 
obtained only for CS/PEO solutions obtained with a 5% CS solution (Fig 6.2B), while less 
viscous solution (3% CS) caused the formation on beads instead of fibres (Fig. 6.2A) and 
highly concentrated CS solution impeded the flow of the solution from the needle (Fig 
6.2C).  
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Fig. 6.1. Viscosity versus shear rate for three different CS concentration of the CS/PEO solutions. 
 
Fig. 6.2. SEM micrographs of electrospun CS/PEO solutions obtained with a 3% (A), 5% (B) and 7% 
(C) CS solutions (Parameters: 30kV, temperature 39°C, distance 12 cm, flow rate 30 μL/min). 
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6.3.1.2 Process parameters 
The optimization of the process parameters required to vary the parameters in a wild 
range of sets. For the fabrication on randomly oriented nanofibres, the voltage applied 
was fixed at 30kV and the distance between needle and collector was at 12 cm. The 
influence of temperature and flow rate was analyzed to maximize the formation of 
homogeneous fibres. The CS/PEO solution obtained with a 5% CS solution was spinnable 
in the range of 25 to 50 μL/min and highly homogenous fibres with a diameters of 118±16 
nm were observed for flow rate of 30 μL/min (Fig. 6.3C). Concerning temperature, an 
increase in temperature allowed to increase the spinnability and to reduce the number of 
defects on the fibres as reported in Fig. 6.4. The electrospinning process was set at 
38±1°C. 
 
Fig. 6.3 . SEM micrographs at different flow rates: 25 μL/min (A), 27,5 μL/min (B), 30 μL/min (C). 
Bars: 2 μm. 
 
Fig.6.4. SEM micrographs at different temperatures: 25 °C (A), 32°C (B), 39 °C (C). Bars: 2 μm. 
6.3.2 Characterization of CS based nanofibres 
6.3.2.1 Fibres morphology and element distribution 
Fibres with optimized parameters were visualized through SEM and qualitative analysis of 
phosphorus (P) element was performed using EDS. Phosphorous was homogeneously 
distributed within both the samples confirming the presence of DSP into the nanofibres 
(Fig. 6.5) and consequently the effectiveness of the crosslinking process. No green spots 
were detected on uncrosslinked samples (data not shown). 
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Crosslinked and uncrosslinked CS based nanofibres showed a comparable fiber diameter 
of 109±17 nm and 128±19 nm, respectively.  
 
Fig.6.5. EDS spectra and SEM images of randomly oriented CS-based nanofibres. Green spots 
correspond to phosphorus (P) elements. Bars 10 μm. 
6.3.2.2 Fourier transform infrared-attenuated total reflectance spectroscopy (FTIR-
ATR) 
Fig. 6.6 reports the spectra of CS-based nanofibres and crosslinked CS-based nanofibres. 
Both spectra presented the peaks related to CS and PEO which are present in the CS-
based nanofibres. Peak wavenumbers and their relative bond vibrations are reported in 
table 6.1. For CS-based nanofibres, the appearance of the peak at 1074 cm-1 is related to 
the stretching of S=O bonds (νS=O) due to the presence of DMSO residues in the 
nanofibres [11]. Furthermore, in the crosslinked nanofibres the effectiveness of the 
crosslinking was confirmed by the appearance of peaks at 1059 cm-1, 944 cm-1 and 858 
cm-1 related to PO3 stretching (νPO3), O-P-O bending (δO-P-O) and P-OH bending (νP-OH), 
respectively [12]. 
 
Fig.6.6. FTIR spectra of aligned CS-based nanofibres (A) and crosslinked CS-based nanofibres (B). 
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Table 6.1. FTIR peaks and their relative bond vibrations 
Bond vibration Wavenumber (cm-1) Material ref 
νO-H 
νN-H 
3222 CS [13] 
νC-H 2883 CS and PEO [14, 15] 
νC=O 1634 CS [13, 14, 16] 
δN-H 1547 CS [13, 14, 16, 17] 
δCH2 1466 PEO [18] 
νC-N 1410 CS [17] 
ωCH2 1360 PEO [18] 
τCH2 1280; 1241 PEO [18] 
νC-O-C 114; 1095; 1060 CS and PEO [14, 19] 
ρCH2 959; 947 PEO [18] 
δC-O-C 842 PEO [19] 
 
6.3.2.3 Thermogravimetric analysis (TGA) 
The derivative of TGA curves (DTG) revealed four separate degradation phenomena both 
for crosslinked and uncrosslinked CS nanofibres. The first decomposition step, started at 
around 80°C, was related to the water evaporation; the second and then third weight loss 
were observed at 140°c and 290°C and were attributed to the decomposition of CS main 
chains, while the weight loss at 417°c was related to PEO [19-21]. The presence of the 
DSP did not modify the thermal phenomena significantly. Compared to results obtained in 
chapter 2, the use of a different CS (having an increased degree of deacetylation) showed 
a different thermal behavior with two decomposition temperatures related to CS instead 
of one at 238°C. 
 
Fig 6.7. DTG curves of CS-based nanofibres (A) and crosslinked CS-based nanofibres (B). 
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6.3.2.4 Mechanical properties 
The mechanical properties of both the uncrosslinked and crosslinked randomly oriented 
CS fibrous matrices were determined using a MTS QTest/10 device; after tensile test, 
samples were examinated through SEM . Figure 6.8 displays a typical stress-strain plot for 
both the CS based nanofibres and crosslinked CS based nanofibres. The average Young’s 
modulus (tensile elastic modulus) of the CS electrospun matrices were determined from 
the slope of the linear elastic region of the stress-strain curve. The E value of the 
crosslinked CS based nanofibres was found to be significantly higher (113.03±8.35 MPa) 
compared to the uncrosslinked nanofibrous matrices (63.28±9.87 MPa). However, the 
crosslinked mats showed a decreased in ultimate tensile strength and elongation at break 
in comparison with the as-spun nanofibres (Fig. 6.8), indicating that the individual fibres 
following DSP addition to the CS/PEO solution become locked together and therefore 
they can not slip past each other. 
The previously described distinct difference in the elasticity of the uncrosslinked versus 
crosslinked CS nanofibres was also supported by the SEM images (Fig. 6.9). These images 
were taken in close proximity to the failure point of the nanofibrous matrices so that 
changes in individual fibre morphology could be observed. Uncrosslinked CS nanofibres 
after mechanical testing displayed both aligned fibres and a multitude of cracks or 
locations where extensions occurred on the fibres prior to their ultimately breaking (Fig. 
6.9B). On the contrary, crosslinked CS nanofibres retained their randomly oriented fibre 
composition and did not demonstrate alignment prior to their failure (Fig. 6.9D), 
confirming the lower elasticity compared to uncrosslinked CS nanofibres. 
 
 
Fig. 6.8 Stress-strain curves of CS-based nanofibres and crosslinked CS-based nanofibres. 
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Fig. 6.9. SEM images of CS-based nanofibres (A, B) and crosslinked CS-based nanofibres (C, D) CS-
based nanofibres before (A, C)and after (B, D) tensile testing. 
6.3.2.5 Fibres dissolution 
To confirm the efficiency of the crosslinking process and to evaluate the stability of CS 
based nanofibres in aqueous environment, a qualitative analysis of the dissolution 
behaviour crosslinked and uncrosslinked of CS-based nanofibres was performed in PBS at 
37°C. After 7 days incubation in PBS, the uncrosslinked nanofibres showed a not fibrous 
structures (Fig. 6.10G). On the other hand, crosslinked nanofibres showed a stable 
morphology at 7 days confirming the effect of crosslinker on nanofibres water stability 
(Fig. 6.10H). Quantitative analysis showed a weight loss around 50% after 1 day 
immersion probably due to the dissolution of PEO, then the nanofibres weigh did not 
significantly vary until 7 days (Fig. 6.11). 
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Fig. 6.10. SEM images of CS-based nanofibres (A, C, E, G) and crosslinked CS-based nanofibres (B, 
D, F, H) CS-based nanofibres before immersion in PBS (A, B) and after 1 hour (C, D), 1 day (E, F) 
and 7 days dissolution in PBS. 
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Fig. 6.11. Quantification of crosslinked CS-based nanofibres at different time points. 
6.4 Conclusion 
Innovative substrates for peripheral nerve regeneration were developed within this 
chapter. CS electrospun nanofibres acting as NGCs internal fillers were prepared in 0.5M 
acetic acid solutions in the form of non-woven nanofibrous matrices with high specific 
surface areas and relatively small pores. Compared to previous work in literature, in this 
work CS was solubilized with a reduced amount of acid solution and without the use of 
potentially cytotoxic organic solvents. Furthermore, an innovative ionic crosslinker (DSP) 
able to neutralize the CS nanofibres without further process was successfully applied. 
Crosslinked CS-based nanofibres were produced showing a fibre dimensions of 109±17 
nm which has been reported to be advantageous for glial cell adhesion and proliferation 
as compared to fibres characterized by a diameter of 700 nm [9, 22]. Furthermore, an 
increase in mechanical properties and water stability was observed for crosslinked 
nanofibres compared to uncrosslinked one. 
The developed crosslinked CS based nanofibres are currently evaluated for their 
application as NGC internal filler in collaboration with the Neuroscience University 
Cavaliere Ottolenghi (Torino, Italy). In vitro cell tests were performed using primary 
Schwann cells and dorsal root ganglia (DRG) extracted from rats. Encouraging preliminary 
in vitro results were obtained confirming the ability of cells to adhere and proliferate on 
CS nanofibrous matrices.  
Furthermore, the fabrication of aligned crosslinked CS-based nanofibres is in progress. 
Aligned nanofibres can improve the regeneration process by mimicking the structure of 
axons and by giving directional cues to cells growth.  
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Chapter 7 
Wound healing dressing: 
state of the art 
 
7.1 Introduction 
The amount of knowledge and understanding concerning the wound healing process and 
dressing practices has expanded and changed dramatically over the past four decades. 
Wound care dressings aim to restore the milieu required for skin regeneration and to 
protect the wound from environmental threats and penetration of bacteria. Any single 
type of wound dressing can not address the need and management of all types of 
wounds. For an effective design of a functional wound bandage, characteristics of the 
wound type, wound healing time, physical, mechanical, and chemical properties of the 
bandage must be taken into consideration. This chapter offers a review of the common 
and advanced wound management dressings, their key advantages and shortcomings. It 
also reviews many of the dressings and novel polymers used for the delivery of drugs to 
acute, chronic and other types of wound. These include hydrocolloids, alginates, 
hydrogels, polyurethane, collagen, chitosan, pectin and hyaluronic acid. The definition 
and classification of wounds together with the different stages of wound healing are also 
briefly described, as they directly affect the choice of a particular dressing. In addition to 
that this chapter also compiles the list of wound care product available in the market. 
7.2 Structure and function of the skin 
The skin is a complex, multilayered organ, which produces several specialized derivative 
structures called appendages (hair follicles, eccrine sweat glands, sebaceous glands, 
apocrine glands) and consists of heterogeneous cell types and extracellular components. 
The skin constitutes about the 15% of total human weight and in adult it shows a surface 
of about 2 m2. It is important to recognize, when considering either normal or abnormal 
skin structure and function, that there also regional variation in the skin which is primarily 
manifested in terms of thickness, composition and density of appendages. Skin is made of 
three overlapping layers: epidermis, dermis and hypodermis (Fig. 7.1). Interaction among 
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these layers is important during development and for maintenance of homeostasis in the 
adult. 
The epidermis or outer layer is composed for the 95% of only one kind of cells, the 
keratinocytes; the remaining 5% of the tissue is made of melanocytes, Langerhans and 
Merkel cells. Epidermis is made up of stratified layers of keratinocytes (basal, spinous, 
granular, lucidum and cornified layers). The differentiation of keratinocytes toward a 
terminally differentiated corneocyte is very tightly regulated. Basal keratinocytes divide 
with daughter cells, migrating into the overlying spinous layer. Keratinocytes in the 
spinous layer subsequently move into a granular layer, and eventually move into the 
outer cornified layer of the epidermis (Fig.7.1). The epidermis is a barrier, preventing the 
penetration in the wound bed of water, microorganisms, extraneous substances and in 
the same time, avoiding the loss of water and electrolytes from the injured tissue. 
Average thickness of epidermis is 70-120 μm, but it can reach values of 1-2 mm in some 
regions of the body, such as on the hand palm; this layer is separated from the dermis 
below by the basement membrane zone (BMZ), which has a thickness of about 200 nm 
and is composed of a complex network, in which macromolecules, proteins and 
glycoproteins guarantee the adhesion between the two superimposed layers. The dermis 
or middle layer is the thick layer (average thickness of about 0.55 mm) of collagen rich 
connective tissue component of the skin and provides its pliability, elasticity and tensile 
strength. It protects the body from mechanical injury, binds water, aids in thermal 
regulation and includes receptor of sensory stimuli. The dermis is less cellular than the 
epidermis, being composed primarily of fibrous and amorphous ECM surrounding the 
epidermally derived appendages, neurovascular networks, sensory receptor and dermal 
cells. About the 70% of the dermis is made of collagen, mainly type I and III, which 
supports the tissue and assures mechanical resistance; whereas the 5% of dermis weight 
derives from elastin fibers which provide elasticity to the tissue. Epidermis and dermis are 
separated by the basement membrane, a sheet composed of specialized collagens and 
matrix proteins such as laminins and collagen IV. The hypodermis is the deepest 
cutaneous layer, situated between the dermis and the muscular and adipose tissues. As 
dermis, the hypodermis is composed of connective tissue and it is particularly rich of 
mesenchymally adipocytes, which are cells responsible of fats synthesis. Due to the 
presence of this kind of cells, the hypodermis insulates the body, serves as a reserve 
energy supply and allows for its mobility ever underlying structures. In this stratum, 
follicles and sudoriferous glandes originate. 
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Fig.7.1. Stratified structure of the skin. 
7.3 Wounds and wound healing process 
A wound can be described as a defect or a break in the skin, resulting from physical or 
thermal damage or as a result of the presence of an underlying medical or physiological 
condition. According to the Wound Healing Society, a wound is the result of ‘disruption of 
normal anatomic structure and function’ [1]. On the basis of wound healing processes, 
there are two types of wounds: acute and chronic wounds. Acute wounds are usually 
tissue injuries that heal completely, with minimal scarring usually in 8–12 weeks [2]. 
Acute wounds are generally caused by mechanical injuries but can be also formed by 
burns and chemical injuries which arise from a variety of sources such as radiation, 
electricity, corrosive chemicals and thermal sources. Chronic wounds on the other hand 
arise from specific diseases such as diabetes, tumors, and persistent infections [3]. They 
also include decubitis ulcers (bedsores or pressure sores) and leg ulcers (venous, 
ischaemic or of traumatic origin). Healing of chronic wounds could take more than 12 
weeks [4] and recurrence of the wounds is not uncommon [5]. Wounds are also classified 
based on the number of skin layers and area of skin affected [5, 6]. Injury that affects the 
epidermal skin surface alone is referred to as a superficial wound, whilst injury involving 
both the epidermis and the deeper dermal layers, including the blood vessels, sweat 
glands and hair follicles is referred to as partial thickness wound. Full thickness wounds 
occur when the underlying subcutaneous fat or deeper tissues are damaged in addition to 
the epidermis and dermal layers. 
The healing of a wound is defined by the Wound Healing Society as “a dynamic and 
complex process leading to the re-establishment of the structure and the functionality of 
the injured tissue” [1]. A healed wound shows peculiar characteristics, connective tissue 
appears completely restored and the epithelium is regenerated; skin structure and 
functionality are re-established, without requiring continuous drainage and tissue 
protection with a dressing. Wound healing progresses through a series of interdependent 
and overlapping stages in which a variety of cellular and matrix components act together 
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to reestablish the integrity of damaged tissue and replacement of lost tissue. There are 4 
major stages of wound healing after a full-thickness skin wound: hemostasis, 
inflammation, proliferation and remodeling (Fig. 7.2). Hemostatisis is the first stage of 
wound healing. Wounds cause leakage of blood from damaged blood vessels. The 
formation of plasma clot is necessary to stop local hemorrhages immediately. It is 
initiated by proteolytic conversion of fibrinogen into fibrin by thrombin. As fibrin 
molecules assemble into fibrin fibers, platelets and neutrophils are entrapped in a mesh 
of fibrin fibers. It act as a temporally shield protecting the denuded tissue [7, 8]. The 
process of clotting induces platelet degranulation and release of cytokines and GFs, 
including platelet derived growth factor (PDGF), insulin-like growth factor-1 (IGF-1), 
epidermal growth factor (EGF) and transforming growth factor-β (TGF-β) [9]. Plasma clot 
is served as a provisional matrix for invading cells as well as a reservoir of cytokines and 
GFs that are released from activated platelets [9]. These GFs act as chemotactic factors 
for lymphocytes, fibroblasts and keratinocytes, and promote various processes of 
reepithelialization and wound contraction. Inflammatory occurred simultaneously with 
homeostasis, sometimes from within a few minutes of injury to 24 hours and lasts for 
about 3 days. The main goal of the inflammatory phase is the removal of bacteria, foreign 
debris and other microorganism from wound bed. This process is activated by a variety of 
mediators released by cells and capillaries of the injured tissue, platelets, cytokines and 
products of hemostasis. Neutrophilis and polymorphonuclear leukocytes (PMN) infiltrate 
at injured sites from the surrounding microvasculature and start the elimination process 
of microorganisms and wound repair by activating local fibroblasts and epithelial cells. 
Neutrophilis appear first at the wound site and are predominant for the first few days, 
then disappear when the wound is no more infected. In presence of infection, neutrophil 
infiltration continues until the wound is not completely clean and the infective process is 
controlled; in absence of infection, the existing monocytes differentiate into 
macrophages, which become predominant phagocytic cells at the wound bed. 
Macrophage tasks include phagocytosis of any remaining pathogenic organisms and other 
cell and matrix debris; in addition they stimulate two fundamental mechanisms of 
inflammatory stage: angiogenesis and fibroplasias. The first one, that is the physiological 
process involving the growth of new blood vessels and the formation of capillary buds, 
starts 3 days after injury and are essential for providing metabolic substances that wound 
needs for a complete healing. The fibroplasia, that is the formation of fibrous tissue and 
collagen synthesis, starts by the third to the fifth day after injury. Moreover, macrophages 
synthesize nitric oxide and secrete different cytokines to initiate the wound repair 
process, including GFs involved in migration, proliferation and organization of new 
connective tissue and vascular beds. As they can secrete cytokines over time, they assure 
the continuity of the tissue repair process. In this phase the release of the protein-rich 
exudates from the wound site causes vasodilatation through the release of histamine and 
serotonin. Histamine and serotonin allows phagocytes to enter the wound and engulf 
dead cells (necrotic tissue). At the end of the inflammation stage, bleeding is controlled 
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and the wound bed is clean and moist, obtaining suitable conditions for the next stage of 
cell proliferation and repair. In the proliferation phase (3-21 days), angiogenesis, 
fibroplasia, and re-epithelialization occur [10]. Within this phase, fibroplasia and 
angiogenesis take place concurrently in a closely orchestrated manner to form ECM and 
granulation tissue. By the fifth day, maximum formation of blood vessels and formation of 
granulation tissue occur. Mesenchymal cells transform into fibroblasts, which lay fibrin 
strands to act as a framework for cellular migration. Fibroblasts and keratinocytes play a 
pivotal role in this stage. Fibroblasts produce collagen and proteoglycans and the 
neovasculature forms granulation tissue which fills wound defects. The early collagen 
secretion results in an initial rapid increase in wound strength, which continues to 
increase more slowly as the collagen fibers reorganize according to the stress on the 
wound. During this phase, the wounded tissue contracts, reducing the size of defect and 
approaching wound edges. This process is mediated by special fibroblasts with contractile 
properties called myofibroblasts. Finally, epithelial cells migrate over the granulation 
tissue and cover the wound bed, providing in this way a barrier to bacterial invasion and 
preventing fluid loss. Basal epithelial cells flatten and migrate across the open wound. The 
epithelial cells may slide across the defect in small groups, or “leapfrog” across one 
another to cover the defect. Migrating epithelial cells secrete mediators, such as 
transforming GFS α and β, which enhance wound closure. Although epithelial cells 
migrate in random directions, migration stops when contact is made with other epithelial 
cells on all sides (i.e., contact inhibition). Epithelial cells migrate across the open wound 
and can cover a properly closed surgical incision within 48 hours. In an open wound, 
epithelial cells must have a healthy bed of granulation tissue to cross. Epithelialization is 
retarded in a desiccated wound [11]. Remodeling, also called maturation, is the final stage 
of wound healing and begins 21 days after injury and can last until 1 or 2 years. This phase 
involves the formation of cellular connective tissue and strengthening of the new 
epithelium which determines the nature of the final scar. During this period, the newly 
laid collagen fibers and fibroblasts reorganize along lines of tension. Fibers in a 
nonfunctional orientation are replaced by functional fibers. The density of cells such as 
macrophages, keratinocytes, fibroblasts and myofibroblasts is reduced by apoptosis. 
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Fig. 7.2. The phases of cutaneous wound healing. 
7.4 Factors which impair wound healing chronic wounds 
Although most wounds will heal uneventfully, the failure of the wound to heal or a 
prolonged healing time usually results in a chronic wound. A chronic wound fails to heal 
because the orderly sequence of events is disrupted at one more of the phases of wound 
healing. Excessive production of exudates can cause maceration of healthy skin tissue 
around the wound [12] and inhibit wound healing. In addition, exudate from chronic 
wound differs from acute wound fluid with relatively higher levels of tissue destructive 
proteinase enzymes [13] and therefore more corrosive. Furthermore, the presence of 
foreign bodies into the wound injury site can cause chronic inflammatory responses 
delaying healing and sometimes leading to granuloma or abscess formation. Other 
problems associated with wound healing include the formation of keloid (raised) scars 
resulting from excess collagen production in the latter part of the wound healing process 
[7]. Pathogenic bacteria such as Staphylococcus aureus, Pseudomonas aeruginosa, 
Streptococcus pyrogenes and some Proteus, Clostridium and Coliform species can be 
detrimental to the healing process. P. aeruginosa and S. aureus have been shown to 
significantly reduced skin graft healing [14]. Inadequate control measures to manage 
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infected wounds can lead to cellulitis (cell inflammation) and ultimately bacteraemia and 
septicaemia, both of which can be fatal. 
Krasner et al., outlined the necessity to control factors that could impair wound healing: 
preventing infection, optimising exudate control and removing foreign bodies have to be 
satisfied on order to manage efficiently the wound injury and to promote healing [15]. 
Poor nutritional status and ageing also reduce the ability to fight infection [16]. Protein, 
vitamin (e.g. vitamin C) and mineral deficiencies impair the inflammatory phase and 
collagen synthesis, leading to prolonged healing times [17]. In addition, underlying 
diseases such as diabetes [18] and anaemia delay wound healing because compromised 
circulation results in the delivery of inadequate nutrients, blood cells and oxygen to the 
wound. Treatment with drugs such as steroids suppress the body’s inflammatory 
responses and thereby impede the inflammatory stage of wound healing, which 
eventually leads to a compromised immune system [19]. Glucocorticoids for example 
have been shown to impair wound healing in both rats and humans [20]. 
Dressings used to protect wounds may establish and maintain favorable conditions for 
the healing process. Before applying the dressing on the injure, foreign matter, necrotic 
tissue, contaminating microorganisms should be removed from the wound site, in order 
to reduce the risk of infection. This can be carried out applying a sterile, atraumatic 
surgical technique and, in case of traumatic wounds, performing initial debridement and 
irrigation. The dressing has the function of protecting the wound site from further 
contamination and it may be produced in order to stimulate the rapid complete 
regeneration of the injured tissue and healing of the wound. 
7.5 Wound dressing 
7.5.1 Classification of wound dressings 
For years, different materials such as linen, honey, animal fats, and vegetables fibers have 
been used for wound dressing [21, 22]. However, most plants, could have many 
drawbacks associated to the presence of microorganism or chemicals which might be 
detrimental to the wound healing process. For this reason, continuous developments 
have led to extensive use of new bandages with improved performance. The attention 
has been focused on finding biocompatible materials, mainly polymers, able to help the 
restoration of the tissue and, once the healing process is terminated, degrading without 
releasing toxic products. Wound dressing are classified in a number of ways depending on 
their function in the wound (debridement, antibacterial, occlusive, absorbent,adherence) 
[23], type of material employed to produce the dressing (e.g. hydrocolloid, 
alginate,collagen) [24] and the physical form of the dressing (ointment, film, foam, gel) 
[25]. Dressings are further classified into primary, secondary and island dressings [26]. 
Dressings which make physical contact with the wound surface are referred to as primary 
dressings while secondary dressings cover the primary dressing. Island dressings possess a 
central absorbent region that is surrounded by an adhesive portion. 
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In this chapter, dressing are classified according to traditional or modern (moist wound 
environment) dressings. Modern dressings are discussed under the type of material 
(hydrocolloid, alginate, hydrogel) employed to produce the dressing and the physical 
form (film, foam) of the dressing. 
7.5.1.1 Traditional dressings 
Ordinary dressings, such as cotton wool, natural or synthetic bandages and gauzes, act as 
a common cover on a wound so that the wound can rehabilitate underneath. Cotton wool 
is used to absorb exudate and applied over a primary wound dressing to avoid 
contaminating the wound with cellulose fibres. Bandages are made from natural (cotton 
wool and cellulose) and synthetic (e.g. polyamide) materials which perform different 
functions (i.e. retention of light, sustained compression in the treatment of venous 
insufficiency, leg ulcers). Gauze dressings are made from woven and nonwoven fibres of 
cotton, rayon polyester or a combination of both. Sterile gauze pads are used for packing 
open wounds to absorb fluid and exudates with the fibres in the dressing acting as a filter 
to draw fluid away from the wound. Gauze dressings need to be changed regularly to 
prevent maceration of the healthy underlying tissue and have been reported to be less 
cost effective compared with the more modern dressings. [27]. Though gauze dressings 
can provide some bacterial protection, this is lost when the outer surface of the dressing 
becomes moistened either by wound exudate or external fluids. All these dressings are 
dry and do not provide a moist wound environment. They may be used as primary or 
secondary dressings, or form part of a composite of several dressings with each 
performing a specific function. The conventional wound dressing materials are not 
suitable for acute and chronic wounds as far as rapid healing of a wound is concerned. 
Moreover, traditional wound dressings can adhere to wounds as exudate dries, and 
capillary loops and granulation tissue can grow through the dressing fabrics causing 
trauma and pain to wounds upon removal [28]. Despite these limitations, many 
conventional dressing are actually available on market in the form of bandeges and 
gauzes [27]. 
7.5.1.2 Modern dressings 
Modern dressings have been developed as an improvement upon the traditional wound 
dressing because they aim to: i) maintain the most suitable environment at the 
wound/dressing interface, ii) absorb excess exudates without leakage to the surface of a 
dressing, iii) provide thermal insulation, iv) mechanical and bacterial protections, v) allow 
gaseous and fluid exchanges and vi) be non adherent to the wound and easily removable 
without trauma. The modern dressing are mainly classified according to the materials 
from which they are produced including hydrocolloids, alginates and hydrogels, and 
generally occur in the form of gels, thin films and foam sheets. 
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7.5.1.2.1 Hydrocolloids 
Hydrocolloids dressing are among the mostly wide used dressings. The term 
‘hydrocolloid’ describes the family of wound products obtained from colloidal materials 
(gel forming agents) combined with elastomers and adhesives. Typical colloidal materials 
are carboxymethylcellulose (CMC), gelatin and pectin. They occur in the form of thin films 
and sheets (Fig. 7.3). Hydrocolloid has the ability to form gels upon contact with wound 
exudates and the high absorption occurs via strong hydrophilic gel formation [29]. The 
formation of gel allows excess fluid to escape without permitting wound desiccation. 
However, the fluid handling capacity of hydrocolloid dressings depends on many factors 
such as the physicochemical properties and the design of the dressing [30]. For their 
intrinsic properties, hydrocolloids dressing are clinically useful for partial- or full-thickness 
acute and chronic wounds [31]. As they are occlusive, hydrocolloid dressings do not allow 
water, oxygen, or bacteria into the wound. This may help facilitate a wound to granulate 
or epithelialize and encourage autolytic debridement in wounds with necrotic or sloughy 
tissue present. However, because of their occlusive nature, hydrocolloids should not be 
used if the wound or surrounding skin is infected and are not recommended for use in 
diabetic foot ulceration. Hydrocolloids also cause the pH of the wound surface to drop; 
the acidic environment can inhibit bacteria growth. Hydrocolloid dressings are 
conformable to the patient's body and adhere well to high-friction areas, such as the 
sacrum and heels. Examples of hydrocolloids dressing include GranuflexTM and AquacelTM 
(Conva Tec, Hounslow, UK), ComfeelTM (Coloplast, Peterborough, UK) and TegasorbTM (3M 
Healthcare, Loughborough, UK). 
 
Fig. 7.3 A typical hydrocolloid dressing. The dressing combines moisture vapour permeability with 
absorbency ad conformability. 
7.5.1.2.2 Alginates 
Alginate dressings are produced from the calcium and sodium salts of alginic acid, a 
polysaccharide comprising mannuronic and guluroinic acid units. Various alginate 
dressings are available which possess different chemical and physical properties 
dependent upon the proportion and arrangement of mannuronic and guluronic acid 
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residues and the content of calcium and sodium ions. They occur in the form of porous 
sheets or as flexible fibers. When the alginate dressing comes into contact with wound 
exudate, ion exchange occurs between the calcium ions of the dressing and the sodium 
ions in the exudate resulting in the formation of a gel on the surface of the wound [32]. 
This gel absorbs moisture and maintains an appropriately moist environment which is 
considered to promote optimal healing [33], limit wound secretion and minimize bacterial 
contamination [31]. As alginates are highly absorbent, they should not be used with dry 
wounds or those covered with hard necrotic tissue. Alginates require a secondary 
dressing; foams or hydrocolloids will secure the alginate and keep it from drying out. 
Moreover, the calcium component of the dressing have been found to improve many 
cellular aspects of wound healing [34]. The role of calcium alginate in the wound healing 
process was investigated by Schmidt who suggested that it may help in the production of 
mouse fibroblast [34]. Thomas et al., have reported that some alginate dressings activate 
human macrophages to produce tumour necrosis factor-α (TNF-α) which initiates 
inflammatory signals, as part of the wound healing process. Calcium ions present in 
alginate dressings, when released into the wound, also play a physiological role aiding in 
the clotting mechanism (haemostat) during the first stage of wound healing [35]. 
7.5.1.2.3 Synthetic hydrogels 
Synthetic hydrogel dressings are insoluble, swellable hydrophilic materials made from 
synthetic polymers such as poly(methacrylates) and polyvinylpyrrolidine. Hydrogel 
dressings are commonly available in two forms: amorphous gel and sheet hydrogel and 
can be useful when managing painful wounds. When applied to a wound as a gel, 
hydrogel dressing usually require a secondary covering such as gauze and need to be 
changed frequently [36]. On the contrary, the sheets do not need a secondary dressing as 
a semi-permeable polymer film nacking controls the transmission of water through the 
dressing. Hydrogel dressings contain significant amounts of water (70–90%) and as a 
result they cannot absorb much exudate, thus they are used for light to moderately 
exuding wounds (i.e. pressure ulcers, skin tears, surgical wounds, and burns). Fluid 
accumulation can lead to skin maceration and bacterial proliferation which produces a 
foul smell in infected wounds. Hydrogels have been found to promote moist healing, to 
be malleable, non adherent and  improve reepithelisation of wounds [36]. 
7.5.1.2.4 Semi-permeable adhesive films 
Film dressings are flexible sheets of transparent polyurethane coated with an acrylic 
adhesive. They can be used as a primary or secondary dressing. These dressings are 
semipermeable, vary in size and thickness, and have an adhesive that holds the dressing 
on the skin. They conform easily to the patient’s body. As films are transparent, the 
wound can be easily monitored. Film dressings generally require a border of dry, intact 
skin for the adhesive edge of the dressing; film dressings will not adhere to moist skin or 
moist wound beds because the moisture inactivates the adhesive. Therefore, the 
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condition of the periwound skin should be assessed before application to determine if a 
film dressing is appropriate. As film dressings are semi-occlusive and trap moisture, they 
allow autolytic debridement of necrotic wounds and create a moist healing environment 
for granulating wounds. Most of the existing brands differ in terms of vapour 
permeability, adhesiveness, conformability and extensibility [37]. OpsiteTM (Smith and 
Nephew, Hull, UK) which is a thin semi-permeable film made from polyurethane covered 
with hypoallergenic acrylic derivatives and is more porous and permeable to water 
vapour and gases but no liquid from exudates [38]. 
7.5.1.2.5 Foam dressings 
Foam dressings are semipermeable and either hydrophilic or hydrophobic with a bacterial 
barrier. They consist of porous polyurethane foam or polyurethane foam film and are 
capable of handling moderate to high volumes of wound exudates [39]. Foam dressings 
provide thermal insulation to the wound, maintain a moist environment around the 
wound, are non-adherent, and allow atraumatic dressing removal [40]. They are highly 
absorbent, property that can be controlled by foam texture, thickness and pore size. The 
open pore structure also gives a high moisture vapour transmission rate [41]. Foam 
dressing are used as primary wound dressings for absorption and insulation and a 
secondary dressing is usually not required due to their high absorbency and moisture 
vapour permeability but they can be used in conjunction with a topical antimicrobial for 
infected wounds. Foam dressings may be manufactured with an adhesive border, which 
eliminates the need for a securing device or without an adhesive boarder. Foam dressings 
are also available which release agents such as antimicrobials, moisturizers or anti-
inflammatory analgesics into the wound. Examples of foam dressing include: Lyofoam 
(Conva Tec), POLYDERM (DeRoyale) and Allevyn1 (Smith and Nephew). 
7.5.1.2.6 Tissue engineered skin substitutes  
Traditional and modern dressings though useful, cannot replace lost tissue, particularly 
missing dermis as occurs in severe burns. Advances in the fabrication of biomaterials, 
mainly polymers, and the culturing of skin cells have led to the development of a new 
generation of engineered skin substitutes (biosynthetic dressing) [42]. Nanofibrous 
matrices, microspheres, hydrogels, films and solid foams obtained from polymeric 
materials should not simply protect and cover the wound site but also allow tissue 
regeneration and cell proliferation, stimulating the physiological processes on which the 
complete healing of the wound is based [43]. For this reason, TE skin substitutes seems to 
be a promising alternative to conventional treatments since these scaffolds aim to: i) 
provide a tough and self- maintaining surface to the body; ii) provide initial contact 
between the outside world and the defensive systems of the body; iii) allow physiological 
functions such as temperature control and neurological sensing; iv) host to structures 
such as sweat glands and hair follicles; and v) create an optimal microenvironment for 
skin regeneration through the delivery of bioactive molecules. Skin substitutes are 
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developed starting from biocompatible and bioresorbable polymeric dermal scaffolds 
such as CS–gelatin composite films, poly(d,L-lactic acid), poly(d, L-lactic acid)–
polyethylene glycol–poly(d, L-lactic acid), poly(lactic co-glycolic acid) membranes 
containing (1→3),(1→6)-β-d-glucans [44, 45], porous scaffolds composed of gelatin, 
hyaluronic acid and (1→3),(1→6)-β-d-glucans crosslinked with 1-ethyl-(3-3-
dimethylaminopropyl) carbodiimide hydrochloride for artificial dermis [46].The use of 
these polymers either in the natural biological form or semi-synthetic forms are reported 
to be able to mimic normal physiologic responses during wound healing [47]. Moreover, 
engineered scaffolds are potentially useful for the release of additional bioactive 
molecules, such as GFs and genetic materials [48, 49], as well as, for the accommodation 
of living cells [50, 51]. 
Two major matrices are employed in TE skin substitutes: acellular and cell containing 
matrices. Acellular matrices are produced either from synthetic collagen and ECM 
combinations such as hyaluronic acid [52] for example IntegraTM , or native dermis with 
the cellular components removed but preserving the dermal architecture [41] for 
example AllodermTM. Cell containing TE dressings include biodegradable films formed 
from, for example, collagen and GAGs (e.g. ApligrafTM) as scaffolds onto which skin cells 
(patient derived or from recombinant sources) can be seeded for the growth of new 
tissues. Some of the developed TE products and skin substitutes available are summarized 
in Table 7.1. Though these advanced dressings have great potential for treating chronic 
wounds and third degree burns, they are still limited by the high costs involved, the risk of 
infection carry over and antigenicity as well as having to create a second wound in the 
case of harvesting patient’s own cells to aid wound healing. These shortcomings in 
addition to the legal and ethical issues surrounding stem cell research have probably 
contributed to the slow adoption of these dressings in routine clinical practice [53]. 
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Table 7.1 Tissue engineered skin substitutes available commercially. 
7.5.1.2.6.1 Biocompatible polymers for wound dressings 
Dressings for wound healing can be produced using different materials, generally both 
natural and synthetic polymers. In this biomedical field, the use of biodegradable 
materials is preferred because skin substitutes should remain on the wound bed until the 
healing process is over, then they are resorbed without requiring the removal of the 
dressing, avoiding to traumas to the healing new tissue. In the last years, starting from 
natural or synthetic polymers, the production of biomimetic ECM micro/nanoscale fibers 
(80 nm–1.5 µm) through electrospinning process has been found to be effective for 
Dressing Type Major components Manufacturers 
IntegraTM Artificial skin Collagen/chondroitin-6 
sulphate matrix overlaid with a 
thin silicone sheet 
Integra LifeScience 
(Plainsborough, NJ) 
BiobraneTM Biosynthetic 
skin substitute 
Silicone, nylon mesh, collagen Dow Hickham/Berte 
Pharmaceuticals 
(Sugar Land, TX) 
AllodermTM Acellular 
dermal graft 
Normal human dermis with all 
the cellular material removed 
Lifecell Corporation 
(Branchberg, NJ) 
DermagraftT
M 
Dermal skin 
substitute 
Cultured human fibroblasts on 
a biodegradable polyglycolic 
acid or polyglactin mesh 
Advanced Tissue 
Sciences (LaJolla, CA) 
EpicelTM Epidermal skin 
substitute 
Cultured autologous human 
keratinocytes 
Genzyme Biosurgery 
(Cambridge, MA) 
MyskinTM Epidermal skin 
substitute 
Cultured autologous human 
keratinocytes on medical 
grade silicone polymer 
substrate 
Celltran Limited 
(University of 
Sheffield, Sheffield, 
UK) 
TranCyteTM Human 
fibroblast 
derived skin 
substitute 
(synthetic 
epidermis) 
Polyglycolic acid/polylactic 
acid, ECM proteins derived 
from allogenic human 
fibroblasts and collagen 
Advanced Tissue 
Sciences 
Hyalograft 
3-D TM 
Epidermal skin 
substitute 
Human fibroblasts on a laser-
microperforated membrane of 
benzyl hyaluronate 
Fidia Advanced 
Biopolymers (Padua, 
Italy) 
BioseedTM Epidermal skin 
substitute 
Fibrin sealant and cultured 
autologous human 
keratinocytes 
BioTissue 
Technologies 
(Freiburg, Germany) 
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wound healing [54, 55]. Natural macromolecules show a relatively low mechanical 
strength compared to synthetic polymers. By cross-linking or blending with synthetic 
polymers, the mechanical properties of natural polymers can be improved; however, their 
biocompatibility is somewhat affected. Modern bandage materials, such as electrospun 
nanofibrous polymeric bandages, hydrogels, porous scaffolds and foams are also used for 
active wound dressings by releasing local active principles such as antimicrobial and 
antiinflammatory drugs [56]. In Table 7.2 biodegradables materials, both of synthetic or 
natural origin, used in wound dressing application are reported. 
7.5.1.2.6.1.1 Natural polymers for wounds healing 
Natural polymers are widely used in the regenerative medicine field, for wounds and 
burns dressing because of their biocompatibility, biodegradability and similarity to the 
ECM [57]. Inducing and stimulating the wound healing process, natural polymers are 
involved in the repair of damaged tissues and consequently in skin regeneration [58]. For 
the regeneration of full-thickness wounds, polysaccharides and proteins are the most 
common natural polymers used.  
Polysaccharides are extensively used for the management of wounds and burns: neutral 
(i-e. glucans, dextrans, cellulose), acidic (alginic acid, hyaluronic acid), basic (chitin, 
chitosan) or sulfated polysaccharides (heparin, chondroitin, dermatan sulfate, keratan 
sulfate) [59]. Among dextrans, carboxymethyl benzylamide sulfonate dextran (CMDBS) is 
a soluble polymer structurally similar to GAG heparin which stimulates wound healing in 
various in vivo experimental models, controls the proliferation of S. aureus biofilm and 
affects proliferation and metabolism of endothelial cells [60]. Moreover, hydrated 
cyclodextrins are used for modern odor-control dressings because of their peculiar 
(bucket-shaped) conformation. Cellulose is used especially as healing scaffold/matrix for 
chronic wound dressings, reducing pain and shortening healing time. For partial and full 
thickness wounds, it stimulates the granulation and epithelialization process. Wound 
dressings with modified cellulose can incorporate by co-immobilization different active 
molecules such as enzymes, antioxidants, hormones, vitamins, antimicrobial drugs [61]. 
Biosynthesized in high amounts by Acetobacter xylinum (Acetobacteraceae), microbial 
cellulose (MC) is a biocompatible, biodegradable, antimicrobial, hypoallergenic and non-
toxic polymer which exhibits a great potential for wound dressings and tissue engineered 
skin due to its similarity with ECM [62-64]. MC is an innovative product, recommended as 
an alternative dressing for superficial partial thickness burn wounds [65, 66]. In a recent 
study, different composites were prepared through impregnation of MC sheets with 2% 
and 4% suspensions of montmorillonite (MMT), Na-MMT, Ca-MMT and Cu-MMT. 
Modified MMTs were obtained through cation exchange technique. MC–MMTs 
nanoreinforced composite films are novel wound dressing materials showing a powerful 
antibacterial effect against Escherichia coli and S. aureus and a potential therapeutic 
importance for wound healing and tissue regeneration [67]. Chitin is the most abundant 
natural amino polysaccharide (poly-N-acetyl-glucosamine) produced annually almost as 
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much as cellulose while CS is a poly N-acetyl-glucosaminoglycan obtained by alkaline 
deacetylation of chitin (see chapter 2). Different formulations of chitin and CS have been 
obtained: water-soluble chitin ointment as a wound healing assistant [68], 
microcrystalline partially deacetylated chitin hydrochloride as promising hemostatic 
material [69], bactericidal films based on chitin and silver nanoparticles for wound 
dressing applications [70], chitin hydrogel–nano zinc oxide composite bandage [71], 
bioactive chitin/CS hydrogel membranes and scaffolds cocultured with keratinocyte and 
fibroblast cells [72], films, sponges and hydrogels of microcrystalline CS with antimicrobial 
and wound-healing effects for wounds and burns [73], CS–gelatin sponge like/composite 
films for wound-healing dressing [74], ciprofloxacin loaded chitosan–gelatin composite 
films [75], CS gel formulation containing epidermal growth factor (EGF) for burn wound 
healing [76]. Alginates are linear unbranched polysaccharides which contain different 
amounts of (1→4’)-linked β-D-mannuronic acid and α-L-guluronic acid residues. Alginate-
based wound dressings are commonly used for their haemostatic properties in 
exudation/bleeding wounds and burns and for their high capacity to absorbe exudates as 
previously described in paragraph 7.5.1.2.2. Glycosaminoglycans (hyaluronic acid, heparin 
and chondroitin sulfate) are the most important components of ECM, essential to skin 
regeneration. According to the structure (polymer length, degree of sulfation), they 
modulate the attraction of skin precursor cells and their potential in TE for wounds and 
burns is well known [77]. Hyaluronic acid (HA) is a naturally occurring non-immunogenic 
linear polysaccharide made from N-acetyl-dglucosamine and glucuronic acid. It has 
remarkable effects in scar-free wound healing, supporting angiogenesis and neuritis out 
growth/repair [78]. HA and silver sulfadiazine-impregnated polyurethane foams have 
been used for wound dressing applications. After one week of foams application in 
experimental model, the wound size decreased around 77% at the rat skin level without 
inflammation [79]. Heparin-coated aligned nanofibers increase endothelial cell infiltration 
in three-dimensional structures and tissue remodeling in vitro and in vivo, in a full-
thickness dermal wound model [80]. 
Among the proteins, collagen and gelatin are widely used in skin TE. Collagen is the most 
abundant protein in the human body and the skin. It is produced by fibroblasts and 
stimulates the wound healing cellular and molecular cascade, development of new tissue 
and wound debridement. Collagen dressings are recommended for the treatment of 
partial and full-thickness wounds with minimal to moderate exudates. Different collagen 
dressings formulations have been developed for wounds and burns: collagen sponges in 
the healing of experimental deep skin wounds [81], collagen–GAG complex (Glycagen), 
collagen–minocycline based hydrogels potentially applicable for the treatment of 
cutaneous wound infections [82], denatured collagen microfiber scaffold seeded with 
human fibroblasts and keratinocytes for skin grafting [83], electrospun collagen 
nanofibrous scaffolds for wound repair [84]. Gelatin is administered in various 
formulations: crosslinked gelatin–alginate and gelatin–hyaluronate sponges with wound 
healing properties on the full-thickness dorsal skin defects of Wistar rat [85], EGF 
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containing gelatin based wound dressings in case of bulk loss of tissue or non-healing 
wounds such as burns, trauma, diabetic [86]. Keratin defines all intermediate filament-
forming proteins found in vertebrate epithelia and corneous tissues like horns, claws, 
hooves [87, 88]. Keratin derivatives are used for chronic wound dressing because of their 
interaction with the proteolytic wound environment facilitating the healing process. 
Novel keratin-based wound dressings with improved properties have been found to the 
release of antibiotics and GFs in a controlled manner [89]. Silk fibroin is widely used for 
wound dressings due to its unique properties such as biocompatibility, biodegradability, 
flexibility, adherence, absorption of exudates and minimal inflammatory reaction. 
Different types of dressing based on SF have been developed: CS blend three dimensional 
scaffolds for tissue regeneration [90], electrospun SF nanofibers with multiwalled carbon 
nanotubes for wound dressing [91, 92], SF–alginate-blended sponges/membranes with 
wound healing effect in full-thickness skin defect of rat [93]. 
7.5.1.2.6.1.2 Synthetic polymers for wound healing 
Synthetic polymers (composite nanobiomaterials with small pores, 2-3 µm diameter, and 
very high specific surface area) used for wounds and burns dressing are obtained by 
various techniques but mainly by electrospinning [54, 55]. Among the bioresorbable 
synthetic materials, PUs, aliphatic polyesters (PLGA, PLA, PGA, PCL), polyvinylpyrrolidone 
(PVP), polyvinyl alcohol (PVA) and polyethylene glycol (PEG) have been frequently used 
for wound healing applications [94, 95]. Some of these polymeric materials can overcome 
the problems typically associated with natural polymers as they can be synthesized and 
processed in a highly controlled way, thus leading to homogeneous materials that will 
present constant and reproducible chemical and physical properties [56]. PUs are 
synthesized by condensation and polymerization methods from a wide range of 
bifunctional or higher-order functional monomers. PUs can lead to hard, flexible or 
elastomeric materials and are also non-toxic, sterilizable, non-adherent and non-
allergenic [96]. They are frequently used in wound dressings because of their good barrier 
properties and oxygen permeability [97]. Research has reported that semi-permeable 
dressings, many of which are PUs, enhance wound healing [98]. Wound-dressing 
materials with antibacterial activity from electrospun PU-dextran nanofiber mats 
containing ciprofloxacin hydrochloride [99], novel absorptive and antibacterial PU 
membranes [100], PU foam combined with pH-sensitive alginate/bentonite hydrogel 
[101], fatty acid-based PU films [102] have been recently developed for wound dressing 
applications. Unnithan et al., prepared an antibacterial electrospun nanofibrous scaffolds 
by physically blending PU with two biopolymers such as cellulose acetate and zein. 
Desirable properties such as better hydrophilicity, excellent cell attachment, proliferation 
and blood clotting ability were obtained by combining PU with natural components [103]. 
Tegaderm™ (3M Medical) is an available polyurethane wound dressing. 
PLA, PGA and PLGA aliphatic polyesters have been extensively investigated because they 
demonstrate good toxicological safety and biodegradability [104]. These polymers when 
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degraded through hydrolysis of their ester bonds result in the formation of lactic and 
glycolic acids, which are safely metabolized into carbon dioxide and water in vivo. As 
such, they have been widely studied for wound dressing [105]. These polymers are 
administered in various formulations for wound dressing applications: curcumin-loaded 
PLA [106] and PLGA/collagen nanofibers [107], fusidic acid-loaded PLGA ultrafine fibres 
[108], collagen–PLLA composite material [109]. 
PCL has been studied for tissue regeneration and wound healing applications since it 
promotes a faster healing and reduced inflammatory infiltrate [110]. Extensive research 
had been conducted on its biocompatibility and efficacy, both in vitro and in vivo, 
resulting in FDA approval of a number of medical and drug delivery devices that are 
composed of PCL. At present, PCL is being regarded as a soft- and hard-tissue-compatible 
bioresorbable material [111] non-woven matrices from PCL homopolymers and poly-L-
lactide–ε-caprolactone [112], silicone-coated non-woven polyester dressing have been 
found to enhance re-epithelialization in a sheep model of dermal wounds [113]. 
PVA is a water-soluble synthetic polymer obtained from vinyl acetate by alcoholysis, 
hydrolysis or aminolysis. It has been applied in several advanced biomedical applications 
among which wound dressing [114] and wound management [115]. However, PVA 
exhibits some unfavorable mechanical properties (e.g. strength and flexibility), as well as 
a relatively poor thermal stability [116] which restrict its use alone as a wound dressing 
polymeric material. Blending PVA with natural polymers (polysaccharides or proteins) and 
some other synthetic polymers is attractive because of the abundance of such polymers, 
easy for chemical derivatization or modification, and in most cases good biocompatibility 
[117]. Different PVA dressings formulations have been developed for wounds and burns: 
PVA–gelatin esterified hydrogel membrane for wound dressing compatible with the L929 
fibroblast cell line and mice splenocytes [118], PVA–sodium carboxymethylcellulose 
membranes loaded with fucidic acid [119], novel porous cryo-foam for potential wound 
healing application starting from PVA and polyacrylic acid based hydrogels [120]. 
PEG is a hydrophilic, biocompatible, flexible, non-toxic and non-immunogenic polyether. 
PEG is widely used in various TE applications and applied as co-solvents, lubricants and 
stabilizers, bases in topical products, precipitants and crystallization agents for proteins, 
and as chemical agents for pegylation of proteins. PEG macromers have low toxicity, and 
can be coupled with peptides or GFs and placed in situ to fill irregular sites [121]. 
Ciprofloxacin hydrochloride loaded PEG/CS scaffold [122], PEG functionalized with low 
molecular weight heparin [123], PEG–protein conjugates was evaluated as an occlusive 
wound dressing material [124], PEG–gelatin based semi-interpenetrating networks [125] 
have been recently investigated for the development of wound dressings. Like PVA and 
PEG, PVP has been extensively used for a wide variety of pharmaceutical and biomedical 
applications (including wound dressings). This is mostly due to its water absorption and 
oxygen permeability properties  [126, 127]. Like the two above-described hydrophilic 
synthetic polymers (i.e. PVA and PEG), PVP is usually blended with other polymers (e.g. 
agar, cellulose or PEG) or cross-linked with carbodiimides in order to modify its solubility, 
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delivery and erosion profiles, mechanical properties, softness and elasticity [128]. PVP–
alginate hydrogel containing nanosilver [129], resveratrol in immobilization on PVP 
hydrogel dressing [130] have been developed for drug delivery and accelerating wound 
healing. 
Table 7.2 Most widely studied biodegradable materials for wound dressings with related 
properties and selected studies where they were used. 
 
 
Wound dressing 
material 
Characteristics Reference 
Natural   
Cellulose Polysaccharide, water-soluble, 
biodegradable by hydrolysis 
[59-65] 
Chitosan  Polysaccharide, enzymatically degradable, 
positively charged, good cell interactions 
[66-74] 
[143][145] 
Alginates Polysaccharide, enzymatically degradable, 
highly absorbent 
[32-35] [131] 
Hyaluronic acid Glycosaminoglycan, ECM component, 
enzymatically degradable, non 
immunogenic,  
[76, 77] 
Collagen ECM protein, enzimatically degradable, 
good cell interaction 
[79-82] 
[141][132] 
Gelatin  ECM protein, enzimatically degradable, 
good cell interaction 
[83, 84] 
Keratin Fibrous structural proteins, enzymatically 
degradable 
[85-87] 
Silk fibroin  Silk protein, enzimatically degradable [88-91] 
   
Synthetic   
Polyester urethane Elastomeric polymer, biodegradable [96-103] [140] 
Poly(L-lactic acid) Aliphatic polyester, very slowly 
biodegradable by hydrolysis 
[106, 
109][144] 
Poly(glycolic acid) Aliphatic polyester, biodegradable by 
hydrolysis 
 
Poly(lactic-co-glycolic 
acid) 
Copolymer of poly(L-lactic acid) and 
poly(glycolic acid), biodegradable by 
hydrolysis 
[107, 108] 
Poly(ε-caprolactone) Aliphatic polyester, biodegradable by 
hydrolysis 
[110-113] 
Polyvinyl alcohol Hydrophilic polymer obtained from vinyl 
acetate biodegradable by hydrolysis 
[114-120] 
[133] 
Poly(vinyl pyrrolidone) Hydrophilic polymer, water-soluble [128-130] 
Poly(ethylene glycol) Polyether, water soluble [122-130] 
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7.6 Medicated dressings for wound delivery 
Despite advances in the development of wound dressings, no single dressing is suitable 
for all types of wounds, and often, different types are needed during the healing of a 
single wound [134]. Current strategies for wound dressings have aimed at the 
development of the medicated dressings, which combines the use of pharmaceutical and 
bioactive agents and dressings used to deliver them. Topical pharmaceutical agents in the 
form of solutions, creams and ointments are generally applied to wound sites. For 
example, solutions such as thymol and hydrogen peroxide used commonly for cleansing 
and debridement, also possess antiseptic and antibacterial actions [135]. The new 
generation of medicated dressings incorporate new chemicals which have therapeutic 
value, and overcome some of the disadvantages associated with topical pharmaceutical 
agents such as short residence times on the wound area. The modern dressings used to 
deliver active agents (both therapeutic and GFs) to wounds include hydrocolloids, 
hydrogels, alginates, polyurethane foam/films and gels [136]. Incorporated drugs and 
proteins play an active role in the wound healing process either directly or indirectly as 
cleansing or debriding agents for removing necrotic tissue, antimicrobials which prevent 
or treat infection or growth factors to aid tissue regeneration.  
Moreover, the development of medicated dressing aims to prolong the action of active 
agents over time by allowing consistent and sustained release from a polymeric matrix 
without the need for frequent dressing change [137]. Drug release from polymeric 
dressings is generally controlled by: i) hydration of the polymer by fluids, ii) swelling to 
form a gel, iii) diffusion if drug through the swollen gel and iv) dissolution of the polymer 
[138-141]. Swelling, drug diffusion and dissolution kinetics are typical of hydrocolloids, 
alginates, hydrogels and PU. Upon contact of a dry dressing with a moist wound surface, 
wound exudates penetrates into the polymer matrix. This causes hydration and 
subsequent swelling of the dressing to form a gel over the wound surface [142]. In 
aqueous medium, the polymer also undergoes a relaxation process resulting in slow, 
dissolution of the hydrated polymer containing the drug [143]. Hydrolytic activity of 
enzymes present in the wound exudates [144] or from bacteria in the case of infected 
wounds [145] could also influence the mechanism of release of drug from polymeric 
dressings. Some of the commonly used active compounds and the dressings (and novel 
polymer systems) used to deliver them to wound sites are described below. 
7.6.1 Antimicrobials 
The purpose of applying antibiotics and other antibacterials is mainly to prevent or 
combat infections especially for diabetic foot ulcers [146] surgical and accident [147] 
wounds. In some cases, the delivery of certain antibiotics from paraffin based ointments 
such as bismuth subgallate are known to take active part in the wound healing process 
[148]. The delivery of antibiotics to local wound sites may be a preferred option to 
systemic administration since aims to: i) reduce the risk of systemic toxicity such as the 
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cumulative cell and organ toxicity of the aminoglycosides in the ears and kidneys [149, 
150], ii) provide tissue compatibility, low occurrence of bacterial resistance and reduced 
interference with wound healing [151] and iii) overcome the problem of ineffective 
systemic antibiotic therapy resulting from poor blood circulation at the extremities in 
diabetic foot ulcers.  
Common antibiotics incorporated into available dressings for delivery to wounds include 
dialkylcarbamoylchloride which is incorporated into Cutisorb® a highly absorbent cotton 
wool dressing, povidone-iodine used with fabric dressing and silver used with most of the 
modern dressings [152]. Other antibiotics delivered to wounds include gentamycin from 
collagen sponges [153], ofloxacin from silicone gel sheets [154] and minocycline from CS 
film dressings [155]. Some of the reported novel antimicrobial wound healing dressings 
reported include lactic acid based system for the delivery of ofloxacin and the inhibition 
of S. aureus and P. aeruginosa in split-thickness wounds in rats [156]. A CS-PU film 
dressing incorporating minocycline has also been developed for treating severe burn 
wounds [142]. Nanofibrous mats composed of PVA and poly(vinyl acetate) fibres loaded 
with ciprofloxacin HCl (CipHCl) have been also investigated for controlled drug release at 
targeted sites of injury [133]. 
The antimicrobial effects of silver are well established, and dressings designed to elute 
silver ions have been shown to be effective at reducing bacterial colonisation of wounds 
[157-159]. In particular silver dressings are extensively used in the management of burn 
wounds following surgical excision [160]. Several products incorporate silver for use as a 
topical antibacterial agent, such as silver nitrate, silver sulphadiazine (Flammazine™) 
[161], silver sulphadiazine/chlorhexidine (Silverex®,), and silver sulphadiazine-
impregnated lipidocolloid wound dressing Urgotul SSD® [159, 162]. Silver impregnated 
modern dressings available on the UK Drug Tariff include various forms such as fibrous 
hydrocolloid, PU foam film and silicone gels [152]. Moreover, newly developed products 
such as Acticoat™ and Silverlon® have a more controlled and prolonged release of 
nanocrystalline silver to the wound area. This mode of silver delivery allows the dressings 
to be changed with less frequency, thereby reducing risk of nosocomial infection, cost of 
care, further tissue damage and patient discomfort [163]. However, consideration of the 
cytotoxic effects of silver and silver-based products should be taken when deciding on 
dressings for specific wound care strategies. 
7.6.2 Growth factors 
GFs take a physiological role in the wound healing process because they are involved with 
cell division, migration, differentiation, protein expression and enzyme production. The 
wound healing properties of GFs are mediated through the stimulation of angiogenesis 
and cellular proliferation, which affects both the production and the degradation of the 
ECM and also plays a role in cell inflammation and migratory phases of wound healing 
[164]. A variety of GFs have been reported to participate in the process of wound healing 
including EGF, PDGF, fibroblast growth factor (FGF), TGF- β, IGF-1 and granulocyte-
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macrophage colony-stimulating factor (GM-CSF) [165]. Different formulation of dressings 
have been developed to topically administer some of the above GFs to wound sites. 
These include hydrogel dressings for delivering TGF- β1 [166], collagen film for delivering 
PDGF [132], alginate dressings in the form of beads used to deliver EGF [131] PU and 
collagen film dressings for delivery of EGF [167]. Morever, the combined use of 
antimicrobials and GFs has been found to significantly enhance wound healing compared 
with dressing containing only the antibiotic agents [168]. 
7.6.3 Supplements 
Other active compounds applied to enhance the wound healing process are vitamins (A, C 
and E) and curcumin [169]. The dressings employed for the delivery of vitamins and 
curcumin include oil based liquid emulsions, creams, ointments, gauze, hydrogels and 
sheets. 
Vitamin A is involved with epithelial cell differentiation [170], collagen synthesis and bone 
tissue development [171]. It has also been shown to facilitate normal physiological wound 
healing [172]. Vitamin C is an essential compound for the synthesis of collagen and other 
organic components of the intra cellular matrix of tissues such as bones,skin and other 
connective tissues [170]. It is also involved with normal responses to physiological 
stressors such as in accident and surgical trauma and the need for ascorbic acid increases 
during times of injury [173]. In addition, vitamin C aids in improving immune function 
particularly during infection [174]. Lazovic et al., have reported the application of collagen 
sheet dressings wetted with vitamin A and C solutions over burn wounds and showed 
significant improvements in the healing of wounds [175]. Vitamin E is an antioxidant and 
an intermediary in arachidonic acid and prostaglandin metabolism, which are important 
in inflammatory processes, including burns [176, 177] Vitamin E also promotes angiogenis 
and reduces scarring [178]. Aloe vera/vitamin E/ CS microparticles loaded into HA 
hydrogels have been used for the treatment of skin burns [179]. The release of vitamin E 
from the polymeric matrices allowed to make one oxidative interruption in the healing 
cascade thus leading to an improvement of the structural quality and a reduction in the 
time of healing compared to HA hydrogels alone [179]. Although the delivery of vitamins 
seems to promote wound healing, these compound are generally administerd orally to 
supplement body stores. 
Curcumin (diferuloylmethane) is a yellow crystalline compound and the active ingredient 
of turmeric, a traditional Asian spice. Curcumin has been reported as a promising wound 
healing agent both in normal and diabetic-impaired wounds when used topically [180]. 
Curcumin promotes wound healing by increasing granulation tissue and enhancing the 
biosynthesis of TGF-β1 and proteins in ECM [181, 182]. Also, it scavenges the free 
radicals, a major cause for the inflammation and inhibits the peroxide induced oxidative 
damage in human keratinocytes and fibroblasts [183]. Curcumin has potential antioxidant 
and anti-infective properties. However, there many drawbacks associated with curcumin 
administration such as its poor water solubility, photosensitivity and low stability [184]. 
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Hence, several strategies including nanoparticles [185, 186], micelles [187], hydrogels 
[188] and films [189], have been adopted to improve the water solubility as well as 
bioavailability of curcumin. Chereddy et al., investigated the combined activity of PLGA 
and curcumin on topical wound healing. The developed curcumin loaded PLGA 
nanoparticles were capable to control and maintain the release of the natural compound 
and lactic acid and significantly accelerated the wound closure by comprehensive healing 
which included down regulation of inflammatory responses, expedited re-epithelialization 
and improved granulation tissue formation [185]. 
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Chapter 8 
Porous CS based membranes with 
improved antimicrobial properties for 
the treatment of chelonian shell injuries 
 
Abstract 
Recently, much attention has been given to the use of CS in veterinary applications, as a 
wound healing agent, antimicrobial agent, bandage material, skin grafting template, 
hemostatic agent and drug delivery vehicle. In this chapter, CS crosslinked porous 
membranes with improved antimicrobial properties were prepared via freeze-drying 
technique to promote wound healing and to reduce the bacterial proliferation in 
chelonians after carapace injuries. Silver nanoparticles (AgNPs) and gentamicin sulphate 
(GS) were incorporated into the CS matrices to impart the proper antibacterial properties. 
CS based porous membranes were tested for their physicochemical, thermal, mechanical 
as well as swelling and degradation behavior at physiological condition. Additionally, GS 
release profile was investigated, showing a moderate burst effect in the first day followed 
by a decreasing release rate which was maintained for at least 56 days. Moreover, porous 
membranes loaded with GS or AgNPs showed good bactericidal activity against both of 
Gram+ and Gram- bacteria. Preliminary in vivo tests were carried out Testudo Hermanni 
showing the potential use of the developed antimicrobial membranes as an alternative to 
wet-to-dry conventional treatment. 
8.1 Introduction 
Shell trauma is one of the most common pathological conditions encountered in 
chelonians and it occurs with different seriousness degrees [1]. Carapace injuries arise 
mostly from dog bites, automobile and mower accidents, but can also result from falls [1]. 
Chelonians suffering shell trauma die following internal hemorrhage, organ damage and 
sepsis due to the recurring bacterial proliferation on the wound site. When a tortoise is 
injured, the first clinical step consists in classifying the trauma seriousness [1]. Shell 
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trauma may result in shell fractures with or without loss of bone tissue. In case of shell 
fracture without loss of bone tissue, closure of the fracture is usually enough to permit 
resolution of the wound while in case of severe fracture with loss of bone tissue, it is 
necessary to replace –at least temporarily- the tissue loss, as it will not regenerate 
spontaneously [2]. To treat chelonian carapace injuries, two clinical approaches are 
currently employed: i) the immediate closure of the shell by means of screws, plates and 
bone cements or epoxy resins [1, 3-7] or ii) the periodical direct medication of the wound 
through wet-to-dry bandages [1, 8], vacuum assisted closure (VAC) [9, 10], platelet-rich-
plasma (PRP) treatment [11, 12] or ointments [13, 14]. In the former, the external fixation 
by means of screws and bone plates is used when wound contamination and infection 
have been prevented and there is no loss of bone tissue [15, 16] while cements/ epoxy 
resins are applied to fill bone missing zone [6, 7, 14, 17]. However, epoxy resins may 
cause an excessive tissue heating due to the exothermic nature of the resin 
polymerization process, they may require potentially toxic solvents for their removal [18] 
and they may increase the risk of contaminations that  results in infection and sepsis 
[19],. In the latter treatment, turtle wound is left open in order to periodically disinfect 
and medicate it. Wet-to-dry bandages are generally used: the primary layer of gauzes is 
moist with sterile saline or dilute antiseptic solution and is allowed to dry out before its 
removal; however, dry gauzes are preferred in the presence of wound exudates and lets 
out necrotic tissue or debris [20]. However, there many drawbacks associated with 
bandages, such as the damage of healthy tissue, the presence of disperse bacteria and 
fibers in the wound bed after the removal of gauzes [10]. The use of VAC technology 
consists on the application of an open-cell foam over the wound, secured to the site with 
adhesive occlusive drape, to which a suction system is attached [9]. With a constant 
negative pressure of about 125 mmHg [1] fluids can be collected from the wound 
permitting the exudate and bacteria removal and granulation tissue formation [21]. 
Disadvantages include the initial price and the need of proper training to use the 
equipment. Moreover, VAC technology is unsuitable in the case of a gross infection, lack 
of wound haemostasis, unprotected vascular anastomoses, foam placement over vessels, 
the presence of necrotic tissue with scar, exposed organs and malignancy in the wound 
bed [22]. PRP is a platelet concentrate derived from blood centrifugation procedures [11] 
which locally delivers high amounts of GFs involved in haemostasis and cell proliferation 
(fibroblasts, osteoblasts, endothelial cells), promoting the wound healing process [23]. 
PRP gel must be applied onto the wound surface and is to be protected by a sterile gauze 
for 48 hours [12], working as a barrier against external microorganisms. Disadvantages of 
this technique include the need of an initial investment, the need of a proper training to 
use the equipment and the lack of a thorough understanding of the biologic interactions 
among PRP gel and the animal tissue. Among ointments, honey and sugar, petroleum 
impregnated gauzes, triple antibiotic ointment, GS cream and a variety of silver based 
products have been widely used in managing chelonian shell wound to prevent infection, 
maintain moisture, enhance healing, or facilitate debridement [14, 24]. Silver (Ag) is 
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known for its broad antibacterial spectrum; it can be used as ointment and cream (silver 
sulfadiazine) [8], or it can be loaded in matrices as nanoparticles for its controlled release 
[25, 26]. Unfortunately, even if it shows an high antimicrobial activity, Ag has a potential 
toxic effect at higher dosage [27]. On the contrary, honey and sugar are cheaper and 
effective against a wide variety of Gram+ and Gram- bacteria, explicating their action by 
hydrogen peroxide release [28, 29]. GS also exherts antibacterial effects against both 
Gram+ and Gram- bacteria [30] but it has a potential nephrotoxic effect depending on its 
concentrations [31].  
In this contest, skin TE could be a promising alternative approach to treat chelonian shell 
injuries. However, only few studies have been investigated in reptiles [14, 32]. During the 
wound healing process, the dressing protects the injury and it is supposed to improve 
dermal and epidermal tissue regeneration [33]. The implantation of biodegradable 
membranes can overcome the clinical approaches above described, since they completely 
cover the wound site, avoiding dirt and bacterial infiltration, and their removal is not 
required at the end of the treatment due to the material biodegradability [33]. Moreover, 
biodegradable membranes can be loaded using proper drugs acting as drug delivery 
systems to guarantee an antibiotic time and space controlled release [34]. The localized 
drug release achieved using biodegradable membranes guarantees lower antibiotic 
concentrations compared to systemic therapy due to the direct drug release in the wound 
site, thus assuming a lower toxicity. Alginates, hydrocolloids, hydrogels and foams are the 
most popular wound dressing in veterinary applications [20] Among the natural polymers, 
CS (alone or coupled with antimicrobial or antibiotic agents) has been widely used in 
wound management both in humans (see paragraph 7.5.1.2.6.1.1) and animals. CS 
stimulates the migration of PMNs and macrophages, explicating an anti-inflammatory 
effect and is a hemostatic effect, as described in chapter 7. 
In this study, CS based porous membranes with improved antimicrobial properties were 
developed to promote the wound healing process and to reduce the bacterial 
proliferation in chelonian shell injury site. To improve the mechanical properties and 
water stability of CS, DSP and GPTMS were used (see chapter 2). GS and AgNPs were 
loaded into the developed membranes to improve the antibacterial effect against Gram+ 
and Gram- bacteria and to guarantee drug controlled release in time and in space without 
exceeded the toxic dosage for systemic circulation. The obtained porous membranes 
were analyzed for their physicochemical and morphological properties by SEM and 
Energy Dispersive X-ray Spectrometry (EDS), their thermal properties by TGA and their 
mechanical properties were evaluated by tensile and compressive tests. Swelling and 
dissolution measurements were investigated in media simulating physiological conditions. 
GS release from CS porous membranes was evaluated by means of UV-VIS spectroscopy, 
whilst the AgNPs release was indirectly investigated from the antibacterial test results 
conducted in vitro against five different bacteria lineages: Staphylococcus Aureus (Gram+), 
Escherichia Coli (Gram-), Enterococcus Faecalis, Pseudomonas Aeruginosa and Proteus 
Mirabilis. 
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8.2 Experimental 
8.2.1 Materials 
CS (medium molecular weight, 75%-85% deacetylation degree), GPTMS, DSP, GS and 
AgNPs (<110 nm particle size) were supplied from Sigma Aldrich. All solvents used were of 
analytical grade and used without further purification. 
8.2.2 Methods 
CS was dissolved in acetic acid solution 0.5M to form a CS solution of 2.5% w/v. Four 
different typologies of CS based membranes were prepared according to the following 
procedures: 
i. CS/GPTMS_DSP were obtained by adding GPTMS and DSP to the CS solution, as 
described in paragraph 2.2.2. Briefly, GPTMS (50% w/w) was added to the CS solution 
and kept under magnetic stirring for about 1 hour. Afterward, DSP 1M solution (7.5 % 
v/v) was added dropwise to CS/GPTMS blend (one drop per second), maintained 
under stirring for about 10 minutes (CS/GPTMS_DSP). 
ii. CS/GPTMS_DSP_AgNPs samples were obtained by adding AgNPs to CS/GPTMS_DSP 
solution. Three different amounts of AgNPs respect to the total amount of CS were 
added: 5%, 10% and 15% w/w (CS/GPTMS_DSP_AgNPs5, CS/GPTMS_DSP_AgNPs10 
and CS/GPTMS_DSP_AgNPs15 respectively). Once AgNPs were incorporated, the 
solutions were kept under magnetic stirring till their homogeneity was reached. 
Then, CS/GPTMS_DSP and CS/GPTMS_DSP_AgNPs solutions were poured in multiwell (2 
ml in each well for compressive tests, 1 ml for the in vitro tests), 20 ml in circular Petri 
dishes (10 cm of diameter) to obtain 2 mm thickness membranes for in vivo test and 90 
ml in squared Petri dishes (12 x 12 cm) to obtain 5 mm thickness membranes for 
antibacterial tests. Once poured, samples were placed in a freezer at -20°C for 24 hours 
and then freeze-dried at -55°C for minimum 24h (48 hours for membranes with 5 mm 
thickness). 
iii. For the incorporation of the antibiotic agent, GS was dissolved in ultrapure water to 
obtain a solution with concentration of 3.5 mg/ml; then, the GS solution was poured 
dropwise onto the surface of CS/GPTMS_DSP porous membranes allowing its 
homogeneous absorption into the CS matrix. Finally, CS/GPTMS_DSP_GS samples 
were cooled down a second time at -20°C for 24 hours and then freeze-dried for 48 
hours depending on the thickness of membranes. 
8.2.3 Sample characterization 
8.2.3.1 Morphological characterization and element distribution 
The external surface and section morphology of CS/GPTMS_DSP, CS/GPTMS_DSP_AgNP5, 
CS/GPTMS_DSP_AgNP10, CS/GPTMS_DSP_AgNP15 and CS/GPTMS_DSP_GS porous 
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membranes was observed by SEM (SEM LEO – 1430, Zeiss). Using an energy dispersive 
spectrometer (EDS), qualitative compositional analysis was performed and punctual 
elemental composition of materials with high spatial resolution was accomplished. 
Samples were sputter coated with gold in a undervacuum chamber prior to SEM-EDS 
examination. 
8.2.3.2 Thermogravimetric analysis (TGA) 
Thermal degradation was measured using a TA INSTRUMENT Q500 equipment. The 
experiments were performed with a 10-15 mg sample in aluminum pans under a dynamic 
nitrogen atmosphere between 40°C and 800 C. The experiments were run at a scanning 
rate of 10°C/min and obtained results were analyzed using TA Universal Analysis 
software. 
8.2.3.3 Mechanical properties 
8.2.3.3.1 Tensile test 
Rectangular strips of 10X30 mm size were cut from each typology of membranes. Samples 
were tested in wet state because of the in vivo implantation procedure on chelonians 
requires to soak the membranes with sterile 0.9% NaCl solution before application (see 
paragraph 8.2.3.8). In addition, the release of exudates from wound site in time maintains 
the developed scaffold in a moist envirorment. Before testing in wet state, specimens 
were immersed in PBS (pH 7.4). Then, samples were strained to break at a constant 
crosshead speed of 2 mm/min. Using the associated software Test Works, stress-strain 
curves were obtained, in which the elastic modulus was calculated from the slope of the 
first linear portion. To measure the thickness of the strips, digital calibrator was used and 
thicknesses were employed for determining the stress value. Three specimens for each 
kind of material were tested. The result was expressed as an average value ± standard 
deviation. 
8.2.3.3.2 Compressive test 
The compressive mechanical properties were performed on wet porous cylindrical 
scaffolds using MTS QTest/10 device equipped with load cells of 50 N, respectively. 
Before testing in wet state, specimens were immersed in PBS (pH 7.4). All samples were 
compressed at a constant crosshead speed of 2 mm/min to approximately 80% of their 
original length. Four specimen for each kind of scaffolds were tested. Young’s modulus 
(E), collapse strength and strain (σ* and ε*, respectively) and collapse modulus (E*) were 
measured from the stress-strain curves. E is the slope of the linear elastic regime, E* is 
the slope of the collapse regime, σ* and ε* are respectively the stress and strain of 
transition from linear to collapse regime (determined from the intersection of E and E* 
regression lines). The resulted was expressed as an average value± standard deviation. 
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8.2.3.4 Water uptake and dissolution tests 
The water uptake and dissolution behavior of porous samples were evaluated by 
immerging the samples in PBS (pH 7.4) at 37°C. The water uptake degree was measured 
after 1, 3, 6, 9 and 24 hours while the dissolution degree was evaluated after 1, 3, 5, 7, 14, 
28 and 56 days. The water uptake percentage was calculated as: 
ΔWs (%) = (Ws-W0)/W0*100 
where W0 and WS are the sample weights before and after swelling respectively. The 
dissolution percentage was calculated as: 
ΔWd (%) = (W0-Wd)/W0*100 
where Wd is the dried sample weight after dissolution. The solution pH was measured at 
the same time intervals during the swelling and the dissolution tests, and its stable value 
at around 7 (physiological pH) was verified. For each experimental time, three samples 
were measured and the results were expressed as averages value ± standard deviation. 
8.2.3.5 Drug release evaluation 
GS release from CS/GPTMS_DSP_GS membranes was carried out by UV-VIS spectroscopy 
(CARY 500 SCAN UV-VIS-NIR Spectrophotometer). Samples were immersed in 5 ml of PBS 
at pH 7.4 and GS concentration in the incubation media was assayed after 1, 3, 6, 24 
hours and 2, 7, 14, 28, 56 days. The GS release concentration was reported as a 
percentage respect to the initial concentration and was calculated from the absorption 
values using the calibration curves that was prepared starting from GS solution of known 
concentrations. UV spectra were recorded in a range of 400-200 nm. Five measures for 
samples were used and the data were reported as mean value ± standard deviation. 
8.2.3.6 Antibacterial tests 
The antibacterial properties of membranes were tested against five pathogenic bacteria 
isolated from turtles wound infection: Staphylococcus aureus, Escherichia coli, 
Enterococcus faecalis, Pseudomonas aeruginosa and Proteus mirabilis. CS/GPTMS_DSP, 
CS/GPTMS_DSP and CS/GPTMS_DSP_AgNP10 samples (5 mm thickness) were prepared 
for antibacterial tests. Strains were stored in tryptone soy broth (TSB, Oxid, Milano) with 
20% glycerol at -80°C until needed. For experimental use, the stock cultures were grown 
on tryptone soy agar (TSA, Oxid) slants, then each strain 2-3 colonies was transferred to 
10 ml of TSB and incubated at 37°C for 18 hours to obtain early stationary phase cells. Cell 
cultures of each microorganism in stationary phase were diluted in TSB and incubated at 
37°C until an optical density of 0.2x105 colony-forming units (CFU/ml) at 600 nm was 
reached. Tubes with 10 ml of Mueller-Hinton broth (MHB, Oxid) were inoculated with 100 
µl of culture. Sample weighing 0.25 g were then cut into 1.5 cm2 pieces and added to each 
tube. The tubes were then incubated at 37 °C for 18 hours. Depending on the turbidity of 
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the tubes, serial dilutions with peptone water were made and plated in Petri dishes with 
15 mL of TSA culture medium. Colonies (CFU) were counted after incubation at 37 °C for 
18 hours. Three replicate plates were used per each dilution of broth.  
8.2.3.7 Preliminary in vivo tests 
The test was performed in collaboration with the Clinica per animali esotici in Rome, Italy. 
Testudo Hermanni chelonians were divided into two different groups consisting of 12 
animals each. The first group was treated with wet-to-dry gauzes (conventional 
treatment), while the second group with GS loaded CS based porous membranes. In 
detail, CS/GPTMS_DSP_GS porous membranes and gauzes were implanted in shell 
traumatized Testudo Hermanni after swab collection, wound lavage, debridement, and 
disinfection of the injury site.  
CS/GPTMS_DSP_ GS dry membranes were moisten with sterile 0.9% NaCl solution before 
their application. After CS/GPTMS_DSP implantation on the wound site, gauzes and 
adhesive tape were applied over the membranes to guarantee that they were pushed 
against the wound site. Depending on the extension of the wound site, more than one 
membrane or gauze could be used. On days 21, the gauzes and CS/GPTMS_DSP_GS were 
removed to evaluate the wound healing process and a new gauze or membrane loaded 
with the antibiotic agent was replaced in case of the formation of granulation tissue was 
not occurred. Follow up: 21 days. 
8.2.3.8 Statistics 
Experiments were repeated three times and results were expressed as an mean ± 
standard deviation. Statistical significance was calculated using analysis of variance 
(ANOVA). A comparison between two means was analyzed using Tukey's test with 
statistical significance level set at p<0.05. 
8.3 Results and discussion 
8.3.1 Morphological characterization and element distribution 
In Fig. 8.1 the surfaces and the fractured sections of CS/GPTMS_DSP membranes loaded 
with AgNPs are reported. The Petri-side surface showed a more compact structure as 
compared to the air-side surface due to the contact with the polystyrene substrate that 
probably induced a compression of the pores (data not shown). All porous scaffolds 
showed a typical foam-like morphology with highly interconnected pores on the sections. 
Mean pore dimensions of the fractured sections were 27.7±2.4 µm, 30±2.5 μm, 16±2.03 
μm and 13±2.9 μm for CS/GPTMS_DSP, CS/GPTMS_DSP_AgNP5, CS/GPTMS_DSP_AgNP10 
and CS/GPTMS_DSP_AgNP15 membranes. The pores showed a spherical shape and a 
decreasing size and density on the surface with increasing the initial AgNPs amount from 
5 to 15 wt.% (Fig. 8.1). 
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SEM images of fracture sections and surfaces of CS/GPTMS_DSP and GS loaded samples 
are reported in Fig. 8.2. Spherical, interconnected pores were observed both on the 
surface and on the section of CS/GPTMS_DSP_GS having a pore size dimension of 
26.7±1.2 μm. Microstructure remodelling of CS/GPTMS_DSP_GS surface occurred after 
the rehydration and re-lyophilization processes used for the GS loading treatment: new 
pores with higher size and formation of sheets on the surface (reducing the 
interconnectivity) compared to control samples were detected and were associated to 
the removal of ice crystals during the second freeze-drying step. SEM analysis also 
evidenced the deposition and homogeneous distribution of the antibiotic agent into the 
bulk of the scaffold (insert in Fig. 8.2D). 
Membrane pore size and its distribution are known to affect cell and nutrient 
permeability. It has been reported that highly open porous polymer matrices are required 
for high-density cell seeding, as well as sufficient nutrient and oxygen supply to the cells 
in the scaffold [35]. Pore sizes of 5-10 μm are favourable for vascularization whilst a 
multi-pore size membrane (212–250 μm, 250–300 μm, 355–500 μm) has been 
investigated to guarantee a better environment for cell proliferation, compared with the 
uniform-pore size scaffold [35]. On the basis of these considerations, 
CS/GPTMS_DSP_AgNP5, CS/GPTMS_DSP_AgNP10 and CS/GPTMS_DSP_GS could be ideal 
candidate materials for the production of porous membranes for wound healing in 
chelionians. However, a selection of the optimal dressing also requires an evaluation of 
the mechanical performance, the water uptake behaviour of porous samples.  
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Fig. 8.1. SEM micrographs of CS based membrane surfaces (A, C, E, G) and sections (B, D, F, H) 
after AgNPs addition: (A, B) CS/GPTMS_DSP; (C, D) CS/GPTMS_DSP_AgNP5; (E,F) 
CS/GPTMS_DSP_AgNP10; (G, H) CS/GPTMS_DSP_AgNP15. 
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Fig. 8.2. SEM micrographs of CS/GPTMS_DSP (A,B) and CS/GPTMS_DSP_GS (C, D) membrane 
surfaces (A, C) and sections (B, D). 
EDS analysis was performed on CS/GPTMS_DSP, CS/GPTMS_AgNP5, CS/GPTMS_AgNP10 
and CS/GPTMS_AgNP15 porous membranes to evaluate the distribution of AgNPs on the 
surfaces and sections of samples. Fig. 8.3 reports the EDS element-mapping on the 
sections and surfaces for control and AgNPs loaded CS/GPTMS_DSP samples, respectively. 
EDS spectra of AgNPs loaded samples showed the characteristic elements of CS (C and O) 
and peaks corresponding to Si, Na and P elements associated both to the presence of 
GPTMS and DSP crosslinkers (data not shown). The green spots corresponding to Ag 
element were uniformly dispersed both on the sections (Fig. 8.3B, C, D) and surfaces (Fig. 
8.3F, G, H) of CS/GPTMS_DSP_AgNPs5, CS/GPTMS_DSP_AgNPs10 and 
CS/GPTMS_DSP_AgNPs15 samples. The EDS mapping results suggested Ag homogeneous 
dispersion of Ag for all the analysed compositions. 
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Fig. 8.3. EDS spectra of sections (A, B, C, D) and surfaces (E, F, G, H) of CS based porous 
membrane: (A, E) CS/GPTMS_DSP; (B, F) CS/GPTMS_DSP_AgNP5; (C, G) CS/GPTMS_DSP_AgNP10; 
(D, H) CS/GPTMS_DSP_AgNP15. Scale bar: 200 µm. Green spots represented Ag element. 
8.3.2 Thermogravimetric analysis (TGA) 
To further explore the interaction between CS/GPTMS_DSP and both the antibacterial 
agents (AgNPs and GS), the prepared membranes were characterized by TGA from 40°C 
to 800 C. The typical DGA curves of AgNPs and GS loaded membranes are reported in Fig 
8.4 and 8.5, respectively. Both the thermal curves clearly exhibited two distinctive 
thermal decomposition patterns (Fig. 8.4 and Fig. 8.5): the first decomposition step 
started from about 90°C and continued to above 150 °C and the second weight loss was 
observed in the 180-550 °C. The initial thermal decomposition is mainly due to the 
evaporation of the water retained in the membranes and the second thermal 
decomposition is attributed to the decomposition (oxidative and thermal) of the base 
membrane matrix, CS, which was completely destroyed around at temperature 550 °C. In 
addition, specimens exhibited small shoulders at 375  C to 550 °C, which were associated 
with the thermal destruction of GPTMS and DSP used as crosslinkers (see paragraph 
2.3.6). 
As shown in Fig. 8.4, after the addition of AgNPs, the onset temperature for the water 
evaporation and thermal destruction of CS/GPTMS_DSP_AgNP5, CS/GPTMS_DSP_AgNP10 
and CS/GPTMS_DSP_AgNP15 membranes delayed slightly to higher temperatures, 
indicating the increase in water holding capacity and thermal stability, which is mainly 
due to the more heat stable metallic Ag [36] (Fig. 8.4). The residual percentages of weight 
of the CS/GPTMS_DSP, CS/GPTMS_AgNP5, CS/GPTMS_AgNP10 and CS/GPTMS_AgNP15 
were 48.3%, 58.4%, 56.5% and 57.2%, respectively. The high residuals of all samples are 
mainly due to the formation of inorganic compounds containing C, N and O. Similar multi-
degradation behavior of CS film was reported in the literature [37]. Additionally, the 
higher residual content of the AgNPs loaded CS/GPTMS_DSP membranes is also 
attributed to the Ag nanoparticles in the membranes. Table 8.1 collects the maximum 
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water evaporation temperature (Twe), the maximum degradation rate temperature (Td) of 
CS based samples and the corresponding weight losses. No differences were observed by 
increasing AgNPs amount from 5 to 15 wt. %. TGA analysis confirmed the improvement of 
the thermal stability of CS porous membranes after the addition of AgNPs. 
Fig 8.5 reports the DGA curve of control and CS/GPTMS_DSP_GS samples. The 
incorporation of GS into CS/GPTMS_DSP membranes did not affect the thermal behavior 
of samples. CS/GPTMS_DSP_GS showed a first thermal degradation at around 140 °C and 
a second stage, associated to the thermal and oxidative decomposition of CS and to the 
vaporization and elimination of volatile products, starting at 210 °C and reaching a 
maximum at 630 °C with a total weight loss of 43.7%. CS decomposition masked GS 
thermal degradation which is known to partially take place in the 200–500 C interval and 
to have a final oxidation between 500°C and 650 C [38]. 
 
Fig. 8.4. First derivative of TGA curves of CS/GPTMS_DSP, CS/GPTMS_DSP_AgNP5, 
CS/GPTMS_DSP_AgNP10 and CS/GPTMS_DSP_AgNP15 porous membranes. 
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Table 8.1 Maximum water evaporation temperature (Twe), maximum degradation rate 
temperature (Td) and corresponding and total weight loss for CS based samples. 
Sample Twe 
(°C) 
Twe Weight 
loss (%) 
Td 
(°C) 
Td Weight 
loss (%) 
Total weight 
loss (%) 
CS/GPTMS_DSP 87.0 10.2 273 41.5 51.7 
CS/GPTMS_DSP_AgNP5 137.8 6.0 291.8 35.6 41.6 
CS/GPTMS_DSP_AgNP10 138.6 6.5 291.8 36.9 43.5 
CS/GPTMS_DSP_AgNP15 138.9 5.8 292.0 37.0 42.8 
 
 
Fig. 8.5. First derivative of TGA curves of CS/GPTMS_DSP and CS/GPTMS_DSP_GS porous 
membranes. 
8.3.3 Mechanical properties 
Tensile and compressive tests were performed on wet state samples to mimic the 
physiological environment. Moreover, for the in vivo implantations on Testudo Hermanni 
cheloninans, membranes were soaked with 0.9 % NaCl solutions prior to implantation to 
have an increase in membranes flexibility resulting in a easy manipulation (see paragraph 
8.2.3.8). 
8.3.3.1 Tensile test 
Tensile tests were performed on CS/GPTMS_DSP, CS/GPTMS_AgNP5, 
CS/GPTMS_AgNP10, CS/GPTMS_AgNP15 and CS/GPTMS_DSP_GS porous membranes in 
wet conditions to determine the effect of the antibacterial agents on sample stiffness. All 
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samples had a uniform thickness of about 2 mm. CS based membranes samples showed 
an elasto-plastic behaviour; for all specimens, at low strains (lower than 10%) the stress 
increased linearly with an increase in the strain while for strains >10%, the stress 
increased slowly with increasing strain until failure occurred (data not shown).  
Addition of AgNPs resulted in a stiffer material confirming the reinforcing effect of the 
nanoparticles in the polymeric matrix, which is consistent with previously reported results 
[36, 39]. As can be seen from Table 8.2, the elastic modulus of the samples containing Ag 
nanoparticles differed significantly from the control (*p<0.05 for CS/GPTMS_DSP_AgNP5 
and CS/GPTMS_DSP_AgNP10; **p<0.01 for CS/GPTMS_DSP_AgNP15). With increasing 
content of AgNPs, the E increased to a value ranging from 0.400-0.460 MPa (for 
CS/GPTMS_DSP_AgNP5 and CS/GPTMS_DSP_AgNP10) to 1.834±0.693 MPa 
(CS/GPTMS_DSP_AgNP15). Moreover, E of membranes containing AgNPs 15 wt.% was 
significantly different from that of CS/GPTMS_DSP_AgNP5 and CS/GPTMS_DSP_AgNP10 
(*p<0.05 and **p<0.01 respectively). The increase stiffness of CS/GPTMS_DSP_AgNP15 
could be ascribed to the decrease of the degree of sample porosity and to the physical 
attraction between CS and AgNPs. 
A significant increase of E value was also observed for CS/GPTMS_DSP_GS samples 
compared to control (*p<0.05) obtaining a value of 1.180±0.560 MPa. This tensile results 
suggested that the incorporation of GS into CS/GPTMS_DSP could improve the tensile 
properties of CS based membrane and is probably associated to the morphological 
changes that occur following the second freeze-drying. 
Materials used to fabricate wound dressing are expected to possess mechanical flexibility 
to favour their surgical application and the in vivo permanence on the wound site. 
Furthermore, a  membrane able to mimic the behaviour of the natural skin tissue should 
possess a similar elastic modulus. In the literature, the Young's modulus of the skin, E, 
varies between 0.42 MPa and 0.85 MPa for torsion tests [40], 4.6 MPa and 20 MPa for 
tensile tests [41, 42] and between 0.05 MPa and 0.15 MPa for suction tests [43]. All the 
investigated samples had an E value in the range of 0.3-2.5 MPa comparable with the skin 
range value reported in the literature. 
Table 8.2. Elastic modulus calculated from the corresponding stress-strain curves of wet 
CS/GPTMS_DSP based samples (average value ± standard deviation). 
Sample Ewet (MPa) 
CS/GPTMS_DSP 0.085±0.010 
CS/GPTMS_DSP_AgNP5 0.405±0.185 
CS/GPTMS_DSP_AgNP10 0.397±4.14 
CS/GPTMS_DSP_AgNP15 1.834±0.693 
CS/GPTMS_DSP_GS 1.180±0.560 
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8.3.3.2 Compressive test 
Fig. 8.6 shows the compressive stress–strain curves for the AgNPs loaded CS/GPTMS_DPS 
porous scaffolds. CS/GPTMS_DSP containing Ag nanoparticles were characterized by a 
linear elastic regime at low deformations (elongation 0-10%) and a collapse regime at 
higher deformations (between 10- 20%). Samples did not reach final fracture and 
underwent densification. Data for wet CS/GPTMS_DSP specimens were not reported 
since load value reached were too low to be acquired by the equipment used. The 
addition of different amount of AgNPs showed an increase of the E and E* by obtaining 
values of about 0.030 MPa and 0.035 MPa for CS/GPTMS_DSP_AgNP5 and 
CS/GPTMS_DSP_AgNP10 to 0.070±0.012 MPa and 0.093±0.007 for CS/GPTMS_DSP based 
membranes containing the highest amount of silver nanoparticles (15 % wt./wt.), 
respectively. 
In addition, the stress and strain values of transition from linear to collapse regime (σ* 
and ε*) were observed for increased stress values (0.009±0.001 MPa for 
CS/GPTMS_DSP_AgNP5 to about 0.011 MPa for CS/GPTMS_DSP_AgNP10 and 
CS/GPTMS_DSP_AgNP15) and for increased elongations (from about 20 % for 
CS/GPTMS_DSP_AgNP5 and CS/GPTMS_DSP_AgNP10 to 12.848±2.640 for 
CS/GPTMS_AgNP15) in the case of the highest amount of AgNPs (15 wt. %) incorporated 
into porous membranes compared to 5 wt.% and 10 wt. % Ag nanoparticles addition 
(Table 8.3). The increase of E and E* values for CS/GPTMS_DSP_AgNP15 samples 
(statistical significant compared to CS/GPTMS_DSP_AgNP5 samples, *p<0.05) was a 
consequence of the mechanical reinforcement associated with the addition of Ag 
nanoparticles and of the decrease of sample porosity with increasing the amount of 
AgNPs. 
The characteristic stress-strain curve of soft and porous materials was also observed for 
CS/GPTMS_DSP_GS samples (data not shown). After the introduction of GS to 
CS/GPTMS_DSP, E, E*, σ* and ε* were comparable to CS/GPTMS_DSP_AgNP15 obtaining 
values of 0.088±0.038 MPa, 0.093±0.029 MPa, 0.010±0.000 MPa and 12.848±3.125, 
respectively (Table 8.3). The surface modification following the incorporation of GS into 
the CS based porous membranes seem to affect the mechanical properties of samples. 
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Fig. 8.6. Compression stress versus strain curves of CS/GPTMS_DSP_AgNP5, 
CS/GPTMS_DSP_AgNP10 and CS/GPTMS_DSP_AgNP15.  
Table 8.3 The elastic modulus (E), the collapse modulus (E*) and the collapse stress and strain (σ* 
and ɛ*, respectively) of CS and CS/GPTMS membranes. 
Sample E (MPa) E* (MPa) σ* (MPa) ɛ* (%) 
CS/GPTMS_DSP_AgNP5 0.032±0.007 0.034±0.005 0.009±0.001 23.720±3.548 
CS/GPTMS_DSP_AgNP10 0.030±0.023 0.040±0.021 0.011±0.001 19.300±9.957 
CS/GPTMS_DSP_AgNP15 0.070±0.012 0.093±0.007 0.011±0.000 12.848±2.640 
CS/GPTMS_DSP_GS 0.088±0.038 0.093±0.029 0.010±0.000 12.848±3.125 
8.3.4 Water uptake and dissolution tests 
Water uptake and dissolution degree of CS/GPTMS_DSP samples loaded with Ag 
nanoparticles and GS are shown in Fig 8.7 and Fig 8.8, respectively. 
Fig 8.7A reports the water uptake of CS/GPTMS_DSP, CS/GPTMS_DSP_AgNP5, 
CS/GPTMS_DSP_AgNP10 and CS/GPTMS_DSP_AgNP15. A comparison of the swelling 
percentage of AgNPs loaded samples to control revealed that the water uptake was 
similar for all samples at each time point. In addition, the incorporation of different 
amount of Ag nanoparticles into the porous membranes did not affect the water uptake 
behavior of samples. In detail, porous membranes increased considerably their weight 
immediately after 1 hour of immersion in PBS solution reaching values of water uptake of 
1219±19%, 1356±9, 1174±126% and 1150±193%, for CS/GPTMS_DSP, 
CS/GPTMS_DSP_AgNP5, CS/GPTMS_DSP_AgNP10 and CS/GPTMS_DSP_AgNP15 
respectively. Then, the swelling values remained stable till the end of the experiment. 
The dissolution profiles of AgNPs loaded CS based samples after 56 days of immersion in 
PBS are presented in Fig. 8.7B. CS/GPTMS_DSP, the CS/GPTMS_DSP_AgNP5, 
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CS/GPTMS_DSP_AgNP10 and the CS/GPTMS_DSP_AgNP15 membranes decreased their 
weight of 11.0±2.0 %, 9.9±3.5 %, 9.0±0.7% and 11.6±2.0 % after 1 day incubation in PBS, 
respectively. The initial high weight loss was associated to the release of salts into PBS 
solution, as described in paragraph 2.3.4. The weight loss values remained stable after 14 
days, then a moderately increase was measured after 28-56 days. Final dissolution values 
of 25.2±3.3% for CS/GPTMS_DSP, 21.8±1.3% for CS/GPTMS_DSP_AgNP5, 21.7±0.2% 
CS/GPTMS_DSP_AgNP10 and 22.5±0.8% for CS/GPTMS_DSP_AgNP15 were reached after 
56 days incubation in PBS. Compared to the control membranes, the addition of AgNPs 
slightly enhanced the stability in aqueous media of CS/GPTMS_DSP for long incubation 
time period in PBS (28 and 56 days). No significant differences were observed between all 
samples at each time point. 
The water uptake of porous membranes was measured to examine the changes of 
properties of CS/GPTMS_DSP in the absence and presence of GS. As shown in Fig 8.8A, 
the water uptake of samples without GS was increased faster than that of the 
CS/GPTMS_DSP_GP. The swelling degree of GS loaded CS/GPTMS_DPS reached values of 
863±205% after 1 hours incubation in PBS and a slightly increase was observed till 24 
hours of immersion in physiological solution (973±165%). Significant differences were 
observed between control and CS/GPTMS_DSP_GS at the first two time points of 
experiment (*p< 0.05). The lower water absorption behavior of CS based samples 
containing GS could be associated to the microstructure remodelling of the surface that 
occurs after the loading of the antibiotic agent. Fig. 8.8B shows the percentage weight 
loss of the CS/GPTMS_DSP and CS/GPTMS_DSP_GS membranes. The weight loss of 
membranes containing the antibiotic decreased of 11.4±0.8 % after 1 day in PBS and 
maintained stable till 5 days, showing comparable values to the control. After this time 
point, the dissolution degree increased from 14.6±1.4% (7 days in PBS) to 22.1±0.0% (28 
days in PBS). Moreover, weight loss of membranes containing GS showed significant 
differences compared to CS/GPTMS_DSP at days 14 (***p<0.001) and was attributed 
both to the degradation of CS and to the GS release from the polymer matrix. On the 
contrary, after 56 the sample containing GS was decreased to about 20% of its own 
weight, meanwhile, the control was decreased approximately to 25% (*p<0.05). 
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Fig. 8.7 Water uptake (A) and dissolution degree (B) of CS/GPTMS_DSP, CS/GPTMS_DSP_AgNP5, 
CS/GPTMS_DSP_AgNP10 and CS/GPTMS_DSP_AgNP15 porous membranes in PBS as a function of 
time. Column heights correspond to the mean values. Bars indicate standard deviations (n = 3). 
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Fig. 8.8 Water uptake (A) and dissolution degree (B) of CS/GPTMS_DSP and CS/GPTMS_DSP_GS 
porous membranes in PBS as a function of time. Column heights correspond to the mean values. 
Bars indicate standard deviations (n = 3).*p< 0.05, ***p<0.001. 
8.3.5 Drug release evaluation 
The GS release from CS/GPTMS_DSP porous membranes was evaluated in vitro 
quantifying the amount of GS in the collected medium. Figure 8.9 shows the cumulative 
release after 1, 3, 6 and 24 hours and at 2, 5, 7, 14, 28 and 56 days. An initial burst in 
release was observed at 24 hours (about 70% with respect to the GS loaded into the 
membranes) followed by a moderate release over the subsequent days (around 0.55% 
each day). During the first 24 hours the release could be mainly due to a diffusive 
mechanism and then, in the following days, the CS/GPTMS_DSP_GS degradation allowed 
the release of a constant and moderate amount of GS. 
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The delivery of antibiotics to local wound sites through the membranes may be a 
preferred option to systemic administration since (i) reduce the risk of systemic toxicity 
such as the cumulative cell and organ toxicity of the aminoglycosides in the ears and 
kidneys [44, 45], (ii) provide tissue compatibility and low occurrence of bacterial 
resistance [46] and (iii) overcome the problem of ineffective systemic antibiotic therapy 
resulting from poor blood circulation. In this specific field for the treatment of chelonian 
shell traumas, the high initial GS release could enhance the antimicrobial effect, reducing 
the bacterial population on the wound site since from the first day after implantation. 
 
Fig. 8.9. GS release after 1, 3, 6, 24 hours and 2, 5, 7, 14 , 28 and 56 days. The curve reports the 
percentage cumulative release values normalized respect to the initial amount of the GS 
incorporated within the CS/GPTMS_DSP_GS porous membranes. Markers correspond to the 
mean values. Bars indicate standard deviations (n = 3) 
8.3.6 Antibacterial tests 
In order to convict the effect of GS and AgNPs on both Gram- (S. Aureus, P. aeruginosa 
and P. mirabilis) and Gram+ (E. Coli, E. faecalis) bacteria, time-killing assay was performed 
on CS/GPTMS_DSP, CS/GPTMS_DSP_GS and CS/GPTMS_DSP_AgNP10 by measuring the 
reduction of the number of CFU recovered at 18 hours. CS/GPTMS_DSP_AgNP10 samples 
was selected as optimized scaffolds. Fig 8.10 shows the qualitative antibacterial efficacy 
exerted by the three membranes on S. Aureus. The results of the antibacterial screening 
of the tested scaffolds are presented in Fig. 8.11. The AgNPs impregnated CS membranes 
showed a bactericidal effect on all bacteria: growth of S. Aureus, E. Coli, E. Fecalis, P. 
aeruginosa and P. mirabilis was reduced by logarithmic orders of 3.4, 1.5, 1.8, 2.3 and 1.6, 
respectively relative to the control. GS loaded CS/GPTMS_DSP membranes revealed total 
bactericidal activity against E. coli, S. aureus and E. fecalis but they were unable to inhibit 
bacterial propagation in case of P. aeruginosa strain as compared to CS/GPTMS_DSP. P. 
mirabilis was reduced by logarithmic orders 1.27 respect to the control, showing results 
comparable to that obtained by CS/GPTMS_DSP_AgNP10. The most effective sample 
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against E. coli, S. aureus and E. fecalis strains was the one impregnated with GS, while the 
highest antibacterial activity against P. aeruginosa was found for membranes containing 
Ag nanoparticles. The simultaneous loading of two agents (GS and AgNPs) on CS 
membranes shows to improve the antibacterial effect against a broad spectrum of strains 
reducing the risk of infections that can consequently compromise the healing process. 
 
Fig. 8.10. S. Aureus growth in contact with control (A), CS/GPTMS_DSP_GS (B) and 
CS/GPTMS_DSP_AgNP10 (C) membranes without MHB dilutions. 
 
Fig. 8.11 Kinetics of growth inhibition of S. Aureus, E. Coli, E. Fecalis, P. aeruginosa and P. mirabilis 
in presence CS/GPTMS_DSP, CS/GPTMS_DSP_GS and CS/GPTMS_DSP_AgNP10. 
8.3.7 Preliminary in vivo tests 
To estimate the wound healing effect of the CS/GPTMS_DSP_GS for the treatment of 
carapace injuries in chelonians, GS loaded porous membranes and wet-to-dry gauzes 
(conventional treatment) were implanted in shell traumatized Testudo Hermanni after 
swab collection, wound lavage, debridement, and disinfection of the injury site. Each 
wound was observed for a period of 21 days post-operation. On day 21, 33% of the total 
wounds treated with the CS/GPTMS_DSP_GS was healed, whereas, 22% and 45% 
evidenced the implant failure and chelonian death, respectively. In addition, all 
chelonians treated with gauze dressing died, showing the potential use of the developed 
antimicrobial membranes as an alternative to wet-to-dry conventional treatments. 
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8.4 Conclusion 
In this chapter, biodegradable wound dressings based on CS porous membranes with 
improved antimicrobial activities were developed to treat chelonian shell injuries. CS 
membranes containing different ratios of AgNPs (5, 10 and 15% wt./wt.) or GS were 
obtained by freeze-drying technique. Mechanical characterization was performed on 
samples showing that the incorporation of AgNPs or GS enhanced the stiffness of 
CS/GPTMS_DSP samples. Moreover, a strict correlation was observed between the Young 
modulus and the amount of AgNPs incorporated into the membranes: E increased as the 
AgNPs concentration shifted from 5% wt. to 15 wt.%. The high swelling degree, which is 
one of the important factor for reducing the risk of wound dehydration, was observed for 
all antimicrobial agent loaded samples reaching final values of about 1200-1300% and 
950% for AgNPs and GS loaded membranes after 24 hours of incubation in physiological 
solution, respectively. However, the incorporation of the antimicrobial agents into 
CS/GPTMS_DSP affected the surface morphologies of porous membranes: i) pore 
occlusion on the surface of CS based membranes containing AgNPs was detected 
increasing the amount of AgNPs. For this reason, CS/GPTMS_DSP_AgNP10 was selected 
as ideal candidate for this application field; ii) new pores with higher size and formation of 
sheets on the surface (reducing the interconnectivity) were formed following rehydration 
and re-lyophilization processes used for the GS loading treatment. GS release profile from 
CS/GPTMS_DSP_GS demonstrated high burst release of the antibiotics in the first 24 
hours (about 70% with respect to the GS loaded into the membranes), followed by 
gradual release at a decreasing rate over time. 
Finally, the investigation focused on the GS and AgNPs (10% wt./wt.) effect on bacterial 
inhibition, shows that the presence of either AgNPs or GS improved the antimicrobial 
activity of CS based porous membranes. GS loaded samples were highly efficient against 
E. coli, S. aureus and E. fecalis strains while CS/GPTMS_DSP_AgNP10 increased the 
inhibitory effect against P. aeruginosa and P. mirabilis bacteria compared to control and 
GS loaded samples. From preliminary in vivo results, 33% of Testudo Hermanni treated 
with of CS/GPTMS_DSP_GS healed confirming the potential use of GS loaded membranes 
for the treatment in chelonian shell injuries. Future works will be addressed to develop 
composite membranes based on CS impregnated with both AgNPs and antibiotics GS with 
the aim to improve the antibacterial activity against a broad spectrum of strains. 
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Chapter 9 
Final discussion and conclusions 
 
9.1 General discussion  
 
Tissue engineering (TE) is defined by Laurencin et al. as the application of biological, 
chemical, and engineering principles to the repair, restoration, or regeneration of living 
tissues by using biomaterials, cells, and factors alone or in combination [1]. It involves the 
fundamental understanding of structure–function relationships in normal and 
pathological tissues and the development of biological substitutes that promote tissue 
repair and/or functional restoration. In this therapeutic approach, biomaterials, usually in 
the form of 3 dimensional frameworks, play multiple significant roles to provide structural 
maintenance of the defect shape and serve as temporary extracellular matrix (ECM) for 
cell adhesion, proliferation, differentiation, and maturation. After some advances and 
relatively successful clinical applications for hard tissues over the past decade[2], much of 
the effort is now being directed at soft tissue reconstruction. Engineering two-
dimensional (2D) soft tissues (e.g. cornea [3] and skin [4, 5]), and complex three-
dimensional (3D) tissues (e.g. cardiac [6] and neural [7]) is a far more challenging task.  
Among the various biomaterials, polysaccharides have recently gained interest as 
materials for scaffold fabrication, since their carbohydrate moieties interact with or are 
integral component of several matrix glycoproteins and cell adhesion molecules [8]. 
Chitosan (CS), a copolymer of glucosamine and N-acetyl-glucosamine, is obtained by 
alkaline deacetylation of chitin, which is the main component of the exoskeleton of 
crustaceans, such as shrimps [9]. CS has been widely investigated in TE because it exhibits 
unique and appealing biological properties in terms of biocompatibility, biodegradability, 
non-toxicity, antimicrobial, haemostatic, antitumoral and anticholesteremic activities [10-
15]. Moreover, due to the cationic nature of CS molecules and the abundant functional 
amine and hydroxyl groups on its backbone, CS can be easily processed into various forms 
(gels, sponges, membranes, beads and scaffolds) [16-19] and physically or chemically 
modified for the delivery of bioactive molecules and drugs [20]. These properties, find 
several biomedical applications in soft tissue engineering (i.e. cartilage [21, 22], liver [23, 
24] and nerve [25, 26]), wound healing [4, 5, 27] and as excipients for drug delivery [16-
18, 28, 29]. For most medical application, CS has been crosslinked in order to improve its 
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mechanical strength and maintain a predefined shape of the implant under physiological 
conditions. Commonly used chemical crosslinkers in literature include epoxy compounds 
[30], aldehydes (formaldehyde, glyceraldehyde and glutaraldehyde) [31, 32] and 
carbodiimides [33]. They all exhibit a certain degree of cytotoxicity and may therefore 
impair biocompatibility of CS scaffolds. For this reason, increasing interest has been 
recently gained by less cytotoxic crosslinking agents such as enzymes [34] or naturally 
derived crosslinking agents, having a lower toxicity [35-38]. The effect of crosslinking 
strongly influences the in vivo performance of the scaffolds in terms of mechanical 
properties, degradation, water stability and cellular response and can be optimized to 
obtain the desired properties required in different biomedical applications. A detailed 
investigation of the influence of different crosslinkers on the features of the final CS 
membrane is fundamental to select the proper methods to crosslink CS to satisfy specific 
biological and surgical requirements.  
 
In this work CS based compact films were crosslinked using different compounds with 
the aim to provide the basis for the selection of a crosslinking strategy able to impart the 
required properties to CS membranes in the design of biomaterial constructs for human 
and veterinary application in soft TE (Chapter 2). Three non cytotoxic and widely used 
compounds were selected: genipin (GP), γ-glycidoxypropyltrimethoxysilane (GPTMS), 
dibasic sodium phosphate (DSP) and a combination of GPTMS and DSP (GPTMS_DSP). CS 
crosslinked flat membranes were prepared via solvent casting following the addition of 
the different crosslinking agents. From the preliminary characterization, it was found that 
CS samples crosslinked with chemical compounds (CS/GP, CS/GPTMS, CS/GPTMS_DSP) 
contributed to improve mechanical strenght and stability in phisiological conditions 
compared to uncrosslinked and ionic crosslinked CS (CS/DSP). On the other hand, DSP 
addition increased the hydrophilicity, the water uptake and the flexibility of CS samples. 
By combining GPTMS with DSP allowed intermediate physic-chemical, mechanical and 
swelling behaviour were observed with respect to the single use of chemical or ionic 
compounds.  
The obtained results provided the basis for choosing the proper crosslinking method for 
the development of different typologies of CS scaffolds in i) human peripheral nerve 
regeneration and ii) animal wound healing applications. 
i) Peripheral nerve regeneration in human 
Peripheral nerve regeneration is a challenging task in neurosurgery with relevant clinical 
and socioeconomic implications since nerve injuries may lead to a lifelong function 
impairment and pain that may seriously compromise the quality of life [39]. The repair of 
peripheral nerve lesions has been attempted in many different ways, which have in 
common the goal of directing the regenerating nerve fibres into the proper distal 
endoneurial tubes. Coaptation of the two nerve ends is commonly used to repair short 
nerve defects [40]. When larger nerve gaps exist (20 mm or longer in humans), the 
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current clinical gold standard for repairing larger nerve deficits involves using nerve 
autografts. However, autografts are plagued by issues such as a shortage of donor nerves, 
a mismatch of donor nerve size with the recipient site, and occurrences of neuroma 
formation; and even in the best-case scenarios, complete recovery of function is rare [41, 
42]. Thus, bioengineering strategies are currently focused on developing devices (nerve 
guide channels, NGCs) that provide an appropriate microenvironment to support and 
enhance the regeneration process. Advances in engineered NGCs are directed to the 
mimicking of the properties of natural tissues using multifunctional materials and/or 
conduits that can solve the limitations associated with traditional surgical approaches 
(short gap length, lay regeneration time, possible neuroma formation). Among the 
various biomaterials investigated, CS potential use in peripheral nerve regeneration has 
been demonstrated both in vitro and in vivo [43, 44]. Moreover, amino groups of CS 
chains have been found to regulate the adhesion and proliferation of glial cells and the 
differentiation of neural stem cells (NSCs) [45]. 
In this thesis work, biocompatible and degradable CS membranes were prepared 
through different fabrication techniques and parameters were optimized to promote 
peripheral nerve regeneration. On the basis of the results of the previous part, two 
crosslinkers were selected (DSP and GPTMS). Two alternative for CS based hollow NGCs 
and a nanostructured internal filler were developed. 
The two NGC developed are characterized by innovative features in terms of possibility to 
wrap the membranes during surgery allowing to adapt the NGC dimensions to the patient 
and to reduce the adhesion of fibrotic tissue to the external part of the conduit that can 
compromise the nerve regeneration process. 
i. CS flat membranes were developed with the aim to obtain a final device that can be 
easily manipulated and rolled up to obtain flexible NGCs adaptable to the size of the 
trunked nerves. CS flat scaffolds were crosslinked using DSP alone (CS/DSP) or 
combined with GPTMS (CS/GPTMS_DSP) (Chapter 4). The constituent ratio of 
crosslinking agents and CS was selected in the first part of the thesis to obtain a 
composite material having both proper mechanical properties and good 
biocompatibility. CS/DSP and CS/GPTMS_DSP flat membranes were obtained by 
solvent casting and they could be easily wrapped to form a NGC. The developed 
membranes showed a good permeability to small molecules, such as glucose and 
salts, guaranteeing the exchange of nutrients across the tube wall. In vitro 
characterization performed on model membranes showed that CS/DSP and 
CS/GPTMS_DSP material extracts did not exert any cytotoxic effects on Schwann–
like cells (RT4_D6P2T). Cell adhesion, proliferation, and function were evaluated 
and confirmed on CS/GPTMS_DSP samples because they showed higher mechanical 
stability under physiological conditions and they were considered as “the worst 
case” (biomaterials employed for CS/GPTMS_DSP fabrication were the same of 
CS/DSP supplemented with GPTM). Moreover, CS/GPTMS_DSP showed to direct 
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RT4-D6P2T attachment resulting in characteristic cell morphology typical of SCs and 
to support the neurite outgrowth of dorsal root ganglia (DRG) cultured on this 
substrate. Finally, in vivo tests were carried out on both the two types of nerve 
scaffolds due to their biocompatibility, easy manipulation and suturability. 
Membranes were used for bridge implantation across 10-mm long median nerve 
defects in rats, and the outcomes of peripheral nerve repair were evaluated. During 
in vivo tests CS/GPTMS_DSP tubes were detached from the distal suturing site and 
functional recovery did not occurred at 12 weeks post-operative as also confirmed 
by histological investigation. On the contrary, crushed nerve encircled with CS/DSP 
membranes, allowed nerve fibre regeneration and functional recovery, with effects 
approaching those elicited by autografts which are considered as the “gold 
standard” for treating large peripheral nerve defects (20 mm in humans). 
CS/DSP_GPTMS conduits revealed a low adhesion of fibrous tissue on the external 
part compared to CS/DSP. 
ii. Bi-layer CS membranes were developed by combining two kinds of CS flat 
membranes crosslinked with different compounds (optimized in Chapter 4) to 
produce scaffolds with high capability to promote nerve regeneration (inner layer) 
and to reduce the risk of collapse under compression during axonal outgrowth on 
the (outer layer) (Chapter 5). Bi-layer membranes were fabricated by a two-step 
coating technique and were composed of a CS/DSP inner layer and a 
CS/GPTMS_DSP outer layer. For the development of the external side, the amount 
of GPTMS was decreased from 50% to 25% wt./wt. compared to flat membranes 
previously prepared (Chapter 4) in order to limit compositional differences between 
the inner and outer layer and to achieve a tight connection of the final device. The 
bi-layer samples showed an adequate mechanical behaviour both in terms of 
elongation at break and resistance, properties imparted by the CS/DSP internal side 
and CS/GPTMS25_DSP external side , respectively. The bi-layer device was easily 
manipulated and wrapped to form a cylindrical conduit under physiological 
condition after immersion in aqueous solutions for 2-3 minutes . Gradual and 
controlled permeation to small molecules was observed. Finally, preliminary in vivo 
tests were carried out on the bi-layers flat membranes for bridge implantation 
across 10-mm long median nerve defects in rats. After 12 weeks post-operative, 
nerves treated with bi-layer tubes displayed regenerated and aligned fibers at the 
injury site with no fibrous capsule formation at the external site. 
iii. An internal filler based on CS electrospun nanofibres were prepared from 0.5 M 
acetic acid solutions in the form of non-woven nanofibrous matrices with high 
specific surface areas and relatively small pores. The electrospun matrices formed a 
three-dimensional microenvironment for cell attachment and growth mimicking the 
ECM structure. In peripheral nerve TE, nanofibres with average diameter around 
100-200 nm have been reported to be advantageous for glial cell adhesion and 
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proliferation as compared to fibres characterized by a diameter of 700 nm [46, 47]. 
Polyethylene oxide (PEO) and dimethylsulphoxide (DMSO) were added to the CS 
solution to allow CS solution spinnability at high polymer concentration (5% 
wt./vol.). Optimization of the process and solution parameters allowed to obtain CS 
nanofibres with size of 128±17 nm. Crosslinked nanofibres with improved 
mechanical and physiological stability were obtained for the first time. DSP was 
selected as nanofibres crosslinker and it was added to the CS optimized solution 
before fibre spinning. As observed by morphological analysis, DSP crosslinking did 
not modify the fibre structure as compared to the uncrosslinked CS nanofibres and 
DSP crosslinked CS nanofibres showed a slightly decrease in fibre dimension 
(109±17 nm). Moreover, DSP enhanced the mechanical strength (E, from 63±10 
MPa to 113±8 MPa) and the structural integrity under physiological condition of CS 
nanofibres. 
ii) Wound healing in veterinary application 
Recently, much attention has been given to CS in veterinary applications, as a wound 
healing agent, antimicrobial agent, bandage material, skin grafting template, hemostatic 
agent and drug delivery vehicle. In this thesis work, due to the similarity of animal wound 
healing process with humans, CS was selected to obtain porous membranes with 
improved antimicrobial activity for the treatment of chelonian shell injuries (Chapter 8). 
The bioengineered membrane has the function of protecting the wound site from 
contamination and it may be produced in order to stimulate the rapid complete 
regeneration of the injured tissue and healing of the wound. Moreover, bioengineered 
membranes should be able to : ii) absorb exudates and toxic components from the wound 
surface; ii) maintain a high humidity at the wound/dressing interface in order to avoid 
dessication and to promote re-epithelialization and cellular migration, iii) be 
biodegradable, avoiding to periodically remove the device causing trauma to the wound 
and iv) allow the local drug delivery of bioactive molecules or antibiotics. Among the 
natural polymers, CS (alone or coupled with antimicrobial or antibiotic agents) has been 
widely used in wound management both in humans and animals [48]. CS have been found 
to enhance the function of antinflammatory cells such as polymorphonuclear leukocytes 
(PMN) and macrophages and to promote the formation of granulation tissue [49]. 
According to the recent literature, the development of skin dressings based on CS for the 
treatment of chelonian shell injuries seem to be the ideal substitute to conventional 
veterinary approaches (i.e. epoxy resins [50-55], wet-to-dry bandages [50, 56], vacuum 
assisted closure (VAC) [57, 58], platelet-rich-plasma (PRP) treatment [59, 60] or ointments 
[61, 62]) which have all several associated drawbacks.  
For this purpose, CS porous membranes with improved antimicrobial properties were 
prepared by the freeze-drying technique to promote the wound healing process and to 
reduce the bacterial proliferation in chelonian shell injury. To increase CS mechanical 
properties and its biocompatibility, GPTMS and DSP crosslinkers were added to the CS 
213 
 
solution (CS/GPTMS_DSP). The constituent ratio of crosslinking agents and CS was 
selected in the first part of the thesis (Chapter 2). Moreover, to impart the desired 
antibacterial properties to the developed membranes, different ratios of silver 
nanoparticles (AgNPs, 5%, 10% and 15% wt./wt. respect to the total amount of CS) and 
gentamicin sulphate (GS, 3.5 mg/ml dosage selected according to the conventional 
veterinary treatment for chelonian carapace healing) were incorporated into the CS 
matrices. The application of dressing materials based on natural products with 
antimicrobial properties limits the systemic use of antibiotics whose side-effects often 
result in wrong action or even damage to the patient’s kidney and liver, and also 
decreasing the bacterial proliferation at the wound site [63, 64]. Mechanical 
characterization performed on samples showed that the incorporation of AgNPs or GS 
enhanced the stiffness of CS/GPTMS_DSP samples. High swelling degree, which is one of 
the important factor for reducing the risk of wound dehydration, was observed for all 
antimicrobial agent loaded samples. From the morphological characterization AgNP 
optimal concentration was selected (10% wt./wt.): total pore occlusion on the surface of 
CS based membranes containing the maximum amount of AgNP incorporated. GS release 
was successfully released from CS/GPTMS_DSP loaded with the antibiotics. Finally, the 
investigation focused on the GS and AgNPs (10 % wt.wt, optimized concentration) effects 
on bacterial inhibition: the presence of either AgNPs or GS improved the antimicrobial 
activity of CS based porous membranes against Gram+ and Gram- bacteria. From 
preliminary in vivo tests, it was found that GS loaded membranes contributed to enhance 
wound healing in chelonians compared to wet-to-dry bandages. 
9.2 Conclusion and future developments 
In conclusion, CS based bioartificial constructs showing promising chemico-physical, 
mechanical and biological properties were developed for soft TE engineering both in 
human and veterinary applications. The easy processability of CS allowed to obtain 
different structures by selecting the proper crosslinking and fabrication methods.  
 
Innovative CS based biomedical devices for peripheral nerve repair developed and 
characterized for their in vitro and in vivo response showing promising results in terms of 
biocompatibility and functional recovery. The dip-coating rotating mandrel technique has 
been preliminary investigated for the obtainment of pre-shaped guides with a diameter 
depending on the mandrel size. The use of pre-shaped devices could reduce the time of 
surgery and the risks of surgical mistakes compared to nerve guide membranes, however, 
adaptability of the device to the nerve size is often required (Fig. 9.1). 
Concerning the CS based internal filler, encouraging preliminary in vitro results were 
obtained in collaboration with the Neuroscience University Cavaliere Ottolenghi (Torino, 
Italy) confirming the ability of cells to adhere and proliferate on CS nanofibrous matrices 
(Fig. 9.2). 
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The developed NGCs (CS/DSP or bi-layer samples) and the prepared internal filler (CS 
nanofibrous matrix) will be finally combined to solve the limitations associated with the 
use of hollow conduits (short gap length, long regeneration time, neuroma formation). 
The incorporation of aligned nanofibres into NGCs has been found to induce Schwann cell 
alignment resulting in oriented axonal growth while preventing neuroma formation in the 
peripheral nerve injury [65]. Further in vivo analysis using rats will be fundamental to 
analyze the influence of different strategies (materials, structure, topological features, 
haptotatic cues and chemotactic stimuli) for the regeneration process. 
 
CS porous membranes with improved antimicrobial properties showed inhibitory effects 
against five different bacterial strains. GS loaded samples were found to totally exert their 
antibacterial activity against E. coli, S. aureus and E. fecalis bacteria, while AgNP loaded 
membranes showed slight inhibitory effect against all Gram+ and Gram- strains. By the 
obtained results, the combined incorporation of both GS and AgNPs into the developed 
porous membranes could improve the antimicrobial activity against a broad spectrum of 
strains and, as a consequence, it could reduce bacterial proliferation during wound 
healing in chelonians. After a preliminary in vitro characterization samples, GS and AgNPs 
samples will be tests for their antibacterial activity . 
 
Fig. 9.1. Qualitative image of CS/DSP cylindrical conduits prepared by the dip-coating rotating 
mandrel technique. 
 
Fig. 9.2. Fluorescent imaging of RT4-D6P2T on control and CS nanofibrous matrices after 1,3, 5 
and 7 days in vitro (DIV). 4'-6-Diamidino-2-phenylindole (DAPI), α- vinculin and α-actin staining of 
proliferating cells on CS nanofibrous matrix and on positive control. 
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